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channel (Ascher and Nowak, 1988), these findings suggest that the M2 re-entrant
loop constitutes to the ion channel lining the pore of the receptor.
NMDA Receptor Structure-
Transmembrane Topology
Figure 1. NMDA Receptor Structure and Transmembrane Topology.
The structure resembles that of the nicotinic acetylcholine receptor, but it has three
transmembrane loops and M2 is a cytoplasm facing re-entrant loop. The N-terminus is
extracellular while the C-terminus is intracellular.
The phosphorylation domain of the receptor is the C-terminus of the different
subunits found intracellularly. The C-terminus of NR1 is phosphorylated in primary
cultures and in transfected HEK 293 cells (Tingley et ah, 1993). The NR2 subunits
are directly phosphorylated on the C-terminus by protein kinases for example PKC
(Figure 4, Table 3). Protein kinases and their sites of phosphorylation on the various
subunits will be discussed in detail in section 1C and IF. Another important feature
of the C-termini of the different subunits is that they bind to cytoskeletal proteins and
neurofilaments regulating synaptic localization of the receptor. The CI exon of the
NR1 N-terminus binds alpha actinin (Wyszynszki et al., 1997). This interaction is
antagonized by calcium calmodulin (Ca2+/CaM). Alpha actinin also selectively binds
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ACC Anterior cingulate cortex
ACPD 1 -amino-cyclopentane-1,3 -dicarboxylic acid
AIDA 1 -aminoindan-1,5 -dicarboxylic acid
ALS Amyotrophic lateral sclerosis
AMPA a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid
AP-4 2-amino 4 phosphobutyric acid
AP-5 2-amino 5-phosphonopentanoic acid





2_|_ .CaMKII Ca -calmodulin-dependent protein kinase II
CaMKIV Ca2+-calmodulin-dependent protein kinase IV
cAMP Cyclic adenosyl monophosphate
Cdk5 Cyclin-dependent kinase 5
CIPP Channel-interacting PDZ protein




DIV Day in vitro
Dig Product of the Drosophila lethal(l)disclarge-l tumor
suppressor gene
El Embryonic day 1
ECso Efficient concentration for half-maximum response
EGLU alpha-ethylglutamic acid
ERK Extracellular signal-related kinase
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fMRI Functional magnetic resonance imaging
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Engineering Mutations into the Mouse NR2B Gene of the NMDA Receptor
iV-methyl-D-aspartate (NMDA) receptors are glutamate gated ion channels and
essential for forms of synaptic plasticity, learning and memory formation. The
developmental expression patterns ofNMDA receptor subunits suggest that they are
important in early postnatal life and therefore it is not surprising that mice lacking
NR1 and NR2B subunits die shortly after birth. The C-terminal domain of NR2B
subunits is not necessary for channel function, but binds proteins involved in signal
transduction. Since mice expressing the C-terminal truncated form of the NR2B
subunit also die at birth, this suggests the importance of the C-terminal domain in the
signalling pathways.
The C-terminus of the NR2B subunit is 616 in length and the terminal valine residue
is essential for binding the PDZ domains of postsynaptic density protein-95 (PSD-
95). PSD-95 is essential for plasticity and learning and is an adaptor for other
signalling proteins such as synaptic Ras GTPase (SynGAP) and neuronal nitric
oxidase synthase (nNOS). Knockin mice were created, which lack the terminal valine
residue of NR2B in order to disrupt the connection between the NR2B and the
downstream signalling components. Although much is needed to be done to properly
characterise this mutant, we made a very important step forward to understand how
molecular interactions within the C-terminal domain of the NR2B subunit affect the
function of the NMDA receptor by generating viable mutants.
I also created a mutation in the calcium- and calmodulin-dependent protein kinase II
(CaMKII) binding site of NR2B, which eliminates a different signalling pathway,
and finally, deleted the COOH-exon of the NR2B subunit and replaced it by that of
the NR2A, which experiment shows the importance of the interactions via the NR2B
cytoplasmic tail. The analysis of the mutant mice can provide precise insight into the




1A General introduction to glutamate receptors
A brief history of synapses and the discovery of glutamate
Human kind's constant fascination with the perfection and imperfection of the brain
has led to extensive research, through the trials and errors of which we uncover more
and more details up till today.
A major milestone in the history of neuroscience was when Golgi developed the
silver impregnation method and was able to visualize the individual units in the
brain. Prior to that, the general belief was that the brain is a glandular organ and that
the nerves are like the veins, carrying fluid to the periphery. With Golgi's method the
cell body and its two types of processes, the dendrites and the axon could be shown,
proving that the brain is a well-organised structure of distinct cells rather than a
syncytium. The work of Golgi and later Ramon y Cajal in the 19th century led to the
neuron doctrine, which stated that the brain is composed of individual signalling
elements, the neurons and that they communicate via specialized points of
interaction.
With the development of anatomy, neurophysiology and pharmacology more and
more details of the function of the brain were available, that turned the interest
towards behavioural studies. One of the most interesting theories of the late 19th
century was that of Franz Joseph Gall. He believed that the cerebral cortex had 35
regions, each of which corresponded to certain mental functions and behaviours, in
that way building up one's personality. He had regions for hope, spirituality as well
as destructiveness, which corresponded to fairly large areas. In contrast areas for
perception, such as visualising colour or for learning certain tasks, such as language,
calculation or order were relatively small. He stated however, that by differential
usage of certain areas, they increased in size differentially, resulting in protrusions,
which could be visualized as bumps on the skull. Since then many different theories
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have emerged, some opposing, some favouring his view, nevertheless the basic idea
is correct, the brain is organised into different regions built up of individual neurons.
These individual neurons are the signalling units of the brain and they are connected
to each other in a precise order, communicate with each other via specialized points
of interaction and certain groups of neurons in different brain regions mediate
different functions of the brain and are involved in certain behavioural patterns.
The term synapse was introduced by Charles Sherrington used for those specialized
points of interaction between neurons, that were histological described by Ramon y
Cajal. During the 1920's, 1930's debate arose whether the means of transmission
was electrical or chemical. The first molecule shown to be an example of the latter
was acetylcholine, mediating synaptic transmission from the vagal nerve to the heart.
In the 1950's with the improvement of physiological techniques both were shown to
exist. The differences between the structure of the electrical and chemical synapses
were visualized using the electron microscope. Electrical synapses can be found in
nerve cells, smooth muscle and the heart. Transmission is ionic current mediated, it
can be bi-directional and is rapid. The cytoplasm of the pre- and postsynaptic cells is
connected via ion channels at the site of interaction, the gap junction. Their distance
is only 3.5 nanometers. Chemical synapses are more common in the brain.
Transmission is chemical messenger mediated, it is unidirectional and can be
excitatory or inhibitory. At chemical synapses the neurons are separated by a cleft,
which is 30-50 nanometers.
In the brain the predominant form of synaptic transmission is chemical. Information
from the presynaptic neuron is transmitted onto the postsynaptic cell via chemical
messengers, where a receptor is activated. The activated receptor then can directly
gate an ion channel, activate the production of a second messenger. There are certain
criteria that a second messenger has to meet in order to be called a transmitter. They
have to be synthesized in the neuron and there is a specific mechanism, which
removes them from the site of action. They have to be present in the presynaptic
neurons and be released in amounts, which are sufficient to induce activation of the
postsynaptic cell. Finally exogenous application of the transmitter has to exert the
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same effects as the endogenous messenger. The first molecules recognised to meet
these criteria were acetylcholine and norepinephrine described in the 1930's. Since
then more have been identified and classified into two groups, small-molecule
transmitters (acetylcholine, amines such as dopamine or norepinephrine or amino
acids) and neuroactive peptides (certain hormones and peptides).
Glutamate, aspartate or homocysteine belong to the group of small-molecule
transmitters and they can be found in the central nervous system in high
concentrations. They are involved in excitatory synaptic transmission and activate
the group of glutamate receptors. Glutamate seems to be the most important of these
having been researched during the past sixty years. In the 1940's it was claimed that
it could improve the condition of mentally impaired patients. In the 1950's it was
shown that glutamate caused convulsions (Hayashi, 1952; Hayashi, 1954) and was
proposed to be a central synaptic transmitter. Later it was proven to be an excitatory
transmitter (Curtis et al., 1959). Since then various receptor subtypes have been
discovered and characterised in detail, which are activated by glutamate. It activates
cation-selective channels, thereby mediating fast excitatory neurotransmission.
According to rough estimations 50% of all central nervous system synapses and
about 90% of all excitatory synapses are mediated by glutamate. In the next section
the different ionotropic receptors will be classified and characterised before
discussing aspects of the iV-methyl-D-aspartate receptor in great detail.
Ionotropic glutamate receptors
Glutamate receptors provide for synaptic plasticity, learning and memory. They
mediate the toxicity of excess glutamate release from cells in pathological conditions
like stroke. All known ionotropic glutamate receptors belong to the same gene
family. They are categorized into three groups, high affinity a-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) or low affinity kainate receptors, high
affinity kainate receptors and A'-methyl-D-aspartate (NMDA) receptors (Wisden and
Seeburg, 1993).
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The high affinity AMPA or low affinity kainate receptor type of the ionotropic
glutamate receptors is a ligand-gated ion channel localized postsynaptically. Its main
agonists are L-glutamate and AMPA. It mediates fast excitatory synaptic
transmission and contributes to LTP (Kakegawa et al., 2004; Kakegawa and Yuzaki,
2005; Sun et al., 2005; Oh et al., 2006) and LTD (Steinberg et al., 2004; Moult et al.,
2006) in various brain regions.
Postsynaptic AMPA receptors are located to the plasma membrane or are
internalized into intracellular pools thereby regulating synaptic strength (Carroll et
al., 2001; Malinow and Malenka, 2002). Receptor internalization occurs during LTD
via clathrin-mediated endocytosis upon which the receptors are stabilized by AMPA
interacting proteins such as GRIP (Dong et al., 1999). Cell surface delivery of the
receptors occurs during LTP (increased synaptic strength) by exocytosis as a result of
NMDA receptor activation (Liao et al., 2001; Park et al., 2004).
AMPA receptors are heteromeric consisting of GluRl-4 or A-D subunits and have a
tetrameric structure (Mansour et al., 2001; Brorson et al., 2004). They exist in two
splice variants, flip and flop, which correspond to two different amino acid
sequences preceding TM4 (Sommer et al., 1990). This sequence difference
determines the distinct kinetic properties of the two splice variants (Sommer et al.,
1990). The GluR-B subunit is present in nearly all AMPA receptors and it influences
properties of the ion flow. In the second membrane domain (M2) a site referred to as
Q/R site has been identified. The GluR-B pre-mRNA can be edited at this site
(Higuchi et al., 1993; Puchalski et al., 1994). The unedited, glutamine-containing
2"b • • • * * * 2"b
(Q607) form is Ca permeable, the edited, arginine-containing (R607) is Ca
impermeable. Ca2+ permeability of the channel is increased, LTP is enhanced, and
motor coordination is reduced in the GluR-B knock-out mutants (Jia et al., 1996;
Gerlai et al., 1998). GluR-B, GluR-C and GluR-D subunits are also edited at the
secondary R/G site influencing the channel kinetics (Lomeli et al., 1994).
High affinity kainate receptors are another type of ionotropic, ligand-gated receptor
channels. The main agonist is L-glutamate, others are kainite and domoate
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(Bleakman, 1999). AMPA and 4 methyl glutamate are GluR5- and GluR6-specific
agonists respectively (Bleakman, 1999). Kainate receptors are localized both pre-
and postsynaptically (Jaskolski et al., 2005). Postsynaptic receptors are stabilized by
protein interactions with PDZ-containing molecules such as PSD-95, SAP-97 or
SAP-102 (Garcia et al., 1998). Kainate receptors are involved in fast excitatory
synaptic transmission and in nociception (Ruscheweyh and Sandkuhler et al., 2002).
They induce NMDA receptor-independent mossy-fibre LTP (Bortolotto et al., 1999;
Bortolotto et al., 2005) and their involvement was implicated in induction of LTD
(Park et al., 2006).
The subunits are divided into two subgroups corresponding to two separate gene
families, the high affinity KA-1 and KA-2, and the low affinity GluR-5, GluR-6 and
GluR-7 subunits. The 5-1 and 5-2 subunits are most related to the first group, but do
not function in vitro (orphans). The receptor is tetrameric in structure. GluR-5, GluR-
6 and GluR-7 can, KA subunits cannot form functional homomeric receptors in vitro
(Wisden and Seeburg, 1993). Homomeric GluR-5 receptors resemble native kainate
receptors in dorsal root ganglia cells and can be gated by AMPA. Homomeric GluR-
6 cannot be gated by AMPA. KA-2/GluR-6 heteromeric receptors are sensitive to
AMPA (Herb et al., 1992; Wisden and Seeburg, 1993).
GluR-5 and GluR-6 subunits are edited at the Q/R site, which is located before the
third transmembrane domain (Sommer et al., 1991). Ca2+ permeability is reduced in
the edited form, which is more abundant in the adult animals. GluR-6 subunits can
also be edited at two sites located to the first transmembrane domain (I/V editing at
position 567 and Y/C editing at position 571), which also influences Ca
permeability (Kohler et al., 1993).
NMDA receptors are the third type of ligand gated-ion channels. L-glutamate and
NMDA are agonists, glycine is coagonist (Wisden and Seeburg, 1993) (Table 1).
They are localized postsynaptically interacting with PSD-95 via PDZ-domain
interactions (Find in detail in section IBand 1C.), but there is evidence of presynaptic
presence as well (Liu et al., 1994; Bardoni et al., 2004).
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NMDA receptors are heteromeric comprising of two NR1 and two NR2A, NR2B,
NR2C or NR2D subunits in vivo, however many previous studies demonstrated
different stoichiometry (Find in detail in section IB.). This heteromeric structure is
the most efficient assembly upon activation of which, the highest increase in current
can be observed. The NR1 and NR2 subunits are only 18% homologous in their
polypeptide sequence. In the second membrane domain (M2) an asparagine residue
is present homologous to the Q/R site in AMPA receptors, which mediates Ca2+
permeability (Burnashev et al., 1992). The glycine binding site is located to the NR1
subunit extracellular 1 domain (Kuryatov et ah, 1994), while the glutamate binding
site is located to the NR2 subunits (Find in detail in section IB.). The NR2 subunits
bear a large (-600 amino acids compared to 50-100 in other ionotropic glutamate
receptors) cytoplasmic tail via which they interact with downstream signalling
molecules (Find in detail in section 1C.).
NMDA receptors are activated by NMDA and glutamate, but not activated by
AMPA and kainite. They mediate excitatory synaptic transmission and are involved
in some forms of learning and memory formation. They are important in
excitotoxicity (overexcitation of neurons caused by excessive glutamate release
resulting in cell-death) (Choi et ah, 1988), numerous neurological and psychiatric
conditions and neuropathic pain. The NMDA receptor is a "coincidence detector",
• .... 9+
for channel opening a simultaneous postsynaptic (depolarization removing the Mg
block) and presynaptic activity (glutamate release) is required. In the next sections
the subunit composition, ion channel properties and signalling functions of the
NMDA receptor will be described in greater detail.
IB NMDA receptor channel
Subunit characterization
The A-methyl-D-aspartate (NMDA) receptors are heteromeric ligand gated ion
channels localized mostly to the postsynaptic site, but there is evidence of
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presynaptic presence (Liu et al., 1994; Bardoni et al., 2004). NMDA receptors are
derived from at least seven known genes. One encodes the NR1 subunit, the
variability of which arises from alternative splicing, which results in eight different
functional forms. Alternative splicing occurs via insertion or deletion of three exons,
the N1 in the N-terminal and the CI and C2 in the C-terminal domain (Hollmann et
al., 1993). Other genes provide for the NR2 subunit diversity, encoding for NR2A-D
forms. Recently NR3A-B subunits have also been reported (Sucher et al., 1995;
Andersson et al., 2001; Nishi et al., 2001; Bendel et al., 2005).
The coassembly of the distinct NR1 splice variants with the particular NR2A-D
subunits is required for functional NMDA receptors. The developmental (NR1 and
NR2B embryonic and postnatal, NR2A and NR2C postnatal, NR2D embryonic
expression) and regional distribution (NR1 all through the brain, NR2A forebrain
and basal ganglia, NR2B forebrain, NR2C cerebellum, NR2D thalamus and
subthalamus) of these subunits results in various receptor types (Monyer et al., 1992;
Monyer et al., 1994; Standaert et al., 1996; Weiss et al., 1998), which have distinct
electrophysiological and pharmacological properties. Modulation by zinc, inhibition
by proton and stimulation by polyamines is attenuated by the presence of the N1
exon of the NR1 subunit (Hollmann et al., 1993; Durand et al., 1993). The CI exon
of the NR1 subunit mediates binding to alpha actinin (Wyszynszki et al., 1997)
regulating synaptic localization. The C2 exon contains an "endoplasmatic reticulum
signal" preventing cell surface delivery of homomeric NR1 subunits (Okabe et al.,
1999; Scott etal.,2001).
The primary structure of the NMDA receptor subunits was proposed based on the
cDNA sequence. The NR1 subunit was cloned from rat cDNA library by expression
cloning (Moriyoshi et al., 1991), the NR2A-D subunits by PCR and cross
hybridisation (Ikeda et al., 1992; Kutsuwada et al., 1992; Meguro et al., 1992;
Monyer et al., 1992; Ishii et al., 1993). All subunits contain an extracellular N-
terminal domain, four hydrophobic membrane domains (Ml-4) and a C-terminal
domain. The size of the different subunits varies with NR1 being the smallest
consisting of 920 amino acids (103 kDa), then NR2C containing 1218 or 1220 amino
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acids (133 or 134 kDa), NR2D containing 1296 amino acids (144 kDa), NR2A with
1445 amino acids (163 kDa) and NR2B with 1456 amino acids (163 kDa). The
various NR2 subunits are very similar, showing considerable (40-50%) homology
while there is only about 18% similarity between the NR1 and the NR2 subunits.
However comparing the C-termini of the NR2 subunits, the homology is only about
30% suggesting that the functional differences arise from the variability of this
domain.
The transmembrane topology (Figure 1) based on the cDNA sequence (Moriyoshi et
ah, 1991) suggested a similar structure to that of the nicotinic acethylcholine
receptor. With the N-terminus being extracellular and having four hydrophobic,
possibly transmembrane domains (Ml-4), the C-terminus was thought to be
extracellular as well. However phosphopeptide mapping revealed that the NR1
subunit is phosphorylated in vivo (Tingley et ah, 1993) and interactions of the C-
termini of the different NR2 subunits with various intracellular molecules were also
described. Glycosylation sites of the N-terminal domain were identified as well
(Hollmann et ah, 1994). These findings suggested that a three transmembrane model
theory is more accurate according to which there are four hydrophobic regions, but
M2 is a cytoplasm facing re-entrant loop and only Ml, 3 and 4 are transmembrane
(Figure 1). The N-terminus is extracellular, while the C-terminus is intracellular. The
region between M3 and M4 is extracellular as well (Sullivan et ah, 1994). The
various domains of the NMDA receptor subunits will be described next.
The channel pore domain is responsible for determining channel properties, ion flux,
and permeability. In the M2 region of NR1 and NR2 subunits there is an asparagine
residue, homologous to the Q/R site in AMPA receptors, which plays a role in the
2+ •
Ca permeability of the channel. In the NR2B subunit it is in position 589. Mutation
of this asparagine to glutamine removes the voltage dependent Mg2+ block and alters
the permeability to divalent cations (Burnashev et ah, 1992). Mutating a tryptophan
residue (W607L) in the NR2 M2 region also abolished Mg2+ block (Williams et ah,
1998) indicating the importance of other residues apart from the asparagines'. Since
2"b
Mg binds to a site in the ionophore that causes voltage-dependent block of the
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channel (Ascher and Nowak, 1988), these findings suggest that the M2 re-entrant
loop constitutes to the ion channel lining the pore of the receptor.
NMDA Receptor Structure-
Transmembrane Topology
Figure 1. NMDA Receptor Structure and Transmembrane Topology.
The structure resembles that of the nicotinic acetylcholine receptor, but it has three
transmembrane loops and M2 is a cytoplasm facing re-entrant loop. The N-terminus is
extracellular while the C-terminus is intracellular.
The phosphorylation domain of the receptor is the C-terminus of the different
subunits found intracellularly. The C-terminus of NR1 is phosphorylated in primary
cultures and in transfected HEK 293 cells (Tingley et ah, 1993). The NR2 subunits
are directly phosphorylated on the C-terminus by protein kinases for example PKC
(Figure 4, Table 3). Protein kinases and their sites of phosphorylation on the various
subunits will be discussed in detail in section 1C and IF. Another important feature
of the C-termini of the different subunits is that they bind to cytoskeletal proteins and
neurofilaments regulating synaptic localization of the receptor. The CI exon of the
NR1 N-terminus binds alpha actinin (Wyszynszki et al., 1997). This interaction is
• 94- •
antagonized by calcium calmodulin (Ca /CaM). Alpha actinin also selectively binds
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NR2B amongst the NR2 subunit types (Wyszynszki et al., 1997). NR1 further
interacts with calmodulin (CaM) via the CO region (Krupp et ah, 1999),
neurofilaments and yotaio while NR2 subunits bind PSD-95, SAP-102 and chapsyn-
110 (Bassand et al., 1999).
The allosteric modulation domain is located in the extracellular region found
between the M3 and M4 transmembrane regions. Polyamines such as spermine and
spermidine can inhibit the NMDA receptor response at high concentrations. At low
concentrations however they potentiate NMDA function (channel opening) by
increasing the channel's affinity to glycine or by increasing the channel's opening
frequency with no change in affinity (Rock and MacDonald, 1992). Cysteine 726 and
780 in NR1 seems important in mediating the effects of certain molecules. The
mutation of these residues eliminates potentiation by dithiothreitol, spermine and
inhibition by proton (Sullivan et al., 1994). Other allosteric modulators are various
redox reagents, ethanol or nitric oxide. Dithiothreitol mediated inhibition of
NR1/NR2A channels is not dependent on alkylation (Kohr et al., 1994) while
modulation of NR1/NR2B, NR1/NR2C and NR1/NR2D receptor activity by
dithiothreitol is blocked by alkylation (Kohr et al., 1994). The effect of nitric oxide is
either mediated by binding to the redox site or via direct channel block. It decreases
the channel conductance in a voltage-dependent and open probability in a voltage-
independent manner (Fagni et al., 1995).
Binding of both glutamate and glycine is required for full activation of the NMDA
receptor (Johnson and Ascher, 1987). The key residues in the ligand binding domain
were identified by site directed mutagenesis. In NR1 a glycine binding domain
(phenylalanine-X-tyrosine) at around residue 370, the phenylalanine 448 in the
amino-terminal and the extracellular region between M3 and M4 were found
important (Kuryatov et al., 1994). The mutations of these sites affect the efficient
concentration for half-maximum response (EC50). The NR2 subunits do not bind
glycine, but modulate interaction by changing the affinity of the receptor for glycine.
NR1/NR2B receptors have a higher affinity while NR1/NR2A receptors have lower
affinity (Honer et al., 1998).
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While NR1 subunits are responsible for the glycine binding, the glutamate binding
site is located to the NR2 subunits. The residues crucial for the interaction are located
to the region N-terminal to the first transmembrane domain (SI) and the extracellular
loop between the third and fourth transmembrane regions (S2) (Armstrong et ah,
1998). Pharmacological effects of agonists and antagonists will be summarized
separately in section IB/Ion channel properties and pharmacology.
Subunit composition
The most commonly used method to determine the subunit composition of the
various NMDA receptors in different brain regions is to solubilize them and then use
immunoprecipitation or immunoaffinity purification using subunit specific anti-
NMDA receptor antibody 1. Thereafter subunit colocalization is determined by
immunoblotting with other high specificity anti-NMDA receptor subunit antibodies.
For normal receptor function NR1 subunits have to co-assemble with distinct NR2
subunits. Although NR1 homomeric channels are expressed in for example Xenopus
oocytes (Yamazaki et al., 1992) and are responsive to glutamate and glycine or
NMDA and glycine, the current responses are relatively small. In mature Purkinje
cells, which only express NR1 and not NR2 subunits, there is no NMDA receptor
activity observed at all (Perkel et al., 1990; Quinlan and Davies, 1985). As opposed
to that the NR1/NR2 heteromeric channels found in other brain regions are highly
active. It is the most efficient assembly upon activation ofwhich, the highest increase
in current can be observed. The responses evoked by glutamate and glycine are
suppressed by 2-amino 5-phosphonopentanoic acid (AP-5), 7-chlorokynurenate,
Mg2+ and dizocilpine (+)-10,l l-dihydro-5-methyl-5H-dibenzo[a,d]cyclohepten-5,10-
imine (MK-801) (Meguro et al., 1992; Monyer et al., 1992). Biochemical studies also
support the heteromeric structure. Anti-NRl subunit antibodies immunoprecipitate
NR2A and NR2B subunits in rat cerebral cortex (Sheng et al., 1994), anti-NR2A
precipitates NR2B and vice versa suggesting that part of the NR2A and NR2B
subunits are present in the same complex in vivo.
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NR1/NR2A containing receptors are present in the forebrain and cerebellum (Sheng
et al., 1994; Chazot et al., 1997), NR1/NR2B containing receptors in the forebrain
(Sheng et al., 1994; Chazot et al., 1997). NR1/NR2C association can be observed in
the cerebellum (Sheng et al., 1994) and NR1/NR2D in the forebrain and the thalamus
(Dunah et al., 1998). In forebrain (Luo et al., 1997) and in developing cerebellar
granule cells (Didier et al., 1995) co-association of three different subunits NR1,
NR2A and NR2B was shown. This receptor population accounts for only a minor
part of the total receptor pool. Ternary complexes of NR1/NR2A/NR2D were found
in forebrain, thalamus and spinal cord (Dunah et al., 1998).
The stoichiometry of NMDA receptors has always been debated. Evidence for both
pentameric and tetrameric structures has been shown. The size of the chemically
cross-linked NMDA receptor suggests pentameric structure (Brose et al., 1993).
According to single channel current patterns some assume that the NMDA receptors
contain three NR1 and two NR2 subunits (Premkumar et al., 1997) some suggest the
association of two NR1 and two NR2 subunits (Laube et al., 1998). Other studies
suggest that both the subunit composition and stoichiometry is variable depending on
the brain region and developmental status. Co-transfection of FLAG and c-Myc
tagged subunits into HEK293 cells suggests the existence of two NR1 and three NR2
subunit-containing receptors (Hawkins et al., 1999). A recent expression study with
truncated subunits supported the tetrameric model (Schorge et al., 2003). Most of the
evidence supports the two NR1 two NR2 assembly in vivo, which is the accepted
model.
Diversity ofNMDA receptors in different neuronal populations
NMDA receptors play an important role in brain development for example in
corticogenesis, synaptogenesis or neural migration. The differences between the
expression patterns of the different NMDA receptor genes during various
developmental stages might account for these processes.
In different species there are only slight alterations between the NR2B gene and
protein expressions in vivo. The expression patterns in vitro (for example in mouse
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primary cultures) match that of the in vivo results. In vivo, from as early as
embryonic day 14 (El4), NR2B expression is evident in the spinal cord and the
hypothalamus (Monyer et ah, 1994). By El7 the expression increases in the cerebral
cortex, thalamus and spinal cord and at a lower level in the hippocampus and the
hypothalamus. After birth and until postnatal day 7-12 (P7-12) the expression
continues to increase mainly in the cerebral cortex and the hippocampus. By P21 the
expression reaches adult level. The NR2A mRNA expression is undetectable until
birth and then increases from P2 to P21 to adult level. It is abundant in the cortex and
hippocampus (Wenzel et ah, 1997). NR2C is expressed in the cerebellum, NR2D in
the subcortical areas whereas NR1 is abundantly expressed throughout the brain from
early stages of development.
In primary cultured cortical neurons prepared from El7 rat neocortex the expression
levels of the different NMDA receptor subunits were low or undetectable.
Expression of NR1 started to increase from day in vitro 1 to 21, NR2A expression
increased from day in vitro 7 to 21 (Zhong et al., 1994). The level ofNR2B increased
from day in vitro (DIV) 1 to 7 and stayed the same until day in vitro 21 (Zhong et al.,
1994).
Apart from neuronal localization, the NMDA receptor subunits can also be found in
non-neuronal tissue like keratinocytes, osteoclasts, osteoblasts or developing rat heart
(Seeber et al., 2000; Itzstein et al., 2001). The presence of different NMDA receptor
subunits in osteoclasts and osteoblasts (Itzstein et al., 2001) suggests a role in bone
cell formation. In developing rat heart it is specifically the NR2B subunit, which is
expressed, NR1 or other NR2 subunits are not, nor are GluR2 or PSD-95. NR1 and
NR2B subunits were observed in the cat retina using immunocytochemical
experiments (Pourcho et al., 2001) and in the rat retina using immunofluorescence
studies (Fletcher et al., 2000).
Subcellular localization at synapses
For determining the cellular and subcellular localization the most frequently used
methods are again immunoblotting and in situ hybridisation. Others are
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immunohistochemistry or electron microscopy. The presence of the various subunits
in the different brain regions and cell types connects them to various functions,
which will be described through a few examples.
In rhesus monkeys the NR2B mRNA is detected throughout the primary sensory
cortex and area 5 and in area 4 with a peak level of expression (Munoz et al., 1999).
This implicates their involvement in processing sensory and motor information.
Connection to the limbic system is suggested by localization in the midline of the
medial septal region in rats (Plant et al., 1997).
In rat vestibular periphery and in rat retina immunohistochemistry and electron
microscopy was used to localize the various NMDA subunits. In the inner plexiform
layer of the rat retina NR1/NR2A, NR1/NR2B and NR1/NR2A/NR2B receptor
complexes colocalized with PSD-95, SAP-102 postsynaptically (Fletcher et al.,
2000), while electron microscopical evidence was demonstrated showing presynaptic
NR1C2 presence (Fletcher et al., 2000). In the rat vestibular periphery NR1, NR2A
and NR2B subunits showed immunoreactivity in the type I vestibular hair cells and
not in type II (Ishiyama et al., 2002).
In cultured hippocampal neurons NR2B mRNA was detected in the dendrites and the
soma (Miyashiro et al., 1994). When hippocampal neurons were transfected with
GFP-NR2A and GFP-NR2B clusters were observed at the dendritic shafts and spines
(Luo et al., 2002). In cultured cortical neurons NR1/NR2B receptors were expressed
in the cell bodies of the mature neurons (Flail and Soderling, 1997). In the rat
striatum NR1/NR2A and NR1/NR2B receptor types were localized to the light
membrane, synaptosomal membrane and intracellular compartments while the
ternary NR1/NR2A/NR2B receptors were only found in the synaptosomal membrane
(Dunah and Standaert, 2003). Considering the cell surface expression the greatest
proportion of the NR2B subunits are found in the plasma membrane while almost
half of the NR1 subunits contribute to an intracellular pool awaiting coassembly with
the available NR2B subunits (Hall and Soderling, 1997).
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The post-synaptic density (PSD) is an organized network of receptors, signalling
molecules and scaffolding proteins located in the vicinity of the postsynaptic
membrane, the function of which is to facilitate synaptic plasticity, protein
phosphorylation, learning and memory formation. Immunoblotting of rat cortical and
cerebellar tissue shows that NR2A and NR2B subunits are highly expressed at the
PSD together with their binding partners, PSD-95 or chapsyn-110 (A1 Hallaq et ah,
2001). Synapse associated protein 102 (SAP-102) is located both at axonal sites and
postsynaptically (El Husseini et ah, 2000).
Ion channel properties and pharmacology
The subunits of the NMDA receptor form a channel permeable to cations. When in
an activated state inward Ca2+ and Na+ flow can be observed, while K+ ions move
outwards, which can be blocked in the presence of Mg2+ and Zn2+ (Nowak et ah,
1984; Paoletti et ah, 1997). For activation of the receptor it is important that the
glutamate binding site is activated, the voltage-dependent Mg2+ blockade is lifted
(upon depolarisation) and that the glycine activated co-agonist binding site is in an
active state (Nowak et ah, 1984; Johnson and Ascher, 1987). The main endogenous
agonists of the glutamate binding sites are glutamate and aspartate, that of the
glycine site is glycine. However the former can bind endogenous homocysteic acid
or quinolinic acid activating the NMDA receptor (Lipton et ah, 1997), the latter
endogenous D-cycloserine (Baranano et ah, 2001) or 3-amino-l-hydroxypirrolidin-2-
one (HA966) (partial agonist) with high affinity.
Aside from the glutamate and glycine binding site there is an allosteric binding site
on the N-terminus. It is activated by endogenous polyamines like spermidine,
spermine or putrescine (Rock and MacDonald, 1992). These are physiological
modulators ofNMDA receptor function and were discussed previously in detail. The
Mg2+ (Ascher and Nowak, 1988) and Zn2+ binding sites can be found inside of the
channel. Another binding site in the same position is the phencyclidin (PCP) or MK-
801 site, which are exposed only in open channel position and are named after their
specific blockers (Table 1).
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The voltage dependent Mg2+ block, which is stronger in NR1/NR2A and NR1/NR2B
receptors than in NR1/NR2C and NR1/NR2D (Kuner and Schoepfer, 1996) is
regulated by the Q/R site in the M2 region of the NR1 and NR2 subunits. In the
NR2B subunit it is in position 589. Mutation of this asparagine to glutamine removes
the voltage dependent Mg2' block and alters the permeability to divalent cations
(Burnashev et al., 1992). It also modulates the inhibition by argiotoxin and Joro toxin
(Raditsch et al., 1993). Mutating the tryptophan residue (W607L) in the NR2 M2
region also abolished Mg2+ block (Williams et al., 1998).
2"hZn mediates voltage-dependent and voltage-independent receptor blockade in a
manner that is NMDA receptor subunit specific. The voltage-dependent inhibition is
the same for NR1/NR2A and NR1/NR2B containing receptors, while the voltage-
independent mechanism is characterized by high affinity inhibition (at lower Zn2+
concentrations) in the case of the NR1/NR2A receptors and a lower affinity
• i • • • 9+
inhibition (at higher Zn concentration) in the NR1/NR2B receptors (Paoletti et al.,
1997). The presence of the N1 exon of the NR1 subunit increases the half maximal
inhibitory concentration (IC50) for Zn2+ in the voltage-independent mechanism
(Traynelis et al., 1998). The binding sites for Zn2+ can be found inside of the channel.
Other binding sites in the intramembrane loop are for phencyclidine (PCP) and
dizocilpine (MK-801) with the latter requiring extra sequence information in the M3
region (Ferrer-Montiel et al., 1995).
NMDA receptors frequently colocalize with AMPA or kainate receptors. Stimulation
of the NMDA receptors results in slow depolarisation and increased Ca2+ influx,
while stimulation of AMPA or kainite receptors results in fast depolarisation and the
2_|_ .Ca permeability stays low. The former is involved in the plasticity of the central
nervous system while the latter is connected to fast synaptic transmission. The reason
is that for the lift of the Mg2+ blockade of the NMDA receptor an intense
depolarising stimulus is required, which happens for example during the prolonged
excitation of the AMPA or kainite receptors (for example during long term
• • • • 9~F •
potentiation). The NMDA receptors contribute to the process via the Ca influx, the
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protein kinase C (PKC) activation and the nitric oxide (NO) release. Through this






NMDA AMPA Kainate Group I Group ll/lll
Signal
transmission






















































Table 1. Glutamate receptor agonists. (Furst K. Introduction to the pharmacology of positive
psychotropic compounds. Pharmacology. 2001: 323-325.)
The agonists and modulators of the various glutamate receptors are summarized.
PA: parcial agonist; ACPD: 1-amino-cyclopentane-1,3-dicarboxylic acid; AIDA: 1-
aminoindan-1,5-dicarboxylic acid; AP-4: 2-amino 4 phosphobutyric acid; AP-5: 2-amino 5-
phosphopentanoic acid; AP-7: 2-amino 7- phosphopentanoic acid; DCG-IV: 3-dicarboxy-
cyclopropylglycine; DHPG: 3,5-dihydroxyphenylglycine; EGLU: alpha-ethylglutamic acid;
GYKI 52466: 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-2,3 benzodiazepine
hydrochloride; HA966: 3-amino-1-hydroxypyrrolidin-2-one; LY 293558: 2-tetrazole-ethyl-
decahydroisoquinoline-3-carboxylic acid; LY 294486: 2-tetrazole-methyl-oxymethyl-alpha-
decahydroisoquinoline-3-carboxylic acid; MAP4: methylamino-phosphonium-butyric acid;
MCCG: 2-methyl-2-carboxypropyl-glycine; MCPG: alpha-methyl-4-carboxyphenylglycine;
MNQX: 5,7-dinitroquinoxaline-2,3-dione; MSOP: alpha-methylserine-O-phosphate; NBQX: 6-
nitro-7-sufamoyl-benzoquinoxaline-2,3-dione; SOP: serine-O-phosphate
If the intracellular Na+ concentration increases due to constant depolarisation,
• • 9+ • •
overactivation of the receptor then the Ca influx increases and it results in apoptotic
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cell death. It can be observed in pathological conditions like ischaemia or
hypoglycaemia. Apart from these NMDA receptor is involved in other acute
neurodegenerative disorders such as stroke, mechanic head injuries and hypoxic
conditions after convulsion or chronic diseases like Alzheimer's disease, Parkinson's
disease, amyotrophic lateral sclerosis (ALS), Huntington-chorea and AIDS-
dementia.
1C NMDA receptor signalling complex
NMDA receptor signalling complex composition
The NMDA receptor complex is a ~2000 kDa complex (Husi et ah, 2000), consisting
of at least 75 proteins, which are either directly interacting with different subunits of
the receptor, or are indirectly linked via other molecules. These proteins can be
categorised into five groups, which are cell adhesion molecules, adaptors,
neurotransmitter receptors, signalling enzymes and cytoskeletal proteins (Husi and
Grant, 2001). There is evidence for the importance of the C-terminal intracellular
domain of the NR2 subunits in providing binding sites for downstream signalling
molecules (Find in detail in section ID and IF.).
The direct binding partners can be categorised into two major groups (Figure 2,
Table 2a, b and c). One is the group of membrane associated guanylate kinase
(MAGUK) proteins. They all contain PDZ domains and via this domain they bind to
the E-S/T-X-V motif located at the extreme C-termini of the NR2 subunits. A few of
these proteins are PSD-95, chapsyn-110 or SAP 102. These further interact with
neuronal nitric oxidase synthase (nNOS) (Holscher et ah, 1997), fyn (Human locus
IDDM15 gene FYN) (Grant et al., 1992) or synaptic Ras GTPase (SynGAP) (Chen et
al., 1998), which is also a regulator of Ras.
The first MAGUK protein to be characterized was Dig, the product of the Drosophila
lethal(l)disclarge-l tumor suppressor gene (Woods and Bryant, 1991) localized to
the septate junction at the apical edge of polarized epithelial cells. Mammalian
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members of the protein family were then cloned, amongst which are the neuronal
proteins, PSD-95 (SAP-90), PSD-93 (Chapsyn-110), SAP-97 (hDLG) and SAP-102
(Cho et ah, 1992; Muller et ah, 1995; Muller et ah, 1996; Brenman et ah, 1996).
PSD-95, PSD-93 (abundantly at the PSD) and SAP-102 can be found
postsynaptically (Muller et ah, 1996; Rao et ah, 1998) while SAP-97 is presynaptic
(Muller et ah, 1995). The zonula occludens proteins (ZOP), ZO-1, ZO-2 and ZO-3
can be found in epithelial and endothelial intracellular junctions (Stevenson et ah,
1986; Jesaitis and Goodenough, 1994; Haskins et ah, 1998). ZO-1 can also be found
in astrocytes, fibroblasts and myeloma cell lines.
The distinct localization and function of the MAGUK proteins might be accounted
for by the differences in their N-terminal structure. All MAGUK proteins contain a
guanylate kinase (GUK), a Src homology (SH3) and a PDZ domain. The N-terminal
region is variable, due to the presence of an additional two PDZ domains or a
CaMKII homology domain and alternative splicing. PSD-95 and PSD-93 contain
cysteine residues in the N-terminal region, which are sites for post-translational
palmitoylation (Brenman et ah, 1996; Topinka and Bredt; 1998; El Husseini et ah,
2000). SAP-102 also contains cysteines, but instead of being palmitoylated they bind
to zinc (Muller et ah, 1996; El Husseini et ah, 2000). SAP-97 lacks N-terminal
cysteines. In addition to that PSD-93 is alternatively spliced at the N-terminus
yielding two major isoforms (a and (3), which contain the cysteine residues at
different positions (Brenman et ah, 1996). Using mutants it was shown that the
subcellular localization of MAGUKs and ion channel clustering at the plasma
membrane (mediated by MAGUK interactions) is connected to palmitoylation (El
Husseini et ah, 2000). The PDZ domains bind voltage and ligand gated ion channels,
the proline rich SH3 domains bind PXXP sequences (with evidence also for binding
molecules without the PXXP motif) and the GUK domain interacts with GKAP
proteins or the microtubule-associated protein-1A (MAP-1A) (Kim et ah, 1996; Kim
et ah, 1997; Garner et ah, 2000; Jia et ah, 2005). These findings suggest that the
MAGUKs are important in the assembly of macromolecular protein complexes and
the interaction with GKAPs was shown to be connected to their recruitment to
synaptic junctions (Thomas et ah, 2000).
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The PDZ domains of PSD-95 are responsible for its binding to NMDA receptors
(second PDZ domain), Shaker-type K+ channels and cell adhesion molecules (Kim
et ah, 1995; Garner et al., 2000; Irie et ah, 1997). PSD-95 enhances NMDA receptor
clustering at the synaptic membrane, inhibits internalization mediated by NR2
subunits (Kim et al., 1996; Roche et al., 2001) and it regulates NMDA channel
gating (increased channel opening probability and channel opening rate) and
trafficking. The deletion of the PDZ binding domain ofNR2A results in the blockade
of PSD-95 induced increase in surface expression of the NMDA receptors and
decrease in internalization (Lin et al., 2004). Overexpression of PSD-95
preferentially stabilizes NR1/NR2A receptor types at the synapses by facilitating
synaptic insertion of NR2A subunits and decreasing NR2B expression (Losi et al.,
2003).
The other group of molecules interacting with the NR2 C-termini is the non-
MAGUK proteins, which bind to sites of the C-terminus other than the terminal E-
S/T-X-V motif, and include for example Ca2+-calmodulin-dependent protein kinase
II (CaMKII), phospholipase C-y (PLC-y) and PI3-K. One signalling pathway
connected to these is the mitogen-activated protein kinase (MAPK) pathway,
connecting MAP kinase kinase (MEK), extracellular signal-related kinase (ERK) and
ribosomal protein S6 kinase (Suzuki et al., 2001).
Ca2+-calmodulin-dependent protein kinase II is a serine/threonine kinase encoded by
four genes, with a and P predominantly found in the brain, yielding over 30
alternatively spliced isoforms. CaMKII monomers assemble into a holoenzyme
possibly dodecamers, a dimer of two hexameric rings (Gaertner et al., 2004).
Postsynaptic calcium influx results in the autophosphorylation of Thr 286 residue of
CaMKIIa, which enables the molecule to remain activated even after dissociating
from Ca2+/CaM, its activator (Miller et al., 1988; Lou and Schulman, 1989). Further
sites then become autophosphorylated in the Ca2+/CaM binding domain of CaMKII
blocking Ca2+/CaM reassociation. Thr 286 autophosphorylated CaMKIIa is
persistently active, translocates to the PSD and is necessary for NMDA dependent
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LTP induction but only at certain synapses such as Schaffer commissural synapses in
the CA1 region (Giese et al., 1998; Cooke et al., 2006). In medial perforant path-
granule cell synapses LTP is connected to cyclic AMP-dependent signalling in Thr
286 autophosphorylation site mutant mice where CaMKII signalling is absent
(Cooke et al., 2006).
CaMKII directly binds to subunits NR1 and NR2B of the NMDA receptor (Leonard
et al., 1999). It demonstrates high affinity binding to the NR2B (induced by
autophosphorylation of CaMKII), but not the NR2A C-terminus (Strack and Colbran,
1998). Residues 1290-1309 of the NR2B subunit are critical for the interaction. The
key residues in this region were identified by site directed mutagenesis (Strack et al.,
2000), which are Lysine (Lys) 1292, Leucine (Leu) 1298, Arginine (Arg) 1299,
Arginine 1300, Glutamine (Glu) 1301 and Serine (Ser) 1303. Phosphorylation of Ser
1303 inhibits binding to CaMKII. For recruitment ofCaMKII to the NMDA receptor
residues 1260-1316 ofNR2B are sufficient (Leonard et al., 1999).
Binding of CaMKII to NR2B can occur in two distinct ways. One is the enzyme-
substrate binding via the catalytic (active) site of CaMKII resulting in the
phosphorylation of NR2B Serine 1303, the other via the non-catalytic site of
CaMKII, which results in the localization of CaMKII to the PSD (Leonard et al.,
1999; Strack et al., 2000; Bayer et al., 2001; Bayer et al., 2006). CaMKII bound to
NR2B in the non-catalytic mode can still bind to and phosphorylate other NR2B
molecules at Serine 1303 (Bayer et al., 2001).
Both NR2A and NR2B bind to the SH2 domain of PLC-y when phosphorylated on
tyrosine residues (Gurd and Bissoon, 1997). Binding of PLC-y triggers its
phosphorylation by receptor- and also non-receptor tyrosine kinases and
consequently its activation leading to the hydrolysis of phosphatidylinositol 4,5-
bisphosphate yielding diacylglycerol and inositol 1,4,5-trisphosphate (Margolis et al.,
1990; Vetter et al., 1991; Liao et al., 1992). This is an important step in many
signalling pathways.
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Calmodulin binds in the region of the CI exon of the NR1 subunit in a calcium-
dependent manner. Ca2+ entering through the NMDA receptor channel binds to
calmodulin thereby activating it, which then binds to NR1 inactivating the NMDA
receptor (Vyklicky, 1993). This high affinity interaction is weakened by PKC-
mediated phosphorylation ofNR1 on serine residues (Hisatsune et al., 1997) thereby
9+
preventing inactivation of NMDA receptor channels by Ca . Inhibitors of
calmodulin also block long-term potentiation and long-term depression in the
hippocampal CA1 region (Malenka et ah, 1989a).
NMDA receptors at excitatory postsynaptic membranes directly bind to or indirectly
interact with cytoskeletal molecules thereby ensuring anchoring at the PSD. Alpha-
actinin-2 (an actin cross-linking protein) binds to the C-terminus of NR1 and NR2B
subunits (Wyszynski et ah, 1997). F-actin depolymerization disperses alpha-actinin-
2, which reduces NMDA receptor clustering at the synapses (Allison et al 1998).
Another actin-binding protein, spectrin is interacting with NR1, NR2A and NR2B
subunits. PKA, PKC mediated phosphorylation of NR1 and calcium/calmodulin
antagonizes association ofNR1 and spectrin, while phosphorylation ofNR2B by Fyn
and also calcium weakens the interaction between NR2B and spectrin (Wechsler and
Teichberg, 1998). The interaction of spectrin with the plasma membrane is also
regulated by calcium (Steiner et ah, 1989). Another molecule, yotaio binds to the CI
region of the NR1 subunit (Lin et ah, 1998).
Other molecules of the NMDA receptor signalling complex, such as nNOS, fyn or
SynGAP, interact with MAGUKs thereby regulating receptor function. SynGAP
interacts with PSD-95 and SAP-102 via PDZ interaction and it is a negative regulator
of Ras thereby modulating synaptic plasticity (Chen et ah, 1998; Kim et ah, 1998).
Phosphorylation by CaMKII inhibits SynGAP resulting in the inhibition of the
inactivation of GTP-bound Ras and the activation of the MAP kinase pathway.
The molecules within the NMDA receptor signalling complex are organized in a well
regulated network providing for synaptic plasticity, some forms of learning and
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memory formation. The involvement of the NMDA receptor in these events will be
discussed in the next chapters.
Interaction of NMDA Receptor NR2B C-terminus
Figure 2. Interactions of the NMDA Receptor NR2B C-terminus.
The binding partners can be categorised into two major groups. The MAGUK proteins all
contain PDZ domains via which they bind to the E-S/T-X-V motif located at the extreme C-
termini of the NR2 subunits. A few of these proteins are PSD-95, chapsyn-110 or SAP 102.
These further interact with nNOS (Holscher et al., 1997), fyn (Grant et al., 1992) or SynGAP
(Chen et al., 1998). The non-MAGUK proteins, which bind to sites of the C-terminus other
than the terminal E-S/T-X-V motif, include for example CaMKII, PLC-y and PKC.
Role of phosphorylation in interactions and signalling
Phosphorylation of receptor ion channels is an important regulatory mechanism that
may be underlying synaptic plasticity. The following findings give bases to that
hypothesis. Phosphorylation of certain signalling molecules activates them, which
enables them to bind to other molecules. Secondly, the agonist-induced responses of
ionotropic glutamate receptors are generally potentiated after phosphorylation.
Thirdly, certain kinases are required for LTP providing for learning and memory.
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Two of these are protein kinase C (PKC) and CaMKII, which are involved in
generation of long term potentiation (LTP) (Lovinger et ah, 1987; Reymann et ah,
1988; Malenka et ah, 1989a; Malenka et ah, 1989b; Malinow et ah, 1989; Giese et
ah, 1998; Cooke et ah, 2006). Others are src family tyrosine kinases (O'Dell et ah,
1991), cAMP-dependent kinase (Frey et ah, 1993; Cooke et ah, 2006) and the
mitogen-activated protein kinase (English et ah, 1997).
"NMDA Receptor NR1 Subunit Interactions
Interacting irmtecute Site of Interaction on JSR2H Reference
NR2A Hawkins et al., 1999
NR2B Hawkins etaL, 1999
NR2C Laurie et al., 1994
NR2D Williams, 1995
NR3 Laurie et al., 1994
CaMKII Leonard et al., 1999
CaM AS 834-863 and 864-900 Krupp et al., 1999
Yntaio AS 864-900 Lin et at, 1998
Spectrin In the region AS 834-938 Wechsler et al., 1998
Tubulin Van Rossum et al., 1999
aartinin 2 AS 834-863 Krupp etal., 1999
Table 2a. NMDA Receptor NR1 Subunit Interactions.
The binding sites for the different molecules interacting with the NR1 C-terminus and the
references are listed above.
Production ofmutant mice was used to determine the function of certain domains of
the NMDA receptor, uncovering the fact that the C-terminus of the NR2 subunit is
the most important in synaptic plasticity via binding to downstream molecules
(Figure 2, Table 2a, b and c), forming the initiating point of signalling cascades (Find
in detail in sections ID and IF.). The NR2 subunit binds to the 1st and 2nd PDZ
domains of PSD-95 through the E-S/T-X-V motif located at the extreme C-termini
(Kornau et al., 1995; Tochio et al., 2000), which is connected to other downstream
signalling molecules. Mice expressing C-terminal truncated forms of NR2A, NR2B
and NR2C subunits were produced (Kohr and Seeburg, 1996; Sprengel et al., 1998).
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No interference with the formation of gateable receptor channels was observed in
vitro however mice expressing these truncated subunits manifested great phenotypic
resemblance with mice lacking the respective subunits (Kutsuwada 1996), namely
that mice lacking the NR2B C-terminus (NR2BAC) died perinatally (Sprengel et ah,
1998). The channel function was normal, however the NR2BAC protein level and
NMDA receptor currents were reduced by about half in both the lethal homozygous
and the surviving heterozygous mice as well. Immunostaining of cultured cerebral
neurons showed a reduced number of NR2B immunofluorescent puncta
demonstrating disrupted clustering and synaptic localization of the NMDA receptor
channel (Mori 1998). This suggests that the cause of lethality is the lack of protein-
protein interactions via the C-terminus, rather than the reduction in receptor currents.
"NMDA Receptor NR2A Subunit Interactions
Interacting mntecute Site nf Interaction on NR2H Reference
NR1 Hawkins et al., 1999
CaMKII AS 1349-1458 Gardoni et al., 1998
PSD-55 E-S/T-X-V motif (AS 1459-1464) Bassand et at, 1999
Chapsyn-llD E-S/T-X-V motif (AS 1459-1464) Bassand et al., 1999
SAP-97 and 1D2 E-S/T-X-V motif (AS 1459-1464) Bassand et al., 1999
PLC-t Y1325(SH2) Gurd et al., 1997
Fyn Y1325(SH2) Takagi et al., 1999
Src Y1325(SH2) Takagi et al., 1999
Veli E-S/T-X-V motif (AS 1459-1464) Jo et al., 1999
Spectrin In the region AS 838-1464 Wechsler et at, 1998
S-SCAM E-S/T-X-V motif (with PDZ-5) Hirao etal., 1998
Table 2b. NMDA Receptor NR2A Subunit Interactions.
The different molecules interacting with the C-terminus of the NR2A subunit, their binding
sites and the references are listed above.
36
NMDA Receptor NR2B Snbiuiit Interactions
Interne ting molecule Site of Interaction on NR2B Reference
NR1 Hawkins et al., 1999
CnMKII AS 1290-1309 Gardom et al., 1998
PS'D-95. Cliapsyii-110, SAP-97
nnd 102
E-S/T-X-V motif (AS 1479-1482) Bassand et al., 1999
PLC-y Y1122, 1252. 1336, 1472(SH2) Gurd et al., 1997
Fyn Y1122, 1252, 1336, 1472 (SH2) Takagi et al., 1999
Src Y1122, 1252, 1336, 1472 (SH2) Takagi et al., 1999
PI3-kiiw.se YAHM (AS 1336-1339) Hisatsune et al., 1999
PTPID Y1122, 1252, 1336, 1472 (SH2) Lin etaf, 1999
C'lPP E-S/T-X-V motif (AS 1479-1482) Kursohner etal., 1998
Veil E-S/T-X-V motif (AS 1479-1482) Jo et al., 1999
Spectrin In the region AS 1086-1481 Wechsler et at, 1998
Tubulin AS 1243-1376 Van Rossum etal., 1999
a-actmin-2 AS 1308-1440 Wyszynski et al., 1997
S-SCAM E-S/T-X-V motif (with PDZ-5) Hirao et al., 2000
Table 2c. NMDA Receptor NR2B Subunit Interactions.
The different molecules interacting with the C-terminus of the NR2B subunit form signalling
cascades by further interacting with other proteins. The binding sites and references are
listed above.
The same method was used for searching for different kinases that are involved in
LTP generation, learning and memory formation (Find in detail in sections ID and
IF.). Mutation in the src family tyrosine kinase or fyn reduces LTP and produces
abnormal hippocampal morphology (Grant et al., 1992). Knockout of PKCy
(Abeliovich et al., 1993), aCaMKII subunit (Silva et al., 1992a) or protein kinase A
(PKA) Rl[3 and Cpi subunits (Brandon et al., 1995; Huang et al., 1995) also reduce
LTP, impair synaptic plasticity. In the next chapters synaptic plasticity and the
involvement of the NMDA receptor in signalling will be discussed in great detail.
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ID Synaptic Plasticity
In determining behaviour, the process of learning and memory formation is
extremely important. Memory can be categorised into two main groups, implicit or
non-declarative and explicit or declarative memory, the former being required for
simple associations or motor skills, which is not dependent on the temporal lobe but
involves sensory, motor and associative pathways, the latter being a conscious recall
of objects, which is dependent on the hippocampus, subiculum and entorhinal cortex.
According to Hebb's hypothesis (1949), "When an axon of cell A is near enough to
excite cell B and repeatedly or persistently takes part in firing it, some growth
process or metabolic change takes place in one or both cells, such that A's efficiency,
as one of the cells firing B, is increased.", the condition that has to be met in order to
strengthen a synapse is the co-activation of the two neurons connected.
Strengthening of the synapse occurs when the use of the synapses is associated with
the generation of action potentials in the postsynaptic neuron. This process was
proposed to account for associative learning.
The first experiment that gave evidence that long lasting plasticity exists was carried
out on the perforant path synapse with the dentate gyrus in the hippocampus (Bliss
and Lomo, 1973). High frequency stimulation (5-100 Hz) in this system produced an
increase in synaptic efficiency termed long-term potentiation (LTP). This form of
synaptic plasticity was observed in the CA3 (Alger et al., 1976) and CA1
(Schwartzkroin et al., 1975) regions of the hippocampus. Evidence for a decrease in
the synaptic efficiency termed long-term depression (LTD) induced by low
frequency (1 Hz) stimulation was also found (Bear et al., 1996). Changes in synaptic
strength were termed synaptic plasticity. These experiments were followed by many
others, confirming the diversity of the different forms of LTP and LTD (See in detail
in the next paragraphs.), however Hebb's postulate remained the basis for many
theories investigating the processes underlying synaptic plasticity, learning and
memory.
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Aplysia and synaptic transmission
Synaptic plasticity and its connection to long-term memory formation in marine
molluscs have been thoroughly studied as a simple, but good model of hippocampal
learning in vertebrates. Associative learning (Find in detail in section IE.) was
examined in Hermissenda (Alkon, 1980), while nonassociative learning types such as
habituation and sensitization were examined in Aplysia (Castellucci and Kandel,
1974; Frost et al., 1985). Habituation was connected to synaptic depression while
sensitization was connected to synaptic facilitation.
In Aplysia sensitization and switch from short to long term memory and the
underlying processes can be studied on the gill- and siphon-withdrawal reflex.
Following a single noxious stimulus to the tail the mollusc acquires a short-term
memory lasting minutes, which results in an enhanced gill- and siphon withdrawal
reflex to tactile stimulation. Five or more stimuli result in a long-term memory
lasting days or weeks. The proposed underlying mechanism is that the noxious
stimulus activates facilitatory interneurons, which synapse on the sensory neurons
and strengthen the connection between the sensory neurons and their target cells
(Hawkins et al., 1981). This can be reconstituted in cell culture as well, where
serotonine (5-HT) can be used as a noxious stimulus (Montarolo et al., 1986). A
single application of 5-HT produces short-term changes in synaptic efficiency while
five separate applications of 5-HT produce long-term changes (Montarolo et al.,
1986; Glanzman et al., 1989).
Short-term facilitation requires covalent modifications of existing proteins and is not
blocked by inhibitors of transcription and translation while long-term changes are
connected to transcription, translation and growth of new synaptic connections
(Bailey and Chen 1988; Bailey and Chen, 1989; Castellucci et al., 1989). Transition
between short-term and long-term synaptic facilitation is CREB-mediated as showed
in experiments using recombinant phospho-CREBl and inhibitory transcription
factor CREB2 (Bartsch et al., 1995; Casadio et al., 1999; Pittenger and Kandel,
2003). Many parallels have been pointed out between the long-term facilitation in
39
Aplysia and the hippocampal long-term LTP in mammals (Find in detail in the next
paragraphs.) and their connection to long-term memory, such as its graded nature, the
involvement of PKA and CREB or the requirement of the growth of new synaptic
connections (Pittenger and Kandel, 2003).
Synaptic plasticity and the involvement of the NMDA receptor
LTP has been studied in great detail in the rodent hippocampus and neocortex. Three
main subtypes have been identified and characterized, which are NMDA receptor-
dependent LTP, AMPA receptor-dependent LTP and mossy fibre LTP. Two forms of
LTD will also be discussed, namely the NMDA receptor-dependent and the
metabotropic glutamate receptor-dependent forms. LTP also has stages like long-
term facilitation in Aplysia, which are early-stage LTP (E-LTP) requiring aCaMKH
and fyn and late-stage LTP (L-LTP) requiring PKA and protein synthesis (Bliss and
Collinridge, 1993; Frey et al., 1993).
NMDA receptor-dependent LTP is triggered by high frequency tetani to a critical
number of afferent fibres or by coincident postsynaptic depolarization (resulting in
2_j_the relief from Mg blockade) and presynaptic stimulation (glutamate release)
allowing for Ca2+ and Na+ influx via the NMDA receptor. This Ca2+ influx was
proposed to be the initiation factor in the induction of LTP (Lynch et al., 1993). The
latter mechanism made the NMDA receptor a candidate for mediating Hebbian
synaptic plasticity.
2"h * •Downstream of the NMDA receptor there are two major Ca -dependent signalling
pathways identified. One is the CaMKII signalling, the other is the cAMP-dependent
signalling. CaMKIl(a) is the major component of the postsynaptic density, in fact it
is one of the most abundant proteins in neurons, 1-2% of the total. It is a molecule
linking the transient calcium signals connected to NMDA/AMPA activation to
neuronal plasticity. It has been suggested as a molecular switch for long-term
memory storage based on its property to autophosphorylate and self-activate and its
ability to bind to NMDA thereby anchoring AMPA receptors at the PSD (Lisman
and Zhabotinsky, 2001).
40
Upon NMDA receptor activation the intracellular Ca2+ concentration increases,
which in turn activates CaMKII. It is autophosphorylated on threonine-286 (Thr-
286), which allows persistent activation of the kinase (Miller et ah, 1988; Lou and
Schulman, 1989). Autophosphorylation of aCaMKII also induces its translocation to
the PSD where it binds the NMDA receptor NR2A or NR2B subunit (Gardoni et ah,
1998; Leonard et ah, 1999; Strack et ah, 2000; Bayer et ah, 2001; Bayer et ah, 2006)
and is necessary for NMDA receptor-dependent LTP induction but only at certain
synapses such as Schaffer commissural synapses in the CA1 region (Giese et ah,
1998; Cooke et ah, 2006). In medial perforant path-granule cell synapses LTP is
connected to cyclic AMP-dependent signalling in Thr 286 autophosphorylation site
mutant mice where CaMKII signalling is absent (Cooke et ah, 2006).
Inhibition of CaMKII also blocks LTP in hippocampal CA1 region (Malinow et al.,
1998). The deletion of aCaMKII impairs E-LTP in the CA1 neurons of the
hippocampus and spatial learning (Silva et al., 1992a; Silva et al., 1992b). CaMKII is
involved in AMPA receptor activation, too. GluRl is CaMKII phosphorylated on
serine-831 (Ser-831) and AMPA receptor delivery to the spine after LTP induction is
CaMKII-dependent, which is the step needed for the transition of silent synapses to
functional (Liao et al., 2001).
There is great evidence for the involvement of the cAMP-signalling cascade in the
induction of protein synthesis-dependent changes important for the formation of LTP
and long-term memory (Nguyen and Kandel., 1997). If the intracellular cAMP
concentration increases, PKA activation occurs, which ultimately leads to activation
of various transcription factors (such as CREB) and translation. It has been shown
that induction of LTP results in PKA activation. Results of the Kandel group showed
that cAMP/PKA have a role in the late-phase LTP. Delivery of one high-frequency
train (100 Hz) induces LTP, which persists for 1-3 hours (Huang et al., 1994). This
was inhibited by CaMKII blockers, but not by inhibitors of PKA. In contrast, the
three high-frequency train-induced LTP persisted for up to 6-10 hours and was
blocked by PKA inhibitors (Huang et al., 1994). There is a clear correlation between
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changes in elevated intracellular cAMP concentration-induced PKA activation and
induction of LTP. This is demonstrated in transgenic mice expressing R(AB), the
inhibitory form of the regulatory subunit of PKA. In these mutants PKA activity and
late-phase LTP was reduced in the CA1 region of the hippocampus and they
exhibited spatial learning deficits (Abel et al., 1997). The cAMP/PKA system is also
involved in other forms of plasticity, for example in the visual cortex contributing to
ocular plasticity (Beaver et al., 2001).
The next step in this signalling cascade is the mitogen-activated kinase (MAPK). The
MAPK/ERK cascade is essential in the signal transduction processes involved in
LTP formation and certain forms of learning (Figure 3). The increase in cAMP
concentration triggers the activation of ERK (Impey et al., 1998) and the nuclear
translocation ofMAPK (Martin et al., 1997). Activation of ERK and translocation of
MAPK, which is required for at least some forms of L-LTP in the mammalian
hippocampus can be mediated by cAMP stimulation of tyrosine receptor kinase (Trk)
via the Ras/raf pathway or by induction of NMDA, AMPA or mGluR followed by
subsequent activation of PI3-K, PKA, PKC or CaMKII (Martin et al., 1997;
Patterson et al., 2001). The downstream substrates of ERK are signalling proteins
like phospholipase A2 (PLA2); cytoskeletal proteins for example microtubule-
associated protein-2 (MAP-2) or Tau; or nuclear proteins like CREB, c-fos or c-jun.
The ultimate effects of ERK activation therefore are translation and transcription
(Thomson et al., 1999). This requires ERK translocation to the nucleus (Boglari et
al., 1998). If ERK is inhibited, the LTP in hippocampal CA1 region and in the
dentate gyrus is suppressed (English and Sweatt, 1997; McGahon et al., 1999). Vice
versa, the induction of LTP leads to phosphorylation of MAPK/ERK (English and
Sweatt, 1997; McGahon et al., 1999). Activation of ERK is increased after
contextual fear conditioning (Atkins et al., 1998).
Activation of CREB is induced by phosphorylation of MAPK/ERK. It is one of the
most important transcription factors in memory formation and it has been associated
with long-term memory (Silva et al., 1998).It is another molecule that has been
implicated to act as a molecular switch (Chen et al., 2003; Mizuno and Giese, 2005)
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for long-term memory (Find in further detail in sections lD/Aplysia and IE).
Phosphorylation of CREB is increased in the hippocampus after contextual fear
conditioning (Impey et ah, 1998) and in hippocampus and the entorhinal cortex after
training in the Morris water maze (Gooney et ah, 2002). CREB activation is the
essential step prior to gene transcription and protein synthesis and it is also involved
in the induction ofmorphological changes such as generation of new dendritic spines
(Murphy and Segal, 1997) proposed to underlie L-LTP and some forms of learning
and memory formation. Mice with targeted disruption of CREB or expressing a
repressor of CREB have disrupted late-phase LTP and hippocampus-dependent long-
term memory (Bourtchuladze et al., 1994; Bozon et ah, 2003). Mice expressing an
inhibitor of an endogenous CREB repressor have enhanced L-LTP and long-term
memory (Chen et ah, 2003).
Phosphatidylinositol 3-kinase (PI3-kinase) is another molecule downstream of
NMDA (Figure 3), which can activate MEK (Divecha and Irvine, 1995) triggering
ERK phosphorylation. PI3-kinase inhibitors block LTP in both CA1 (Sanna et ah,
2002) and the dentate gyrus (Kelly and Lynch, 2000). Inhibition of PI3-kinase also
blocks LTP-triggered activation ofERK and cAMP response element binding protein
(CREB) (Lin et ah, 2001), which might be the reason for PI3-kinase inhibitor
induced blockade of LTP and interference with long-term fear memory (Lin et ah,
2001), which requires translation and transcription connected to ERK/CREB. The
short-term memory however is intact.
AMPA receptor-dependent LTP
AMPA receptors contribute to fast excitatory synaptic transmission and have been
postulated to be involved in expression of LTP (Figure 3). The GluR2 subunit
modulates the calcium entry. If its expression is high for example in pyramidal cells
of the hippocampus then the calcium permeability of the AMPA receptor is low. In
GluR2 mutant mice the calcium permeability is higher and the LTP is enhanced (Jia
et ah, 1996). Evidence suggests that the primary requirement of LTP induction is the
increased expression of AMPA receptors at the postsynaptic membrane. This is the
base of the silent synapse theory, which suggests that certain synapses are not
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functional (silent) because of the lack of AMPA receptors (Isaac et al., 1995). The
different mutants are listed in section 1H.
A type of use-dependent LTP can be observed even in the presence of NMDA
receptor blockers in the amygdala and the dorsal horn (Gu et al., 1996; Mahanty and
Sah, 1998). This LTP is induced by Ca2+ permeable AMPA channels. The Ca2+
influx is maximal when presynaptic glutamate release coincides with postsynaptic
hyperpolarization.
Mossy fibre LTP
Mossy fibre LTP is observed in the hippocampus, in mossy fibre synapses on CA3
pyramidal neurons (Harris and Cotman, 1986). This form of LTP does not require
coincident pre- and postsynaptic activity and its expression is thought to be
presynaptic. Initial experiments using ionotropic glutamate receptor blockers
suggested that this form of LTP is independent of AMPA, NMDA and kainite
9+
receptors, dependent on Ca entry into the presynaptic neuron via voltage-gated ion
channels and cAMP signalling (Castillo et al., 1994; Weisskopf et al., 1994; Yeckel
et al., 1999). In later experiments however the selective GluR5 subunit-containing
kainite receptor antagonist 6-(4-carboxyphenyl)-methyl-decahydroisoquinoline-3-
carboxylic acid (LY382884) completely blocked mossy fibre LTP (Bortolotto et al.,
1999). Experiments with different kainite receptor knockout mice suggested the
importance of the GluR6 subunit containing receptor in the mossy fibre LTP
(Contractor et al., 2001).
Long term depression (LTD)
LTD is a long lasting decrease in synaptic strength. Different types of LTD have
been characterized such as the NMDA receptor-dependent, AMPA receptor-
dependent and metabotropic glutamate receptor (mGluR)-dependent forms (Bashir et
al., 1993; Mulkey et al., 1994; O'Mara et al., 1995; Kobayashi et al., 1996; Levenes
et al., 1998; Laezza et al., 1999; Morishita et al., 2005).
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The standard protocol to induce LTD uses long trains of low-frequency (1 Hz)
stimulation or mismatching of pre- and postsynaptic potentials (Dudek and Bear,
1992; Markram et ah, 1997). In earlier experiments LTD was only induced (in the
Schaffer-CAl synapses) in neonatal or juvenile animals using this protocol and not
in adults (Kemp et al., 2000). Novel types of protocols however managed to induce
LTD in the hippocampus of the adult animals as well (Kemp et al., 2000; Chen et al.,
2006). It was proposed that the 2 Hz tetanus-induced LTD is NMDA receptor-
dependent and the 5 Hz tetanus-induced LTD is mGluR-dependent corresponding to
different signalling mechanisms (Chen et al., 2006). LTD could also be produced in
the anterior cingulate cortex (ACC) of the adult mouse (Toyoda et al., 2005).
NMDA receptor-dependent LTD was described in hippocampal CA1 region. It
• • 9+ • •
requires prolonged, low concentration Ca influx and protein phosphatase activity
(Mulkey et al., 1994; Cummings et al., 1996). Serine/threonine protein phosphatase 1
(PP1) was shown to contribute to NMDA receptor-dependent LTD induction
(Mulkey et al., 1994).
The mGluR-dependent LTD type was observed in the CA1 area of the hippocampus,
the dentate gyrus and at mossy fibre-CA3 synapses (Bashir et al., 1993; O'Mara et
al., 1995; Kobayashi et al., 1996). It is blocked by mGluR antagonist (MCPG). The
underlying mechanism was proposed to be the tyrosine dephosphorylation of AMPA
receptors by protein tyrosine phosphatases upon which they are removed from the
synapses (Moult et al., 2006; Huang and Hsu, 2006).
An unusual form of LTD can be observed in the hippocampal CA3 interneurons
• 9+
expressing Ca permeable AMPA channels. Induction of this form of LTD requires
activation of presynaptic mGluRs and postsynaptic Ca2+ influx through AMPA
receptors (Laezza et al., 1999).
Cerebellar LTD at parallel fibre-Purkinje cell synapses is implicated in some forms
• 2+of motor learning. It requires a cascade of Ca influx, mGluR 1 activation, PKCa
activation and serine 880 phosphorylation of GluR2 subunit (Levenes et al., 1998;
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Shin and Linden, 2005). Mossy fibre-deep cerebellar nuclear (DCN) synapses
demonstrate non-NMDA receptor-dependent LTD, which requires mGluR activity
(mGluRl) and protein translation (Zhang and Linden, 2006).
Signalling Involved in LTP, Learning and Memory
Trk mGluR NMDA, AMPA, mGluR
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Figure 3. NMDA Receptor Signalling (Based on Lynch, 2004).
Various signalling cascades via ERK contribute to LTP, learning and memory formation.
NMDA receptors interact with ERK via PI-3K, PKA, PKC or CaMKII.
IE Learning and Memory
The action of the brain includes relatively simple motor behaviours and elaborate
affective and cognitive behaviours. Learning is the process of acquiring knowledge
about the world that falls into the second category. Memory is the retention or
storage of that knowledge. The study of learning and memory is central to
understanding both normal and abnormal behaviour. Early studies of memory
formation suggest that input to the brain is processed in a short-term memory store,
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which has very limited capacity. If the information is converted into long-term
memory, that process requires the synthesis of new proteins and the formation of
new synaptic connections.
Associative and nonassociative learning
Psychologists study learning by exposing animals to information about the world like
sensory experience. The use of two major procedures showed the existence of the
first two distinct forms of learning types that had been thoroughly investigated, the
nonassociative and the associative (Kandel et al., 1991; Milner et al., 1998).
Nonassociative learning results when the animal is exposed to a single type of
stimulus. During associative learning the animal learns the relationship of two
stimuli. There are different subtypes of these learning forms as described below.
Examples for nonassociative learning are habituation or sensitization. Habituation is
a decrease in behavioural response to a repeated, nonnoxious stimulus. Sensitization
or pseudoconditioning means an increased response following an intense or noxious
stimulus. Dishabituation is the process when an already habituated response is
restored by a sensitising stimulus.
When studying associative learning different conditioning experiments were
developed. Classical conditioning was introduced to science by Ivan Pavlov. The
basic concept is to pair an unconditioned stimulus with a conditioned one. The
conditioned stimulus produces no or weak responses. The unconditioned stimulus or
reinforcement produces overt response termed unconditioned response without
learning (for example salivation upon presentation of food). After the conditioned
stimulus has been repeatedly followed by the unconditioned one the conditioned
stimulus will elicit response termed conditioned response. It can be appetitive or
defensive depending on weather the unconditioned response is rewarding or not.
After repeated pairing of the two stimuli the conditioned stimulus will produce the
response previously evoked by the unconditioned one. A widely used type of
classical conditioning is the "rabbit eyeblink response" (Gormezano et al., 1962). It
localized that particular type of memory to the cerebellum (Thompson and Krupa,
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1994; Christian and Thompson, 2003). Recently the cerebellar interpositus nucleus
was implicated in long-term memory storage of tasks leamt in classical conditioning
(Christian and Thompson, 2005).
Operant conditioning was developed by Edward Thorndike. The animal learns the
relationship of one reinforcing stimulus in connection with its own behaviour. An
example of this type of conditioning is when a hungry animal is placed in a cage
where if it presses a lever, it will be given food. The animal learns that a certain
behaviour or response is rewarded and will repeat it.
During food-aversion conditioning animals learn to associate stimuli, which are
relevant to their survival. It enables them to distinguish for example poisonous food
from harmless. If a conditioned stimulus like a particular taste is followed by nausea
caused by poison then a strong aversion will be produced to that flavour. It develops
even if the nausea occurs several hours after the tasting. Food aversion is useful in
the treatment of chronic alcoholism.
Storage of information, implicit and explicit memory
According to the storage and recall of information, long-term memory can be divided
into two categories, implicit, non-declarative or reflexive memory and explicit or
declarative memory (Kandel et al., 1991; Milner et al., 1998; Cooke and Bliss, 2006).
Implicit, non-declarative or reflexive memory is not dependent on comparison or
evaluation and the formation and recall is non-conscious (Kandel et ah, 1991; Milner
et ah, 1998; Cooke and Bliss, 2006). It develops over many trials. Examples of
implicit memory are the learning of perceptual and motor skills or different rules
such as grammar. Different brain areas are involved such as the cerebellum in motor
learning (associative memory); amygdala in emotional responses, leamt fear
(associative memory); the basal ganglia in operant conditioning; the neocortex in
priming or the primary sensory pathways in habituation and sensitization
(nonassociative memory) (Milner et ah, 1998).
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The cerebellum is connected to memories of motor acts. It was thought to be
responsible for only the coordination of voluntary movements (such as posture,
speech) at first. It was however found that the cerebellum is also responsible for
learnt motor responses tested in for example conditioned eye-blink response
(Thompson, 1990; Thach et al., 1992; Thompson and Krupa, 1994; Christian and
Thompson, 2003). The underlying site is the mossy fibre-parallel fibre Purkinje cell
synapse (Thompson et al., 1998).
The amygdala is involved in emotional memory, recognition of emotional expression
in faces (Morris et al., 1996). Electric stimulation to the amygdala produces fear
while damage to the amygdala produces tameness. Blocking noradrenaline receptors
interferes with formation of emotional memory in humans suggesting a role for the
cAMP pathway (Cahill et al., 1994). LTP was previously shown to be existing in
synapses known to be responsible for fear conditioning. It is graded (early and late
phase), in part dependent on NMDA receptor activation and is dependent on PKA
and MAP kinase activity (Chapman et al., 1990; Huang and Kandel, 1998).
Disruption of PKA also interferes with fear conditioning demonstrating that LTP
might account for that type of memory (Schafe et al., 1999). Another group showed
LTP underlying fear conditioning to be AMPA receptor-dependent in the inhibitory
interneurons of the basolateral amygdala (Mahanty and Sah, 1998). The amygdala is
also involved in the enhancement of declarative memory when there is an emotional
implication (Adolphs et al., 1997).
For studying the neocortex-dependent implicit memory type a special task is used
(Warrington and Weiskrantz, 1968). The patients are showed a list of words and
pictures of objects together with novel objects and designs. When later shown a
fragment of a word they tend to complete it to form a word previously studied rather
than any other possible options. Severely amnesic patients have intact priming
however they are unable to recognise the objects previously shown to them
(Warrington and Weiskrantz, 1968; Tulving and Schacter, 1990).
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Explicit, declarative or procedural memory is dependent on comparison or evaluation
and means the conscious recall of things (Kandel et al., 1991; Milner et ah, 1998;
Cooke and Bliss, 2006). It encodes information about a specific event and also
personal associations. It can be obtained in a single trial and is dependent on the
medial temporal lobe and the hippocampus in particular. It can be subdivided into
episodic memory, which is the recall of autobiographical information and semantic
memory, which relates to non-autobiographical facts (Cooke and Bliss, 2006). The
involvement of the medial temporal lobe is involved in spatial, semantic and
recognition memory was shown in functional magnetic resonance imaging (fMRI)
studies (Bartha et al., 2003; Rosenbaum et al., 2004; Kirwan and Stark, 2004). A
well studied example of explicit memory is the spatial learning in mice, which will
be discussed in the next paragraphs.
The case of patient HM served as an initial evidence for the necessity of the medial
temporal lobe in declarative memory (Scoville and Milner, 1957; Penfield and
Milner, 1958; Milner 1972). H.M. underwent bilateral medial temporal lobectomy at
the age of 23 to control severe epileptic seizures. The dramatic result of the surgery
was amnesia for events following the surgery however intact memory for events 19
months prior to the lobectomy and no apparent intellectual loss. In later observations
it was noted that he could acquire new motor skills such as "mirror drawing task"
learnt over a period of three days (Milner and Glickman, 1965; Milner et al., 1989),
but couldn't recall new faces or places thus the hippocampus was implicated in
formation of explicit, but not implicit memory.
In the hippocampus four major pathways can be easily detected, which are the
perforant pathway, the Schaffer collateral pathway, the mossy fibre pathway and the
commissural connections. Experiments with lesions or genetically modified mice
suggest that the Schaffer collateral (CA3 synapses onto CA1 pyramidal cells) has a
major role in the encoding and storage of spatial memory. Interfering with mossy
fibre LTP doesn't affect spatial or contextual memory (Huang et al., 1995).
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Spatial memory in rodents is often tested in the water maze. In the hidden platform
task, the platform is submerged and the animal has to learn the location of the
platform by learning the spatial cues in the environment (Morris et ah, 1982). Once
the training sessions are done during which the animal is supposed to learn the task,
the platform is removed and the animals are assessed by checking how much time
they spend in the quadrant of the previously submerged platform. The visible
platform task is not dependent on the hippocampus and is used as a control.
The correlation between LTP and memory in the Schaffer collateral was shown in
several experiments using pharmacological blockade or genetic modifications.
Knocking out certain genes in a spatially and temporally controlled manner can give
specific information in the underlying processes ofmemory formation. Knocking out
the NR1 subunit of the NMDA receptor in the pyramidal cells of the CA1 region
resulted in disrupted LTP in the Schaffer collateral pathway and the mice displayed
deficits in spatial learning (Tsien et al., 1996b). Expressing a persistently active form
of CaMKII interfered with LTP formation in the hippocampus and the mice were
deficient in spatial learning and memory, however when the transgene was turned
off, LTP and spatial learning were both restored (Mayford et al., 1996). In transgenic
mice expressing R(AB), the inhibitory form of the regulatory subunit of PKA the
PKA activity was reduced, late-phase LTP was reduced in the CA1 region of the
hippocampus and they exhibited spatial learning deficits (Abel et al., 1997).
Disruption of CREB results in deficits of the late-phase LTP and hippocampal-
dependent spatial memory (Bourtchuladze et al., 1994).
In summary interference with E-LTP in the Schaffer collateral blocks L-LTP and
produces deficits in both short and long-term memory while interfering with L-LTP
results in impaired long-term memory however the short-term memory remains
intact.
The hippocampus is also involved in contextual memory tested in contextual
conditioning (Anagnostaras et al., 2001). The task involves learning the environment
as a whole (a context) and associate it with a noxious stimulus such as mild foot
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shock upon which the animal exhibits "freezing". Hippocampal contextual long-term
memory has similar molecular requirements as spatial learning (Mizuno and Giese et
al., 2005). CREB mutant mice that are impaired in spatial learning are also impaired
in contextual memory (Bourtchuladze et al., 1994). The requirement for CREB
activating kinases, which phosphorylate CREB at Serine 133 (Sun et al., 1996), for
example CaMKIV, is similar (Kang et al., 2001). Dominant negative PKA mutants
have impaired long-term memory in contextual conditioning and impaired spatial
memory formation (Abel et al., 1997). Other molecules however have distinct roles
in the two types of long-term memory formation such as the involvement of
CaMKKp (Ca2+ calmodulin kinase kinase phosphorylating CaMKIV) and Rapl
(Ras related small GTPase) in spatial memory and CaMKKa (Ca2+ calmodulin
kinase kinase phosphorylating CaMKIV) and pituitary adenylate cyclase activating
polypeptide (PACAP) type I receptor (PAC1) (G-protein coupled receptor) in
contextual memory (Mizuno and Giese, 2005).
Molecular mechanism of the storage of the memory
Short-term memory lasts minutes to hours requiring only covalent modification of
pre-existing molecules, while long-term memory requires synthesis of new proteins
and growth of new synaptic connections (Bliss and Collinridge, 1993; Frey et al.,
1993; Pittenger and Kandel, 2003). In parallel, LTP in Drosophila and mammals or
long-term facilitation in Aplysia also has stages, which are early-stage LTP (E-LTP)
requiring aCaMKII and fyn and late-stage LTP (L-LTP) requiring PKA, CREB and
protein synthesis (Bliss and Collinridge, 1993; Frey et al., 1993; Yin et al., 1994).
aCaMKII deficient mice display a partial loss of E-LTP in hippocampal CA1
neurons and impaired spatial memory (Silva et al., 1992a; Silva et al., 1992b).
Expression of the dominant negative inhibitor of PKA in the hippocampus and the
forebrain using aCaMKII promoter results in reduced hippocampal PKA activity,
normal E-LTP and decreased L-LTP in the CA1 region in mice (Abel et al., 1997). In
parallel, it also resulted in deficient spatial memory and long-term memory for
contextual fear conditioning (Abel et al., 1997).
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In the conversion of short-term to long-term memory thus cAMP, PKA and CREB is
essential (Find in detail in section ID.). The importance of CREB was shown in
Aplysia, Drosophila and mice as well (Casadio et ah, 1999; Yin et al., 1994;
Bourtchuladze et al., 1994). Mice with targeted disruption of CREB or expressing a
repressor of CREB have disrupted LTP and hippocampal-dependent long-term
memory (Bourtchuladze et al., 1994; Bozon et al., 2003). Mice expressing an
inhibitor of an endogenous CREB repressor have enhanced LTP and long-term
memory (Chen et al., 2003).
IF Involvement of NMDA receptor signalling in learning and
memory
Hippocampal function has been studied by pharmacological experiments using
various receptor antagonists and by analysing genetically modified mice.
Intrahippocampal injection of NMDA receptor antagonists is a more targeted
approach to uncover the role of hippocampus specifically in learning and memory.
Injection of AP-5 prevents spatial learning tested by Morris water maze, which
shows that the NMDA receptor is essential for learning (Morris et al., 1986),
however it is not required for recall of information (Morris et al., 1989). Normal
hippocampal function and AMPA receptor activity is essential for the recall of the
spatial information (Morris et al., 1990). Analysis ofmutant mice also gave evidence
for the importance of the NMDA receptor signalling in learning and memory (Find in
detail in section 1H).
In the hippocampus both NR2A and NR2B subunit-dependent signalling is
implicated in long-term synaptic plasticity (McHugh et al., 1996; Kohr et al., 2003).
It has been suggested that the NR2A containing NMDA receptors are important in
the induction of LTP while NR2B containing receptors are important for LTD in the
hippocampus (Liu et al., 2004). Previous studies however using NR2B
overexpressing mice with enhanced CA1 LTP and long-term memory suggested the
contribution ofNR2B subunits to hippocampal LTP and learning (Tang et al., 1999).
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While the hippocampus is crucial for spatial memory formation, yet it does not store
long-lasting memories, the anterior cingulate cortex (ACC) has been implicated in
remote fear and spatial memory as well (Maviel et ah, 2004; Frankland et ah, 2004).
Both NR2A and NR2B subunits were shown to be important for LTP induction in
the ACC and the NR2B subunit was implicated in mediating contextual fear memory
tested by assessing freezing behaviour (Zhao et ah, 2005). The phosphorylation of
the NMDA receptors, which is thought to be contributing to LTP (Lu et ah, 1998), is
decreased in the ACC compared to the hippocampus in both NR2A and NR2B
containing NMDA receptors (Zhao et ah, 2005). It was hypothesized that while in
the hippocampus the differential phosphorylation of NR2A and NR2B subunits
allows for them to participate in distinct forms of synaptic plasticity (LTP and LTD),
in the ACC the lower basal phosphorylation of the particular subunits doesn't allow
that (Zhao et ah, 2005).
Regulation of NMDA receptors by phosphorylation
Generation of mice carrying mutations in the NMDA receptor phosphorylation sites
or in the kinases, which phosphorylate the NMDA receptor is a very useful tool in
uncovering the role of these molecules in synaptic plasticity, learning and memory
formation. Below are a few examples of these kinases and the effect of various
mutations on hippocampal function and learning ability.
The phosphorylation state of the NR2B subunit of the NMDA receptor is implicated
in LTP in various brain areas. Prenatal ablation of CA1 neurons resulted in decreased
CaMKII-dependent phosphorylation ofNR2A and NR2B and impaired LTP (Caputi
et ah, 1999). After the induction of LTP in the CA1 region of mice it was specifically
the Tyr 1472 residue, which was shown to be phosphorylated (Nakazawa et ah,
2001). In H-Ras knockout mice in the hippocampus the phosphorylation of NR2A
and NR2B subunits is increased, NMDA receptor-dependent synaptic responses are
enhanced and LTP is enhanced (Manabe et ah, 2000). LTP in the dentate gyrus is
also correlated with the phosphorylation of the NR2B subunit (Rosenblum et ah,
1996). Recently generation of Y1472F mutant mice implicated the NR2B Tyr 1472
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phosphorylation in fear learning and synaptic plasticity of the amygdala (Nakazawa
et ah, 2006). The NMDA receptor-dependent CaMKII signalling was impaired, LTP
was reduced in the amygdala and the amygdala-dependent fear learning was




















Figure 4. NMDA Receptor Phosphorylation Sites.
NMDA receptors are highly regulated by tyrosine and serine phosphorylation. Genetically
modified mice carrying mutations in the NMDA receptor and the different kinases helped to
uncover the details of the signalling cascades involved in learning and memory formation.
The phosphorylation sites of the various subunits are displayed.
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NMDA Receptor Phosphorylation Sites
NR1 NK2A NR2B








PKA Ser 897 Tingley et al,
1997

























CaMKII Ser1289 Gardoni et al,
1999
Ser1303 Omkumar et al,
1996
Cdk5 Ser1232 Liet al, 2001
Pyk2 + Linet al, 2001
Unknown Ser1480 Chung et al, 2001
Table 3. NMDA Receptor Phosphorylation sites.
Kinases involved in NMDA receptor signalling phosphorylate the particular receptor subunits
on different serine and tyrosine residues.
Phospholipase C (PLC)-y
The NMDA receptor is highly phosphorylated on serine and tyrosine residues, which
potentiates receptor responses and induces transduction of intracellular signals. An
early event in most signalling pathways is the generation of second messengers
diacylglycerol and inositol 1,4,5-trisphosphate by hydrolysis of phosphatidylinositol
4,5-bisphosphate by PLC. For activation of PLC-y its phosphorylation is essential,
which occurs via its binding to phosphotyrosine residues of receptor tyrosine kinases.
Both NR2A and NR2B subunits of the NMDA receptor bind to the SH2 domain of
PLC-y (Gurd and Bissoon, 1997) triggering various signalling pathways.
Phosphorylation of PLC-y is increased in transgenic mice overexpressing
neurotrophin receptor trkB (Koponen et al., 2004). These mice display enhanced
learning and memory in water maze and conditioned taste aversion tests, suggesting
the importance of the particular signalling cascade.
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Fyn
In the C-terminus of the NR2B subunit 25 tyrosine (Tyr) residues can be found.
Seven out of twenty-five are phosphorylated in vitro (Nakazawa et ah, 2000),
confirmed by phosphopeptide mapping. Coexpression with Fyn in HEK 293 cells
results in the phosphorylation of Tyr 1252, Tyr 1336 and Tyr 1472 (Figure 4, Table
3) with the latter being the major site of phosphorylation (Nakazawa et ah, 2000).
Tyrosine phosphorylation of NR2B by Fyn is responsible for binding of NR2B to
phosphatidylinositol 3-kinase (PI3K). In Fyn deficient mice this binding is decreased
(Hisatsune et ah, 1999). Fyn knock out mice have disrupted hippocampal
morphology and although the NMDA receptor contribution to excitatory
postsynaptic current (EPSC) is normal, they display learning deficits (Grant et ah,
1992).
Ca2+-calmodulin-dependent protein kinase II (CaMKII)
CaMKII directly binds to subunits NR1 and NR2B of the NMDA receptor (Leonard
et ah, 1999) (Find in detail in section 1C.). Residues 1290-1309 of the NR2B subunit
are critical for the interaction. The key residues in this region were identified by site
directed mutagenesis (Strack et ah, 2000), which are Lysine (Lys) 1292, Leucine
(Leu) 1298, Arginine (Arg) 1299, Arg 1300, Glutamine (Glu) 1301 and Ser 1303.
Phosphorylation of Ser 1303 inhibits binding to CaMKII. For recruitment ofCaMKII
to the NMDA receptor residues 1260-1316 of NR2B are sufficient (Leonard et ah,
1999). The deletion of aCaMKII impairs E-LTP in the CA1 neurons of the
hippocampus and spatial learning (Silva et ah, 1992a; Silva et ah, 1992b) (Find in
further detail in section ID and 1H.).
Protein kinase C (PKC)
Protein kinase C phosphorylates subunits NR1, NR2A and NR2B (Leonard and Hell,
1997; Sanchez-Perez et ah, 2005) with NR2B being directly phosphorylated on
residues Ser 1303 and Ser 1323 (Liao et ah, 2001) (Figure 4, Table 3). PKC
activation also induces tyrosine phosphorylation ofNR2B (Grosshans and Browning,
57
2001). Mice lacking PKCy exhibited impaired LTP but only mild learning deficits
(Abeliovich et al., 1993).
Protein kinase A (PKA)
Protein kinase A similarly to PKC phosphorylates the NR1, NR2A and NR2B
subunits of the NMDA receptor (Leonard and Hell, 1997) (Figure 4, Table 3). It has
two regulatory (R) and two catalytic (C) subunits and is physically attached to the
NMDA receptor via a scaffolding protein called yotiao (Lin et ah, 1998), which
directly binds to NR1. PKA R1P or Cpi mutant mice have impaired LTP, but normal
learning (Brandon et ah, 1995; Huang et ah, 1995), which might be due to the fact
that PKA activity was unaffected by the mutation.
Mitogen-activated protein kinase (MAPK) pathway
Apart from the pharmacological evidence, the phenotype of ERK1 and ERK2 knock
out mice show the importance of the MAPK pathway in LTP formation, learning and
memory and also viability (Find in detail in section ID and IE.). ERK1 has a
modulatory function, while ERK2 is required for LTP induction (English et al.,
1996). ERK1 knock out mice show some LTP reduction, but only using certain
electrophysiological protocols (Mazzucchelli et al., 2002). Interestingly they display
improved memory in the two-way avoidance test Mazzucchelli et al., 2002). ERK2
knock out mice are embryonically lethal (Adams et al., 2002).
1G Mouse genome manipulation
General gene targeting
A major milestone in the in vitro technology that enabled the production of mutant
mice was the establishment of embryonic stem (ES) cell lines, derived from the inner
cell mass of pre-implantation embryos (Evans et al., 1981; Martin et al., 1981). They
maintain their pluripotency under the right culture conditions and using them, the in
vitro manipulation of the endogenous gene locus can be achieved by homologous
recombination. The targeting of endogenous loci by homologous recombination is a
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rare event but the use of drug resistance cassettes increases efficiency significantly.
The drug-resistant colonies can however have the targeting vector inserted correctly
or incorrectly. For that reason the clones have to be checked by polymerase chain
reaction (PCR) and Southern blotting to ensure the insertion of the targeting vector
into the right locus. The cultured ES cells carrying the right mutation can be injected
into blastocysts, forming chimaeras with exogenous ES cell contribution to all
somatic tissues (Bradley et al., 1984). If the ES cells contribute to the germ line of
the chimaera, the mutation can be transmitted resulting in mice carrying the mutated
gene in all of their cells (Gossler et al., 1986; Robertson et al., 1986). By crossing
these littermates we can obtain homozygosity.
Conditional gene targeting
In general gene targeting approaches different point mutations are produced or
expression of various genes is abolished in an all or none manner. Knockout mice are
useful to state the importance of a certain molecule in the signalling process of
interest, but in a lot of cases the mutation itself is lethal therefore further
physiological or biochemical analysis of the homozygous mice is not possible. For
that reason the temporal and spatial control of gene expression is very important in
these cases and is widely used for example in the studies of learning and memory
formation. By producing conditional knockouts, it is possible to maintain viability
and have a more thorough investigation of the function of a particular protein not
only in specific brain regions, but also in different phases of memory, for example
encoding versus retrieval.
In conditional gene inactivation techniques loxP or FRT sites as part of the targeting
vector are inserted into specific loci by homologous recombination. These sites are
short, 34 base pair recognition sequences for the bacteriophage recombinase Cre or
the yeast recombinase Flp. In the absence of the particular recombinase the gene
function is maintained, if it is present, recombination of two recognition sites in
series excises the intervening DNA resulting in the loss of gene product. Using this
method the expression of the gene in interest can be ablated in certain brain areas or
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at certain developmental time points by either crossing the mice with Cre-expressing
mice or by injecting the mice with Cre-expressing vectors, such as adenoviruses.
Different Cre-expressing mice have been produced by usage of tissue-specific
promoters. Using the Thy-1 promoter restricts the expression to the brain
(Kellendonk et ah, 1999), while aCaMKII promoter-driven Cre restricts it to the
forebrain (Tsien et ah, 1996a). Different transgenic lines using the same promoter
might however exhibit different expression patterns. A good example is the
aCaMKII-driven Cre line T29-2 line. It exhibits particularly high expression in the
CA1 region with little expression outside the hippocampus (Tsien et ah, 1996a). It
has been useful for the study of CA1 function in synaptic plasticity, learning and
memory (Tsien et ah, 1996a; Tsien et ah, 1996b).
In addition, the Tet system (Find detailed description below.) can regulate Cre
expression in a temporal fashion (St-Onge et ah, 1996), however a Tet-driven Cre
transgenic exhibiting suitably restricted brain expression has not yet been developed.
To combine the advantages of the temporal and spatial control direct injection of
Cre-expressing vectors can be used. One possibility is the usage of the adenoviral
system. Systemic injection of Cre-expressing adenovirus resulted in a wide tissue
distribution, although preference for certain organs was observed while expression
was absent from the brain (Akagi 1997). If green fluorescent protein-expressing
adenovirus is used for the injections (Harding et ah, 1998) the specific brain regions
can be accurately targeted at a chosen time point.
The tetracycline-controlled transcriptional activator (tTA) drives expression via the
tetracycline (Tet) resistance operon (tetO), but in the presence of the tetracycline
analogue, doxycycline, transcription is repressed (Gossen et ah, 1992). Since
doxycycline is stored in muscle and bone, tTA was mutated and a reverse tTA
identified, in which doxycycline stimulates transcription (Gossen et ah, 1995). This
system was used in the production of transgenic mice expressing either a calcium-
independent CaMKII or a calcineurin inhibitor peptide under the control of the tetO
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promoter (Malleret et al., 2001). These animals exhibited phenotypes that were
reversible.
1H Knockouts affecting synaptic plasticity and learning
NMDA receptor transgenic mice
As the central molecule in learning and memory formation, the NMDA receptor is
the obvious target of gene manipulation when trying to determine signalling
pathways involved in the underlying processes. To examine their functional roles all
NMDA receptor subunits have been genetically modified. Most of the mice produced
are global knockouts (the expression of the gene of interest is abolished throughout
the brain), but conditional knockouts (the deletion of the expression of the gene of
interest is located to specific brain areas) and knockins (for example over-expression
models) have also been made.
Global NR1 knockouts have been produced by homologous recombination in
embryonic stem cells. Normal expression of the NR1 subunit is essential to NMDA
receptor function, somatosensory map formation and neonatal survival. In the case
of one of the NR1 global knockouts (Forrest et al., 1994) the NR1 expression is lost
throughout the brain and the NR2B expression is reduced. This mutation is lethal
within a day of birth due to respiratory failure. A complete loss of NMDA-induced
rise in intracellular calcium and a complete loss of whisker-related barrel formation
can be observed (Forrest et al., 1994; Li et al., 1994). The condition can be rescued
by ectopic expression of the NRl-la splice variant and viability is dependent on the
level of expression (Forrest et al., 1994; Li et al., 1994; Iwasato et al, 1997). Another
global NR1 mutant has been produced by homologous recombination (Mohn et al,
1999) in which case the NR1 expression is reduced to about 5-10% of the normal
level. These mice develop to normal size, but have abnormal sexual function,
locomotor and behavioural deficits (Mohn et al, 1999).
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When using a global knockout for studying spatial memory it is not possible to out
rule that the deficits arise from the loss of gene product and its developmental
consequences rather than the lack of hippocampal LTP. It is possible to overcome
these problems if the gene deletion is restricted to a particular area of the brain such
as the CA1 region of the hippocampus (Tsien et ah, 1996a).
NR1 conditional knockouts have been created using cre-loxP recombination. The
expression has been abolished in the hippocampal CA1, CA3 or the cortical region.
When NR1 subunit expression is abolished in the CA1 region of the hippocampus,
mice are viable and develop normally, but LTP and LTD cannot be induced in the
CA1 neurons (Tsien et al., 1996b). However LTP can be induced in the dentate
gyrus. The mice are deficient in spatial learning tasks as tried using the hidden
platform in the Morris water maze test and they have a deficit in relational memory,
however memory consolidation is unaffected (McHugh et al., 1996; Shimizu et al.,
2000). The nonspatial learning abilities were measured using a slightly submerged
platform in the water maze (Kolb et al., 1994) together with a large "landmark" cue.
The animals could perform this task, which only relies on a simple association and is
not hippocampus-dependent (Tsien et al., 1996b). These results show that NMDA
synaptic plasticity in CA1 hippocampal neurons is important in acquisition and
representation of spatial information. Plasticity in CA3 on the other hand is involved
in associative memory. When the NR1 expression is abolished in the CA3 pyramidal
cells in adult mice, NMDA dependent LTP in CA1-CA3 synapses is absent
(Nakazawa et al., 2002). The spatial memory is normal tested by Morris water maze
(Nakazawa et al., 2002), but there is a deficit in pattern completion after some cues
are removed. Cortical NR1 knockouts are viable, but they develop slower than wild
type littermates (Iwasato et al., 2000). NMDA receptor mediated synaptic plasticity
is absent in the barrel cortex. In the barrel cortex there are no barrel boundaries
formed, the cells are distributed uniformly (Iwasato et al., 2000). This shows that the
NMDA receptor activity is required to form maps in the somatosensory cortex. The
maps in the brain stem however are normal.
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Point mutations in the NR1 gene have also been generated by homologous
recombination in embryonic stem cells. Replacing asparagine (N) 598 by glutamine
(Q) or arginine (R) alters the ion channel properties of the NMDA receptor (Single et
al., 2000). The calcium permeability of the ion channel decreases and in the case of
the second mutation the magnesium block is incomplete. Homozygous mice die
within an hour of birth due to respiratory failure and lack of suckling response
(Single et al., 2000). Heterozygous mice can survive up to weeks.
Global NR2 knockouts have also been produced by homologous recombination in
embryonic stem cells. C-terminal deletion mutants and over-expression models are
available. Since it is the NR2B subunit, which is expressed in embryonic stage and
also in juvenile animals, this subunit is the most important in neonatal survival and
somatosensory map formation. Therefore the most severe deficits and lethality can
be observed in NR2B mutants (Find in detail below.).
The NR2A subunit is not expressed in the embryonic brain therefore the global
NR2A knockout mice develop normally and have normal fertility. The neuroanatomy
is normal, the somatosensory maps are intact, but there is a reduction of the NMDA
receptor current and LTP at CA1 synapses (Sakimura et al., 1995). They show
impaired spatial learning in the Morris water maze and deficits in associative
learning (Sakimura et al., 1995). NR2A C-terminal deletion mice are viable and
show similar LTP deficits as the global knockout mutants (Sprengel et al., 1998).
The NR2B subunit is essential for neonatal survival and somatosensory map
formation as it is highly expressed in embryonic brain. The C-terminus of the NR2B
receptor is important for correct synaptic targeting of the NMDA receptor (Mori et
al., 1998) and for normal signal transduction. Global NR2B knockout mice have
been produced by homologous recombination (Kutsuwada et al., 1996). Loss of
barrel formation and lack of LTD in CA1 neurons can be observed (Kutsuwada et al.,
1996). NR2B C-terminal deletion has similar effects as the global knockout, the
barrel formation is disrupted in the brainstem, the number of NMDA receptors,
which are synaptically localized is decreased (Sprengel et al., 1998; Mohrmann et al.,
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2002). The homozygous mice die perinatally (Sprengel et ah, 1998). In culture
conditions the synaptic localization improves when the NR2A subunits are expressed
(Mohrmann et ah, 2002). NR2B knockin was created by pronuclear injection where
the NR2B subunit is overexpressed in the forebrain (Tang et ah, 1999). The
neuroanatomy and development is normal, but LTP is enhanced in CA1 neurons
resulting in improved ability to retain information, better long-term memory (Tang et
ah, 1999).
Two different NR2C knockout strains have been created, the first shows reduction in
the EPSC component mediated by NMDA, the second shows higher EPSC peak
amplitude, but shorter decay time (Ebralidze et ah, 1996). Mice lacking both NR2A
and NR2C subunits display motor coordination deficits (Kadotani et ah, 1996).
Deletion of the C-terminus impairs NMDA dependent LTP (Sprengel et ah, 1998).
NR2D knockout mice grow normally (Ikeda et ah, 1995), suggesting that the role of
the subunit is compensated by NR2B. They display reduced locomotion and reduced
sensitivity to stress (Miyamoto et ah, 2002) measured in elevated maze or forced
swimming tests. NR2D subunit overexpression results in impairement of CA1 LTD
in juvenile mice and CA1 LTP in adult mice (Okabe et ah, 1998). Overexpression
also decreases the development of induced epileptic seizures, which suggests a role
for NR2D in epilepsy (Bengson et ah, 1999).
Mutations in other molecules of the NMDA receptor complex
The NMDA receptor complex (Husi et ah, 2000) consists of numerous proteins
directly interacting with different subunits of the receptor, and a lot more, which are
indirectly linked via other molecules, forming different signalling pathways. The
core is the NMDA receptor, but mutations in the other molecules of the complex can
also generate useful data determining details of signalling pathways involved in
learning and memory formation.
The fact that metabotropic glutamate receptor (mGluR) agonist ACPD enhances LTP
(McGuinness et ah, 1991) was evidence for the involvement of metabotropic
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glutamate receptors in LTP formation and learning. Since mGluR inhibition didn't
consistently block LTP in experiments of different groups (Anwyl et al., 1999),
mutant mice were generated. The mGluRl knockout mice are viable, have normal
hippocampal anatomy (Aiba et al., 1994). They are however deficient in LTD, have
reduced LTP and moderate impairment of associative learning (Aiba and Chen et al.,
1994). LTP is absent at the mossy fiber-CA3 synapses in mGluR2 knockout mice
(Yokoi et al., 1996). Enhanced LTP in CA1 was also reported (Jia et al., 2001), but
conclusion on the changes in spatial learning couldn't be made since mGluR2
knockout mice exhibit reduced exploration. Mutant mice lacking mGluR5 exhibit
impaired CA1 and dentate gyrus (DG) LTP, but normal CA3 LTP (Lu et al., 1997;
Jia et al., 2001). They also exhibit impaired spatial learning (Lu et al., 1997; Jia et al.,
2001). These findings suggest that some forms of learning are dependent on mGluR
activation.
Mutation of some other receptors alters induction of LTP or has an effect on spatial
learning. Serotonin receptor 5-HT(lA) knockout mice have normal CA1 LTP, but
impaired spatial learning (Sarnyai et al., 2000). Serotonin receptor 5-HT(3C)
knockout mice exhibit impaired DG LTP and spatial learning (Heisler et al., 1999).
In TrkB knockout mice both CA1 LTP and spatial learning is impaired (Minichiello
et al., 1999). CA1 LTP is normal, DG LTP is impaired in mu-opioid receptor
knockout mice (Matthies et al., 2000) while nociceptin knockout mice exhibit
enhanced LTP in CA1 and enhanced spatial learning (Noda et al., 2000).
Mutations of many signalling molecules have similar effects to that of the above
receptors. Fyn knockout mice are viable, they develop normally, but LTP in
hippocampal CA1 synapses is impaired and they exhibit impaired spatial learning
tested in the Morris water maze (Grant et al., 1992). Long-term potentiation can be
rescued by introduction of Fyn transgene (Kojima et al., 1997). Alpha-CaMKII
knockout mice are also viable, have no obvious neuroanatomical abnormalities and
have intact NMDA receptor function (Silva and Stevens et al., 1992). They however
have impaired spatial learning and behavioural abnormalities, such as decreased fear
response or increase in defensive aggression (Silva and Paylor et al., 1992; Stevens et
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al., 1994). Impaired CA1 LTP was also shown in alpha-CaMKII knockout mice
(Silva and Stevens et al., 1992; Hinds et al., 1998). Expression of CaMKII-Asp-286
impairs CA1 LTP and spatial memory, however contextual memory remains normal
(Bach et al., 1995). PKCy knockout mice have reduced LTP in hippocampal CA1
synapses (Abeliovitch et al., 1993) and impaired spatial learning (Abeliovitch et al.,
1993). Knocking out SynGAP or expressing inhibitory PKA regulatory subunit (eg.
R(AB) mice) impairs both CA1 LTP and spatial learning (Abel et al., 1997;
Komiyama et al., 2002).
Some structural proteins, presynaptic molecules have also been mutated triggering
changes in LTP or spatial memory. Neural-cell adhesion molecule (N-CAM)
knockout mice have normal LTP, but impaired spatial learning (Bliss et al., 2000).
Thy-1 knockout mice are viable, show impairment in DG LTP, but normal spatial
learning (Nosten-Bertrand, 1996). Overexpression of presynaptic protein GAP43
enhances LTP in the dentate gyrus and enhances spatial learning (Routtenberg et al.,
2000). Abolishing somatostatin (type2) expression leaves the LTP normal, but again
spatial learning is enhanced (Dutar et al., 2002).
In some of the above examples the changes in hippocampal LTP coincide with the
changes in spatial learning, in others the correlation is not coincident. These
differences contribute to the debate whether LTP and spatial learning is based on the
same cellular mechanism, if LTP is a model for some forms of learning. Some
studies showed that saturating LTP impairs spatial learning (Castro et al., 1989),
some others failed to find correlation. Reasons for LTP not blocking learning might
be that LTP was induced in the wrong pathway or to a lesser extent than required
(Bliss et al., 1993). On the other hand evidences for sharing the same cellular
mechanism are that they both are accompanied by glutamate release, PKC or ERK
activation; they both are inhibited by AP-5 (Morris et al., 1986); and both LTP and
spatial learning is decreased in aged or stressed rats (Rapp et al., 1987). The findings




Analysis of different mouse mutants has been a successful approach in examining the
functions of different genes and gene products. It is possible to introduce point
mutations, to delete certain sequences or whole genes. The effects of these mutations
can be analysed in vitro using embryonic stem (ES) cells and in vivo by generating
the mutant mice by injecting the ES cells carrying the mutation back into the host
blastocyst. The evolution of different gene targeting techniques and the increasing
amount of data available enables laboratories to use this type of analysis in all fields
of research.
The aim of this project is to acquire basic knowledge on the molecular mechanisms
of NMDA ion channel and receptor function, learning and memory by producing
mice carrying different mutations in the C-terminus of the NR2B subunit of the
NMDA receptor, which is believed to be involved in different signalling pathways as
a part of a multi-component signalling complex. Its binding partners can be
categorised into two major groups. One is the MAGUK proteins, which all contain
PDZ domains via which they bind to the E-S/T-X-V motif located at the extreme C-
termini of the NR2 subunits. A few of these proteins are PSD-95, chapsyn-110 or
SAP 102. These further interact with nNOS (Holscher et al., 1997), fyn (Grant et al.,
1992) or SynGAP (Chen et al., 1998). The other group is the non-MAGUK proteins,
which bind to sites of the C-terminus other than the terminal E-S/T-X-V motif and
include for example CaMKII, PLC-y and PKC.
I introduced three different mutations into the C-terminus of the NR2B subunit of the
NMDA receptor. One is designed to ablate the interactions with the PDZ domain
containing molecules by deleting the terminal valine from the E-S/T-X-V motif of
the NR2B C-terminus (NR2B DelValine mutation). The other is designed to prevent
the interaction between the NR2B subunit and CaMKII by modifying key residues in
the binding site (NR2B CaMKII mutation). The third, when deleting the COOH-exon
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of the NR2B subunit and replacing it by that of the NR2A (NR2A/NR2B SWAP
mutation), reveals the functional differences between the NR2A and NR2B subunits
and the importance of the interactions via the NR2B cytoplasmic tail.
In further sections abbreviations will be used for various mutations generated and
different mutant mice already available, which were used for breeding purposes. In
the case of the NR2B DelValine mutation the ES cell clones will be named DelVal
and their respective number (eg. DelVal 8-8). The chimaera with which we achieved
germline transmission will be called DelVal 8-8 chimaera coming from the name of
the ES cell line it originated from. In the NR2B CaMKII mutation the ES cell clones
will be referred to as CaMKII and their respective number (eg. CaMKII 1-6) while in
the case of the NR2A/NR2B SWAP mutation, NR2A and their respective number
(eg. NR2A 2-20). Mice expressing C-terminal truncated forms of NR2A or NR2B
subunits (Sprengel et al., 1998) will be referred to as NR2AAt and NR2BAC
respectively.
68
Chapter 2: Materials and Methods
2A Techniques related to manipulation of DNA
Vector preparation, subcloning
Small-scale plasmid purification was achieved using Promega's Wizard Plus
Minipreps DNA Purification System. One colony was inoculated into 3 ml of LB
media, incubated overnight at 37 °C providing appropriate aeration by shaking at 225
rpm. The saturated culture was spun at 10000 g in a picofuge for 2 minutes and the
resulting pellet was resuspended in 200 pi Cell Resuspension Solution (50 mM Tris-
HC1 pH 7.5, 10 mM EDTA, 100 pg/ml Rnase A). 200 pi Cell Lysis Solution (0.2 M
NaOH, 1% SDS) was added followed by 200 pi Neutralization Solution (1.32 M
potassium acetate pH 4.8). The tube was spun at 14000 rpm for 5 minutes and the
DNA containing supernatant was transferred into a new tube and mixed with 1 ml of
DNA Purification Resin. The mixture was filtered through a Minicolumn and washed
with 2 ml Column Wash Solution (80 mM potassium acetate, 8.3 mM Tris-HCl pH
7.5, 40 pM EDTA, 55% ethanol). 50 pi TE (lOmM Tris-Cl pH 8.0, 1 mM EDTA)
buffer was added to the Minicolumn and the plasmid DNA was eluted by spinning at
14000 rpm for 30 seconds. The DNA was stored at -20 °C.
Large-scale plasmid purification was achieved using Qiagen's Plasmid Midi Kit. A
few colonies were inoculated into 50 ml of LB media, incubated overnight at 37 °C
providing appropriate aeration by shaking at 225 rpm. The saturated culture was spun
in a Falcon tube at 3000 rpm for 15 minutes at 4 °C. The pellet was resuspended in 4
ml buffer PI (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 100 pg/ml Rnase A) and the
solution was transferred into a Falcon 2059 tube. 4 ml buffer P2 (0.2 M NaOH, 1%
SDS) was added followed by 4 ml buffer P3 (3.0 M potassium acetate pH 5.5). A
midiprep column was washed with 10 ml buffer QBT (750 mM NaCl, 50 mM MOPS
pH 7.0, 15% isopropanol, 0.15% triton X-100), then the solution was added and the
column was washed with 10 ml buffer QC (1 M NaCl, 50 mM MOPS pH 7.0, 15%
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isopropanol) twice. The DNA was eluted with 5 ml buffer QF (1.25 M NaCl, 50 mM
Tris-HCl pH 8.5, 15% isopropanol), mixed with 3.5 ml isopropanol and spun at 8000
rpm for 30 minutes at 4 °C. The pellet was washed with 2 ml 70% ethanol, spun at
8000 rpm for 10 minutes at 4 °C, air-dried and resuspended in 0.5 ml TE (10 mM
Tris-Cl pH 8.0, 1 mM EDTA) buffer. The DNA was stored at -20 °C.
Restriction digestion of DNA
Digests were performed at 10 unit restriction enzyme per pg DNA, in reactions of
50-100 pg/ml DNA using lx restriction enzyme buffer for 1-2 hours at the
recommended temperature. After digestion the DNA fragment of interest was
separated from other fragments by electrophoresis on a 0.8 - 2% agarose gel and
recovered from the gel. When the digestion was used for vector linearization
approximately 200 ng digest was run alongside uncut DNA on a gel to check
digestion. The linearised vector was purified by phenol: chloroform extraction and
ethanol precipitation. When used for ligations with phosphorylated insert, the vector
was dephosphorylated before purification to prevent self-ligation.
Dephosphorylation of vector DNA
Dephosphorylation of the vector 5' end was performed to prevent self-ligation of
vector digested with only one restriction enzyme. Directly following vector
restriction digestion, 3 units of calf intestinal alkaline phosphatase per pg vector
DNA was added (CIAP, Boehringer Mannheim). After incubating for one hour at 37
°C, extra 0.5 units CIAP per pg vector DNA was added, followed by 15 minutes
incubation at 55 °C. The entire reaction was run on a 1% agarose gel to separate the
vector backbone from the stuffer fragment before recovering the dephosphorylated
vector from the gel, using the phenol: chloroform extraction method. CIAP-treated
DNA requires phenol: chloroform extractions twice (Stratagene Catalogue) to
separate the CIAP as it binds strongly to the DNA.
Phenol: chloroform: isoamyl alcohol extraction of DNA
After estimating the volume of the DNA solution an equal volume of phenol:
chloroform: isoamyl alcohol solution (25:24:1) was added. The mixture was vortexed
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or if purifying genomic DNA inverted 6 times to minimize shearing and spun at
14000 g for 3 minutes. The aqueous top phase was transferred into a new tube and to
the phenol phase equivalent volume of TE (0.1 mM EDTA, 10 mM Tris-ElCl pH 8)
was added. After vortexing and spinning again the aqueous layer was transferred to
the new tube to ensure maximum DNA recovery. The DNA was then ethanol
precipitated.
Ethanol precipitation of DNA
After estimating the volume of the DNA solution 3 M Potassium Acetate (pH 5.2)
was added to a final concentration of 0.3 M followed by two volumes -20 °C ethanol.
The mixed solution was incubated in the -70 °C freezer or snap frozen in liquid
nitrogen to allow DNA precipitation for 15-20 min. DNA was recovered by spinning
at 4 °C for 10 minutes at 14000 g (10,500 rpm SS-35). After removing the
supernatant the tube was filled halfway with ice cold 70% ethanol and spun at 14000
g for 2 minutes at 4 °C (10500rpm SS-35). The resulting pellet was air-dried at room
temperature and dissolved in TE. After phenol: chloroform: IAA DNA extraction
and ethanol precipitation, DNA recovery should be above 80%.
Recovery of DNA from agarose gels (phenol method)
The desired DNA band was excised from the gel using a sterile blade. After
estimating the volume of the gel piece it was doubled with TE buffer then melted at
65 °C for 5-10 minutes. Equal volume of Tris-buffered phenol was added and after
mixing the tube was spun for 3 minutes at 10-12000 rpm. The aqueous phase was
transferred to a new tube and the phenol extraction step was repeated. 0.1 volume of
4 M lithium chloride was added to the aqueous solution and after the formation of a
white precipitate the tube was placed on ice for two minutes, spun for 3 minutes at
10-12000 rpm. 1 pi of carrier (glycogen) and 2.5 volumes of cold ethanol were added
to the aqueous phase, which was transferred to a new tube. The sample was snap
frozen in liquid nitrogen to precipitate and spun as previously at 10-12000 rpm for 10
minutes. The pellet was washed with 1 ml 70% ethanol, air-dried and resuspended in
10-20 pi of TE buffer.
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Recovery of DNA from agarose gels using BIO101 Geneclean Spin Kit
When smaller amount of DNA was available and when working with smaller DNA
fragments BIOlOl's Geneclean Spin Kit was used for recovering the desired
fragments from agarose gel. The standard protocol described in the kit was used. The
elution was achieved by adding 11 pi TE buffer to the Spin Filter and spinning for 30
seconds at 10-12000 rpm. This step was repeated twice for increasing DNA yield.
Ligation of insert and vector
The vector and the insert was ligated in reactions containing 50 ng or 100 ng vector
with a varying insert to vector ratios of 1:1 to 5:1. The control reactions were to
assay for re-ligation of the digested vector (no insert DNA control), to monitor
ligation reagents for contaminants (no DNA control), to check for contaminating
plasmids (competent cells only) and to monitor for background level (no ligase). The
ligation reactions were set up containing 3 units of T4 DNA ligase (Promega) in lx
ligase buffer. The tubes were incubated on ice overnight and competent E. coli cells
were transformed with the ligation mixture next day.
Preparation of chemical competent cells
The DH5a cells were spread onto a bacterial plate from glycerol stock-solution kept
at -20 °C and the plate was incubated overnight at 37 °C. A few colonies were
inoculated into a 50 ml LB media-containing beaker next day and incubated
overnight at 37 °C providing appropriate aeration by shaking at 225 rpm. The
following day the saturated culture was diluted 100X into 10 ml of fresh LB media
and incubated at 37 °C while shaking at 225 rpm until the optical density reached
0.6-0.7. After incubating on ice for 5 minutes the culture was spun at 3000 rpm for
15 minutes in the cold room. The pellet was then dissolved in 1 ml 10 mM CaCb
solution by shaking then diluted to 10 ml. After incubating on ice for 1 hour the
culture was spun again at 3000 rpm for 15 minutes in the cold room. The pellet was
resuspended in a final volume of 1 ml 10 mM CaCh solution. 100 pi cell suspension
was used per transformation.
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Transformation of chemical competent cells
5 pi of DNA ligation mixture was added to a 100 pi aliquot of competent cells. The
tubes were incubated on ice for 20 minutes followed by a 1-minute heat shock at 42
°C to allow DNA uptake by the cells. After 5 more minutes of incubation on ice 900
pi of SOC medium (1.5 mL SOB base; 7.5 pi 2M MgCh; 30 pi 1M glucose) was
added to the cells. The tubes were shaken at 225 rpm, 37 °C for 45 minutes to allow
expression of the ampicillin resistance gene. For vector stock transformations 50-100
pi of the culture was spread onto L-agar plates containing the appropriate antibiotics.
For ligation reactions the cells were pelleted by spinning at 3000 rpm for 2 minutes,
resuspended in 100-200 pi of the supernatant and plated out using 100 pi stock.
Preparation of electro competent cells
The DH5a cells were spread onto a bacterial plate from glycerol stock-solution kept
at -20 °C and the plate was incubated overnight at 37 °C. A few colonies were
inoculated into a 50 ml LB media-containing beaker next day and incubated
overnight at 37 °C providing appropriate aeration by shaking at 225 rpm. The
following day the saturated culture was diluted 100X by adding 2,5 ml solution to
250 ml of fresh LB media and incubated at 37 °C while shaking at 225 rpm until the
optical density reached 0.6-0.7. After incubating on ice for 30 minutes the culture
was poured into 4 Falcon tubes, each containing 45 ml and spun at 3000 rpm for 15
minutes in the cold room. The supernatant was decanted and the rest of the culture
solution was added and the tube was spun again. The pellet was then dissolved in 45
ml 10% glycerol spun at 3000 rpm for 5 minutes in cold room. This step was
repeated twice and the pellet was resuspended into a final volume of 150 pi. The
contents of the four tubes were merged and the solution was aliquoted into 0.5 ml
eppendorf tubes (40 pi each). The tubes were snap frozen in liquid nitrogen and
stored at -80 °C.
Transformation of electro competent cells
An aliquot of electro competent cells was thawed on ice and 5pi of DNA ligation
mixture was added. The cell-DNA mixture was transferred into a prechilled Gene
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Pulser (BioRad) cuvette and was electroporated at 25 pF, 200 £2, 2,5 kV. After
electroporation 900pl of SOC medium (1.5 mL SOB base [2% tryptone, 0.5% yeast
extract, 10 mM NaCl]; 7.5 pi 2 M MgCl2; 30 pi 1 M glucose) was added to the cells.
The rest of the procedure was the same when using chemical competent cells.
Sequencing reaction for automated sequencer
PCR reactions were carried out on Omnigene (Hybaid) or Mastercycler gradient
(Eppendorf) PCR machines. The dNTPs were supplied by Roche.
The reaction mixture was prepared in a total volume of 10 pi containing 0.5 pg DNA
template, 1 pi of 3.2 pmol/pl primer, 4 pi Big Dye Terminator Ready Reaction Mix
and dFf20 up to 10 pi. A drop of mineral oil was added to the tube and the
sequencing reaction (96 °C 30 seconds, 50 °C 15 seconds, 60 °C 4 minutes repeated
25 times) was run. After the program finished, 10 pi dH20 was added to the reaction
mixture to increase the volume and the whole solution was removed from under the
mineral oil and transferred into a new tube. 2 pi 3 M sodium acetate pH 4.6 and 50
pi 95% ethanol was added to the tube and incubated on ice for 15 minutes. The
solution was spun at 14000 rpm for 20 minutes increasing the speed gradually. The
pellet was washed with 120 pi 70% ethanol, air-dried and resuspended in 4 pi ABI
loading buffer (deionised formamide and 25 mM EDTA pH 8.0 containing 50 mg/ml
Blue dextran in a ratio of 5:1 formamide to EDTA/Blue dextran). The samples were
sequenced in ABI PRISM 310 Genetic Analyzer.
Analysis of embryonic stem cell derived genomic DNA
Southern Blotting
Preparation of filter
Genomic DNA was digested with the appropriate high concentration enzyme
overnight. A small amount of extra enzyme was added the next day and the samples
were further incubated for 6-8 hours to ensure complete digestion. The samples were
run on an agarose gel containing no ethidium bromide at 12-18 V overnight. The gel
was stained and photographed as normal then immersed in 0.2 N HC1 for 10 minutes,
in 0.5 M NaOH; 1.5 M NaCl for 45min followed by 30 minute incubation in 1 M
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Tris-Cl pH 7.4; 1.5 M NaCl. Between each step the gel was rinsed with dH^O. The
gel was then placed on a gel tank turned upside down, which was previously covered
with a layer of dFBO and Saran wrap in a way that no air bubbles were present. A
piece of nitrocellulose (Hybond™-N) was cut to the same dimensions as the gel and
was given an orientation marker. The nitrocellulose was carefully placed onto the gel
followed by 3 mm Whatman filter paper cut to the same dimensions as the gel.
Finally a stack of Kleenex paper was placed on top enough that it stood at 10-15 cm
of height. A gel tray and a small weight was placed on he top of the stack and the
filter was left that way overnight at room temperature. Next day the sheets of paper
were removed with forceps and the DNA was crosslinked to the filter using UV.
Prehybridisation
The hybridisation tube was pre-warmed to 65 °C. The prehybridisation solution (27
ml of 6X SSC and 0.5% SDS, 3 ml of 50X Denhardts (BSA, Ficoll, PVP), 300 pi of
Salmon Testes DNA previously fragmented by boiling at 100 °C for 5 minutes and
placing it on ice for 2 minutes) was prepared and poured into the hybridisation tube.
The filter was soaked in 20X SSC for 5 seconds and placed into the hybridisation
tube with the DNA facing to the inside of the tube. The tube was then rotated at 65
°C for 4 hours.
Probing the filter
The DNA probe to be labelled was diluted to a concentration of 2.5-25 ng/45 pi in
TE buffer, denatured by heating to 95-100 °C for 5 minutes in water bath and placed
on ice for 5 minutes. The DNA then was added to the reaction tube of Rediprime1M
II, random prime labelling system (Amersham Pharmacia), mixed with 5 pi Redivue
[32P] dCTP and mix and incubated at 37 °C for 10 minutes. 5 pi 0.2 M EDTA was
added to stop the reaction and the reaction mixture was added to a ProbeQuant G-50
Microcolumn, spun at 3000 rpm for 1 minute. The labelled DNA was denatured by
heating to 95-100 °C for 5 minutes in water bath then placed on ice for 5 minutes.
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The freshly prepared probe was added to the hybridisation solution and the filter was
then incubated at 65 °C overnight.
Washing the filter
The hybridisation solution was discarded from the tube and the filter was rinsed with
65 °C wash buffer 1 (2X SSC, 0.5% SDS). After rinsing twice 30 ml wash buffer 1
was added and the hybridisation tube was rotated at 65 °C for 10 minutes. The
additional steps were using 30 ml wash buffer 1 for another 10 minutes, 30 ml wash
buffer 2 (IX SSC, 0.25% SDS) for 15 minutes and 30 ml wash with buffer 3 (0.5X
SSC, 0.1% SDS) for 15 minutes if the background was still high. The filter then was
wrapped in Saran wrap while still damp, placed into a cassette. Kodak X-ray film
was placed over the filter in the dark room and the cassette was left at -80 °C to
expose. The film was developed 3-5 days later.
Genotyping
Preparation of high molecular weight (HMW) DNA from mouse tails
Mice were earmarked at three weeks of age and half an inch of tail was cut and
placed into 750 pi of tail buffer (50 mM Tris pH 8.0, 1 mM EDTA, 1 mM NaCl, 1%
SDS). After adding 30 pi of 10 mg/ml Proteinase K the tail was incubated in a
rotator at 55 °C overnight. Next day 20 pi of 30 mg/ml RNAse A was added and the
tube was incubated in water bath at 37 °C for 1 hour. 500 pi of phenol was then
added and the tail was rotated overnight at 4 °C. Next day the tube was spun at
14000 rpm for 5 minutes, the aqueous top layer and interphase was transferred into a
new tube. 500 pi of phenol: chloroform: isoamyl alcohol solution (25:24:1) was
added and rotating for 4 hours at 4 °C the tube was spun at 14000 rpm for 5 minutes.
The aqueous top layer was transferred into a new tube and the previous cleaning step
was repeated using 500 pi of chloroform: isoamyl alcohol solution (24:1). 1 ml of
isopropanyl alcohol was added to the final aqueous top layer and upon gentle mixing
the precipitation of fibrous HMW DNA could be observed. The DNA was spooled
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with a yellow tip, dipped briefly into 70% ethanol then placed into 100 pi of TE (pH
7.4). The DNA was allowed to resuspend overnight at 4 °C.
NR2Aac genotyping
The mastermix (5 pi 10X buffer, 5 pi DMSO, 1 pi lOmM dNTP's, 1 pi 40 pM
primer RsplO, 1 pi 40 pM primer Rsp 26, 34.75 pi dT^O, 0.25 pi Qiagen Hot Star
Taq added last after 2.5 minute UV irradiation of the mastermix) was prepared and
48 pi was dispensed per tube. 2 pi of tail DNA solution was added to each sample
and the samples were run on Hybaid PCR machine (15 minutes at 95 °C then 40
cycles of 30 seconds at 94 °C, 1 minute at 57 °C, 3 minutes at 72 °C).
NR2Bac genotyping
The mastermix (5 pi 10X buffer, 1 pi lOmM dNTP's, 1 pi 40 pM primer NR2B-1, 1
pi 40 pM primer NR2B-3, 39.75 pi dH20, 0.25 pi Qiagen Hot Star Taq added last
after 2.5 minute UV irradiation of the mastermix) was prepared and 48 pi was
dispensed per tube. 2 pi of tail DNA solution was added to each sample and the
samples were run on Hybaid PCR machine (15 minutes at 95 °C then 35 cycles of 20
seconds at 94 °C, 30 seconds at 55 °C, 1 minute at 72 °C then a final 10 minutes at
72 °C). The homozygous band is 1311 bp, the WT band is 136 bp.
NR2B DelValine genotyping
Reaction using Qiagen Hot Star Taq
The mastermix (5 pi 10X buffer, 1 pi lOmM dNTP's, 1 pi 40 pM primer 1, 1 pi 40
pM primer 2, 39.75 pi d^O, 0.25 pi Qiagen Hot Star Taq added last after 2.5
minute UV irradiation of the mastermix) was prepared and 48 pi was dispensed per
tube. 2 pi of tail DNA solution was added to each sample and the samples were run
on Hybaid PCR machine (15 minutes at 95 °C then 35 cycles of 20 seconds at 94 °C,
30 seconds at 65 °C, 2 minute at 72 °C then a final 10 minutes at 72 °C). For the
analysis different combinations of primers A (NR2B 5910), B (pLox 413), C (pLox
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1540) and D (NR2B 6456) and primers A' (SWAP NR2A 3924), B' (pLox 91), C'
(pLox 1603) and D' (NR2B 8035) were used explained in the figure below.
Reaction using Long Range PCR
25 pi of mastermix A (20 pi dLLO, 0.6 pi 25mM dNTP's, 2 pi 20 pM primer NR2B
5910, 2 pi 20 pM primer NR2B 6456 per tube), 19 pi of mastermix B (16 pi dLLO, 5
pi buffer 1), 2 pi of dLLO and 2 pi tail DNA was combined and mixed. Samples
were run on Eppendorf PCR machine. After 30 seconds at 93 °C the reaction was
paused and incubated at 93 °C for 15 minutes (hot start) and 1 pi expand enzyme
(Roche) was added to each sample. The reaction was then restarted (10 cycles of 10
seconds at 93 °C, 30 seconds at 60 °C, 2 minutes at 65 °C then 20 cycles of 10
seconds at 93 °C, 30 seconds at 60 °C, 2 minutes at 65 °C with 20 seconds of
increment followed by 7 minutes incubation at 68 °C).
Analysis of results
The offsprings were first genotyped using three different combinations of primers A
(NR2B 5910), B (pLox 413), C (pLox 1540) and D (NR2B 6456) with Qiagen Hot
Star Taq. The reaction with Long Range PCR used primers NR2B 5910 and NR2B
6456. Depending on the primers and the reaction used different sizes of bands or
none were amplified. Comparing the results of the different reactions (Find in detail
in the table below.) the genotype could be specified.
In wild type mice AXB and CXD combination didn't result in amplification because
of the lack of the neo cassette while the AXD combination gave a 546 base pair band
(-0.5 kB). In the heterozygous offsprings a 642 base pair band was amplified in the
AXB combination, a 546 base pair band in the AXD combination (-0.5 kB) and an
extra 2346 base pair band using Long Range PCR. In homozygous mice (further
described) we got a 642 base pair band in the AXB and a 734 base pair band in the
CXD combination (-0.5 kB). The AXD combination produced a 2.3 kB homozygous
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band, but only using Long Range PCR since the Taq polymerase can't amplify that
size fragment.
Another set of primers was designed to get a larger band that is easier to visualize,
which were primers A' (SWAP NR2A 3924), B' (pLox 91), C' (pLox 1603) and D'
(NR2B 8035). By using the Qiagen Hot Star Taq system and primer combination
A'XB' a -2.3 kB band was obtained in heterozygous and homozygous mice and no
band in wild type mice. By using the Qiagen Hot Star Taq system and the primer
combination C'XD' a -2 kB band was obtained in heterozygous and homozygous
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2B Tissue culture of embryonic stem cells
The main supplier of the tissue culture is Iwaki from Bibby Sterilin. Other suppliers
used are Falcon, Corning and Nunc.
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The 25, 75 and 150 cm2flasks; 6, 12, 24 and 96 well plates; and the 100 mm dishes
were provided by Iwaki. The 4 and 48 well plates, the 1 ml cryotubes were provided
by Nunc. The 30 ml universals and the 30, 60 and 100 mm petri dishes were
purchased from Bibby Sterilin. The 15 and 150 ml tubes, the 60 mm dishes were
provided by Corning. The electroporation cuvette was purchased from Biorad.
Media preparation
All media was prepared in the Class II cabinets using sterile technique. For 440 ml (1
bottle) media 380 ml of IX GMEM, 4 ml of non-essential amino acids, 8 ml of
glutamine: sodium pyruvate mixture, 400 pi ofmercaptoethanol and 40 ml of foetal
calf serum (FCS) was mixed. Once the media was prepared a TESTER was set up
(5ml of media should be added to the 5ml tester) and incubated overnight to ensure
sterility. For ES cells lul of leukemia inhibitory factor (LIF) / ml of media was added
to get a final concentration of 1000 units LIF/ ml media.
Thawing embryonic stem cells
E14TG2a cells were kept in liquid nitrogen storage in individual vials. When
thawing the cells, 9.5 ml of prewarmed media was placed into a universal. The
frozen cells were retrieved from the liquid nitrogen and thawed as quickly as possible
by placing them in the 37 °C water bath or by holding the vial in bare hand. The cells
then were transferred into the warm media to dilute out the DMSO in which the cells
had been frozen. The cells were then spun at 1000 rpm for 5 minutes, resuspended in
an adequate amount of prewarmed media and transferred to an appropriate flask
followed by gassing with a C02/air mixture (5%/95%). The cells were then placed in
the tissue culture incubator at 37 °C and 5% CO2.
Passaging embryonic stem cells
The cell culture grown to 80-90% confluence was washed with PBS twice after
removing the media by aspirator. Appropriate volume of trypsin was added (1ml for
small flask, 0.5 ml for 1 well of a 6 well plate or 4 drops of trypsin for 1 well of a 24
well plate) and the culture was placed into the incubator for approximately for 4
minutes. The flask was then tapped gently to dissociate the cells and placed back into
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the incubator for 1 minute. 4 ml of media was added for 1ml of trypsin to stop the
action of the trypsin, the cells were then transferred to a universal and spun for 5
minutes at 1200 rpm. The resuspended cells (in 5 ml media) were counted using a
6 2
haemocytometer and 10 cells were added to a 25 cm gelatinised flask. The number
of cells added to larger flasks was adjusted accordingly. The flask was gassed with
5%C02/95% air mixture and returned to the incubator.
Freezing embryonic stem cells
10% DMSO in culture media was used as freezing solution prepared by adding 2 ml
of DMSO to 18 ml ofmedia to provide a stock solution.
The cells were trypsinised as normal, but at the end of the procedure they were
resuspended in an appropriate volume of freezing solution instead of media. 0.5 ml
cell suspension was placed into each cryotube and stored in the -80 °C freezer
overnight, then transferred to the cellbank the following day.
Embryonic stem cell electroporation
150 pg of vector was linearised with NotI, precipitated, washed with 70% ethanol
and resuspended in 100 pi PBS the night before electroporation. E14TG2a cells were
grown up from frozen stock to yield about 5xl07 cells, trypsinised and resuspended
in a final volume of PBS that gave about 1X108 cells/600 pi. Using a plugged pipette
the cells were added to the electroporation cuvette followed by the 100 pi DNA
solution. The cuvette was placed in the gene pulsar and the cells were electroporated
at 0.8 kV, 3 pF. (Time constant should be 0.1 s.) The mixture was then incubated in
the cuvette at room temperature for 10 minutes. After incubation the cells were
added to 20 ml warm media and plated in 10 cm tissue culture dishes at densities of
5xl06, 106, 5x10 s and 10 s cells per plate. G418 (200 pg/ml) was added one day after
electroporation and selection was continued for 10 days.
A large number of colonies were picked 10-12 days after electroporation and grown
up in 24 well plates. The confluent wells were split to generate one plate to freeze
for later expansion of cell line and a duplicate plate from which DNA was extracted
for analysis by Southern blotting.
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Picking colonies
Two drops of trypsin or media was added to alternate rows of 96 well plates. Well-
separated colonies were chosen and marked on the underside of the plate. The plate
was washed with PBS twice then 5 ml PBS was added. A p200 Gilson pipette set to
50 pi was used to pick up the colony by scraping it off the plate and drawing it into
the pipette tip. The colony was placed into the prepared 96 well plate and was
dissociated. The solution containing the cells was then transferred into 1 well of a 24
well plate and 1.5 ml of media was added.
Extraction of genomic DNA from embryonic stem cells in culture
The extraction buffer contains 0.1 M EDTA, 0.2 M NaCl, 0.05 M Tris-HCl pH 8,
0.5% SDS and 50 pg/ml DNase-free RNase.
For large scale extraction 108 cells were grown up as a monolayer and the cells were
recovered by trypsinisation. Trypsin was quenched with media and transferred to a
50 ml Falcon tube. The tube was centrifuged at 500 g for 10 minutes and the cell
pellet resuspended in 20 ml Extraction Buffer. Proteinase K was added to achieve
100 pg/ml concentration and gently mixed. The tube was incubated in the water bath
for 3 hours, gently inverting the tube every 20 minutes. The solution should be
reasonably clear and viscous at the end of the incubation. The solution then was
transferred to a large beaker and 20 ml of pre-equilibrated phenol: chloroform: IAA
(first check pH = 8) was added. The beaker was then gently swirled by hand for 10-
15 minutes to mix the two phases. After transferring the mixture to a 50 ml plastic
tube it was centrifuged at 1500 g for 10 minutes at room temperature to separate the
phases. The aqueous phase was removed into a new tube using a 5 ml disposable
pipette tip, which had the end cut off. The aqueous phase was dialysed against 1000
volume of TE.
For small scale extraction from a 24 well plate 500 pi of extraction buffer/well was
used and extraction was performed overnight at 37 °C as normal. 500 pi phenol then
500 pi phenol: chloroform: IAA was used for cleaning of DNA. The genomic DNA
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was then used in the resulting form or the procedure used previously was followed
and the DNA was resuspended in 100 pi TE buffer.
2C Animals
All animals were housed and treated in accordance with the animals (scientific
procedures) act 1986. Animals were housed in a 12:12 hour light dark cycle with
food and water provided ad libitum. Wild type littermate controls were used with the
mutants.
Targeted gene replacement in mice
Embryonic stem cells (E14TG2a) isolated from the light coloured 129 P2/01a Hsd
mouse strain were targeted to carry the mutations specified before in one
chromosome. These cells were then injected into blastocyst-stage embryos coming
from superovulated and mated C57B1/6 mice where upon survival they assimilated
into the inner cell mass and participated in the formation of the chimaeric mice (mice
containing cells from two different strains). The microinjections were carried out by
Jane Robinson, our chief technician.
The agouti gene produces brown fur colour even if present in one copy in the cells
therefore the chimaeras are easy to select from amongst the offsprings. Chimaeric
males were mated back first to MF1 females (white), which was general procedure at
the Centre for Genome Research, to obtain big litters and confirm germline
transmission, which was indicated by silver fur colour and identified by analysis of
their DNA. The chimaeras were then crossed with C57B1/6 (black) females in which
case germline transmission was indicated by agouti pups (black pups indicated no
transmission) followed by mating with 129 P2/01a Hsd females (beige), in which
case all pups are beige and genotyping is needed to check germline transmission. The
heterozygous offsprings from these test crosses were then intercrossed to produce
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Dimethyl sulfoxide (DMSO) Sigma
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Production of mutant mice has been used to determine the function of certain
domains of the NMDA receptor uncovering the fact that the C-terminus of the NR2
subunit is the most important in synaptic plasticity via binding to downstream
molecules, forming the initiating point of signalling cascades. The binding partners
can be categorised into two major groups (Figure 2, Table 2a, b and c). One is the
group ofMAGUK proteins. They all contain PDZ domains and via this domain they
bind to the E-S/T-X-V motif located at the extreme C-termini of the NR2 subunits. A
few of these proteins are PSD-95, chapsyn-110 or SAP 102. These further interact
with nNOS (Holscher et al., 1997), fyn (Grant et ah, 1992) or SynGAP (Chen et ah,
1998), which is also a regulator of Ras. The other group is the non-MAGUK
proteins, which bind to sites of the C-terminus other than the terminal E-S/T-X-V
motif, and include for example CaMKII, PLC-y and PI3-K.
I introduced three different mutations into the C-terminus of the NR2B subunit of the
NMDA receptor. One is designed to ablate the interactions with the PDZ domain
containing molecules by deleting the terminal valine from the E-S/T-X-V motif
(NR2B DelValine mutation) of the NR2B C-terminus (Figure 9). The second is
designed to prevent the interaction between the NR2B subunit and CaMKII (NR2B
CaMKII mutation) by modifying key residues in the binding site (Figure 41). The
third is to exchange the COOH exon of the NR2B subunit with that of NR2A
(NR2A/NR2B SWAP mutation) (Figure 48).
All mutants were generated using conventional gene targeting technology. The
mutation was introduced and the neo selection cassette was inserted. Unlike in
conditional systems, in this case the spatial and temporal control over gene
expression is not possible.
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3B NR2B DelValine Mutation
Introduction
According to the time expression of the different subunits NR1 and NR2B play an
important role in brain development and therefore it is not surprising that mice
lacking these subunits die shortly after birth (Forrest et ah, 1994; Li et al., 1994;
Kutsuwada 1996). Mice without postnatally expressed NR2A and NR2C subunits are
viable (Sakimura et al., 1995; Ebralidze et al., 1996).




































Figure 5. Electrophysiological data of NR2AaC mice.
LTP of mutant mice is reduced compared to wild type using the 5 Hz/3 min protocol. The
data was produced by collaborator Dr Thomas J O'Dell.
The intracellular C-terminal domains of the NMDA receptors appear to be involved
in different signalling pathways by coupling to proteins such as PSD-95, chapsyn-
110 or other proteins in the membrane-associated guanylate kinase family. Mice
expressing C-terminal truncated forms of NR2A, NR2B and NR2C subunits have
been produced (Kohr and Seeburg, 1996; Sprengel et al., 1998). No interference with
the formation of gateable receptor channels have been observed in vitro however
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mice expressing these truncated subunits manifested great phenotypic resemblance
with mice lacking the respective subunits (Kutsuwada 1996), namely that mice
lacking the NR2B C-terminus (NR2BAC) died perinatally (Sprengel et al., 1998).
The analysis of various mouse mutants helps to determine the underlying
mechanisms of learning and memory formation. Experiments comparing the LTP
data are only possible if the mice are viable. In the case of NR2Aac mice frequency
dependent reduction of LTP can be observed (Figure 5). Since NR2BAC mice are not
viable a different strain had to be produced in which the interaction between the
NR2B subunit and downstream molecules was inhibited, but the viability was
preserved. It is the E-S/T-X-V motif of the C-terminus, which binds to PSD-95
therefore I deleted the terminal valine codon present at the very end of the C-terminal
tail of the NR2B subunit (NR2B DelValine) to prevent the interaction between these
two molecules.
Enhanced LTP in PSD-95 mutants is
NMDA receptor dependent
5Hz/3min.,WT 5Hz/3 min„ PSD95
Figure 6. Electrophysiological data of PSD-95 mutant mice.
The enhanced LTP of the mutant mice is abolished by the NMDA receptor antagonist AP-5.
The data was produced by collaborator Dr Thomas J O'Dell.
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In PSD-95 mutant mice enhanced LTP can be observed (Figure 6). This is NMDA-
receptor dependent since treatment with AP-5 brings LTP to baseline. In the case of
the NR2B DelValine mice, the changes in the LTP features due to interrupted
interaction between NR2B and PSD-95 could be observed, which was not possible to
do in NR2BAt mice.
In the next section I will describe the construction of the DelValine targeting vector
in detail to provide an insight into basic DNA manipulation techniques. Further
sections will only contain the details of the most important targeting steps.
Vector construction
The vectors and subclones used (Figure 57) were provided by collaborator Dr Rolf
Sprengel. From the plasmid pNR2B-2.6 the Ndel-EcoRI fragment was subcloned
into pRK172 vector (Figure 8, Figure 7 Step 1). This vector consists of 2558 base
pairs and contains an Ndel site at position 2392 and an EcoRI site at position 2415.
Both pNR2B-2.6 containing the desired fragment and pRK172 were restriction
digested by Ndel and EcoRI as described in the methods. The resulting fragments
were purified, ligated, the DNA mixture was then electroporated into DH5a cells,
which were plated and grown on ampicillin containing bacterial plates. From the
resulting colonies six individual ones were picked and tested for correct subcloning
by digesting with Ndel and EcoRI. In the case of the correct clones an 872 base pair
band (Ndel-EcoRI fragment inserted) and the backbone of the vector (~2.5 kB) was
visualized. The smaller band was identical to that cut out from the original vector
pNR2B-2.6. All six colonies were tested positive (Figure 8).
The new vector, pRK172-NdeI-EcoRI was used as a template for site directed
mutagenesis to delete the valine from the end of the COOH exon of NR2B using
Stratagene Quick ChangerM Site-directed Mutagenesis Kit. At the same time an Xhol
and an Nhel site was created to use later for checking homologous recombination
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Figure 7. Targeting strategy of NR2B Valine deletion vector.
Fragments from the plasmids pNR2B-5.4 and pNR2B-13 were inserted into pBlueScript KSII
containing the artificial polylinker to produce the targeting vector. The vectors and subclones
used were provided by collaborator Dr Rolf Sprengel.
18 colonies were picked from the bacterial plates for further testing. Prescreening of
correct mutagenesis was done by Xhol restriction digestion. Xhol digest linearised
the circular plasmid DNA of the correct clones. By digesting with Xbal and Xhol the
correct band of 472 bases was obtained (and the backbone ~3 kB) in the cases of the
four subclones 14, 16, 17 and 18. The parental subclone was only linearised by Xbal
(~3.5 kB), which is present in the original vector pRK172 (Figure 10). All four
subclones were found correct by restriction digestion and 16, 17, 18 were checked by
sequencing. The sequencing primers used were DelVal 1 to 4 and DelVal I to VI
(Find sequence information in the appendix.). Only pBlue-DelVal 16 and 17 were
containing the correct sequence. Subclone pBlue-DelVal 17 was used for further
cloning reactions.
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Ligation of pNR2B-2.6 Ndel-EcoRI
Fragment into pRK172






uncut Ndel-EcoRI uc N-E
Figure 8. Ligation of pNR2B-2.6 Ndel-EcoRI fragment into pRK172.
Ndel-EcoRI fragments from pNR2B-2.6 clone and pRK172 vector were isolated. The gel
picture shows the result of the ligation of the two fragments. Correct subcloning was tested
by Ndel-EcoRI restriction digestion of the colonies picked after ligation and also the original
pNR2B-2.6 clone. The resulting bands, about 800 bases, are the same in both cases.
A new plasmid was generated from pBlueScript KSII by inserting an artificial
polylinker -Xbal-Ndel-EcoRI-. This was done to enable us to insert various
fragments from the plasmids pNR2B-5.4 and pNR2B-13 (Figure 7) to produce the
final targeting vector.
First the Ndel-EcoRI fragment carrying the mutation was inserted into the modified
pBlueScript KSII (Figure 7 Step 3, Figure 11). From the bacterial plate 12 colonies
were picked and were prescreened by Ndel-EcoRI digest. Using this digest I
obtained the 472 base pair fragment containing the mutation that was inserted. Two
of them were further screened with Xhol, EcoRI and Ndel digest (Figure 11) and
both clones were found correct. The parental clone pRK172-DelValMut was also
digested with the same enzymes. On the gel photo the size difference between the
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two vectors (pRKl72-2558 base pairs, pBlueIIKS-2961 base pairs) can be seen
(Figure 11).
NR2B C-terminal Valine Deletion
NR2B S S I E S D V stop
tct agt att gag tct gat gtc tga
NR2BAV s S I E S D stop
tct agt att gag tct gat tag eta get cga g
Nhel
Xhol
Figure 9. NR2B C-terminal valine deletion.
Stratagene Quick Change™ Site-directed Mutagenesis Kit was used to delete the terminal
valine codon. The primers used were DelValMut 1 and 2.
In the next step the EcoRI-Hindlll fragment was inserted 3' (Figure 7 Step 4, Figure
12). Six clones were picked from the bacterial plate, grown and the resulting DNA
was digested by Flindlll-EcoRI along with the parental clone. A 1325 base pair
fragment can be visualized (insert) in all six clones and the size difference between
the uncut vectors (parental clone-3833 base pairs, clones 1 to 6-5158 base pairs) can
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Figure 10. NR2B C-terminal valine deletion- Screening for correct mutagenesis.
On the figure the parental subclone (Par.) and clones 14, 16, 17 and 18 are presented. By
digesting with Xbal and Xhol correct bands of about 500 bases were obtained in the cases of
the four subclones while the parental subclone was only linearised by Xbal which is present
in pRK172. The last two lanes on the right show single digestions of two colonies by Xbal
and Xhol resulting in linearization.
In the next step the Xbal-Ndel fragment (Figure 7 Step 5, Figure 13) was inserted 5'.
On the bacterial plates only twelve colonies grew as a result of lower transformation
efficiency due to a larger plasmid being transformed. All 12 colonies were grown up
and the resulting DNA was digested with Ndel-Xbal to check correct insertion.
Clones 1, 2, 4, 6, 7, 8, 9, 10 and 11 were found correct in which cases I could
visualize the 2443 base pair Ndel-Xbal fragment and the backbone of the vector,
which was equal in size as the only visible band of the incorrect clones (No insertion
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Figure 11. Ligation of Ndel-DelVal-EcoRI fragment.
On the figure the parental subclone (Par.) and clones 1 and 2 are presented. By digesting
clones 1 and 2 with Xhol I could visualize a band of about 500 bases (Xhol site is present in
pBluellKS and in the mutation site) indicated by the black arrows. The parental clone only
contains one Xhol site in the mutation site therefore the vector is only linearised.
When digesting with EcoRI or Ndel all clones are linearised and the size difference resulting
from the different vectors (pRK172-2558 base pairs, pBlullKS-2961 base pairs) can be seen.
When digesting with EcoRI-Ndel, the 872 base pair inserted fragment was dropped
(indicated by the blue arrows), which is the same size in the two clones and the parental
subclone. Again the size difference can be seen in the backbone of the vector. The top
bands correspond to linearised plasmid DNA (incomplete double digest) where the size
difference can also be visualized.
The Xbal-Xbal (Figure 7 Step 6, Figure 14) fragment was then inserted 5'. From the
resulting 7 colonies 4 were grown up and screened with Xbal, Ndel and Hindlll
digest. The Xbal digest clarified that the fragment was inserted only in clones 1, 2
and 3 where the 2993 base pair fragment could be seen on the gel picture. The other
two digests clarified whether the orientation of the fragment was correct. In the case
of the Ndel digest I could see a 3295 base pair Ndel-Ndel band if the orientation was
correct (clone 1) and a 4584 base pair Ndel-Ndel band if the orientation was
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incorrect (clone 2 and 3). The Hindlll digest resulted in a 3030 and a 3769 base pair
Hindlll-Hindlll fragment in the correct orientation, while in the case of the incorrect
orientation a 1705 base pair and a 3769 base pair Hindlll-Hindlll fragment was
visualized.
Ligation of EcoRI-Hindlll Fragment








Figure 12. Ligation of EcoRI-Hindlll fragment.
The parental clone and clones 1 to 6 are shown on the figure. The size difference between
the uncut vectors is apparent. The Hindlll-EcoRI digest excises the 1325 base pair inserted
fragment in all 6 clones (In the case of clone 1 and 6 it is not clearly visible on the photo.)
while the backbone of the vector is the same size as the linear parental clone confirming that
all 6 clones are correct.
The Notl-Sall fragment was then excised and inserted into Kasal vector (Modified
pUC8 vector in which the KasI-PvuII fragment was replaced by a 59 base pair
polylinker sequence, obtained from Noboru H Komiyama.) to ablete the Xhol site
present in the polylinker of pBluellKS (Figure 7 Step 7, Figure 15). The resulting
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vector contained only one Xhol site into which the XhoI-neo-Xhol sequence could
be inserted.








uncut -*• Ndel-Xbal <
Figure 13. Ligation of Xbal-Ndel fragment.
Undigested vector DNA from clone 2 was run alongside the Ndel-Xbal digested DNA of
clones 1 to 12. In the correct clones (1, 2, 4, 6, 7, 8, 9, 10 and 11) a 2443 base pair fragment
could be visualized. In the incorrect clones only one band of ~ 5100 base pairs could be
seen showing a lack of insertion.
Three colonies were picked from the bacterial plates and the DNA was checked
using Xhol and Notl-Sall digest. Xhol digest linearised the correct clones giving a
9975 base pair band. When digesting with Notl-Sall the resulting smaller band was
the same size as the band from the digested Kasal vector (-2350 base pairs). All
three clones were correct.
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Ligation of Xbal-Xbal Fragment
Clones 1 2341 2341234 1234
12.0 kB
—0.5 kB
uncut Xbal Ndel Hindlll
Figure 14. Ligation of Xbal-Xbal fragment.
The uncut DNA showed an apparent size difference between clones 1, 2 and 3 with the
Xbal-Xbal fragment inserted and clone 4 without the insertion. The Xbal digest resulted in a
2993 base pair band and a backbone of 7601 base pairs in the case of the first 3 clones. In
clone 4 I visualized the linearised vector DNA of 7601 base pairs. In all four clones there was
residual undigested DNA that account for the extra bands.
The Ndel digest gave a 3295 base pair band (backbone 7299 base pairs) in clone 1 (correct
orientation) and a 4584 base pair band (backbone 6010 base pairs) in clone 2 and 3
(incorrect orientation) and linearised clone 4. Undigested DNA could be seen too.
The Hindlll digest resulted in a 3030 and a 3769 base pair Hindlll-Hindlll fragment in clone 1
(correct orientation). The backbone is 3795 base pairs therefore the gel photo showed a
double band (top band). In clones 2 and 3 (incorrect orientation) a 1705 and a 3769 base
pair Hindlll-Hindlll fragment and the 5120 base pair backbone was obtained.
The neo coding sequence flanked by two loxP sites was inserted at the Xhol site
created by mutagenesis (Figure 7 Step 8, Figure 16a and b). Ten clones were
screened using Xhol and Xbal digests. Clones 2, 6 and 9 were found positive with
the neo-containing fragment inserted in the right orientation In the right orientation I
visualized a 2993, a 4718 (containing the mutation site) and a 4231 base pair band
(Figure 16a and b).
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Figure 15. Ligation of Notl-Sall fragment.
The parental clone (Par), the Kasal vector (K), the pBluellKS (P) and the three clones are
presented. The size difference between the uncut vectors is apparent.
In the parental clone the Xhol digest produced a 1725 base pair fragment and the backbone,
Kasal vector was not affected and pBluellKS vector was linearised. In the correct clones (1,
2, 3) only one Xhol site remained resulting in one 9985 base pair band.
The Notl-Sall digest produced one visible band in the case of the Kasal and the pBluellKS
vector. A 7633 base pair Notl-Sall band was dropped in the parental and the three positive
clones while the smaller bands indicated the size difference between the two vectors (Kasal-
2352 base pairs, pBluellKS-2961 base pairs).
The vector then was excised by Notl-Sall and inserted into DTA containing
pBluescript vector, which was digested by Notl-Xhol (Figure 7 Step 9, Figure 17).
This cloning step ablated the Sail site at the 3' end, but allowing linearization by
NotI before ES cell targeting. Only one colony grew after transformation of the
ligation mixture due to lower transformation efficiency resulting from the large
plasmid size. The clone (pBlueDTA-DelValMut) proved to be positive.
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Ligation of Xhol-neo-Xhol









Figure 16a. Ligation of Xhol-neo-Xhol.
On the figure clones 1 to 5 are presented. If the neo-containing fragment was inserted, the
Xhol digest resulted in a 1957 base pair band and the backbone (9985 base pairs)
regardless of the orientation of the fragment. Xbal digest produced three bands in all clones.
In the right orientation (clone 2) a 2993, a 4718 (containing the mutation site) and a 4231
base pair band was visualized. In clones where the fragment was inserted in the opposite
orientation (1, 3, 4, 5) the three bands were of 2993, 2973 (containing the mutation site) and
5976 base pairs. In that case I saw only two bands, one of which was a double band.
The final vector (Figure 18) is 9590 base pairs (plus the 4 kB pBlue-DTA vector
backbone) with a 3' homology arm of 2.3 kB and a 5' homology arm of 5.8 kB. It
contains the DelValine mutation alongside with two sites created for further analysis
(Nhel, Xhol). The neo selection cassette is inserted at the Xhol site. The final clone
pBlueDTA-DelValMut was further tested by Spel, Clal, Ncol, Nhel and Ndel digests
and was shown to be correct.
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Ligation of Xhol-neo-Xhol









Figure 16b. Ligation of Xhol-neo-Xhol.
On the figure clones 6 to 10 are presented. The Xhol-neo-Xhol fragment wasn't inserted into
clone 8 indicated by the presence of only one Xhol and only two Xbal sites. Digest patterns
of clones 6 and 9 proved that the neo-containing fragment was inserted in the right
orientation. Clone 7 contained the neo fragment in the opposite orientation. Clone 10
contained the desired fragment in the opposite orientation (double band in the case of Xbal
digest was visualized), but the Xbal digest was incomplete resulting in an extra band.
The final vector was further screened by sequencing with primers DelVal 2, 3, 358,
3261, 6102, 6211, 6662, 7914, III and V to check whether the ligation junctions were
correct and the mutation site was intact. The details of the sequencing reaction can be
found in the materials and methods. Sequencing results revealed that the targeting
vector was correct and ready for electroporation into embryonic stem cells.
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Figure 17. Insertion of the final targeting vector into DTA-containing pBluescript vector.
The parental clone and clone pBlueDTA-DelValMut were digested by Sail and Notl-Sall. Sail
digest only linearised the parental vector while Notl-Sall digest gave two bands in the
parental clone, but only linearised the final vector, in which the Sail site was ablated.
ES cell targeting
The pBlueDTA-DelValine vector was electroporated into E14TG2a ES cells as
described in detail in the materials and methods.
150pg of vector was linearised with NotI, precipitated, washed with 70% ethanol and
resuspended in 100 pi PBS the night before electroporation. Passage number 10
E14TG2a cells (2.3xl06) were grown up from frozen stock to yield about 5xl07
o
cells, trypsinised and resuspended in a final volume of PBS that gave about 1X10
cells/600 pi. The cells (passage 15, 5.4x107 in total) were electroporated at 0.8 kV, 3
pF (resulting in a time constant of 0.2 sec) in the gene pulsar and plated at a density
of 5xl06, 106, SxlO^ and lO7 cells per plate (21 plates in total).
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G418 (200pg/ml) was added one day after electroporation and selection was
continued for 10 days. About 200 neomycin-resistant colonies were picked and
expanded. From the colonies 136 grew up and were transferred into 24 well plates
for expansion. Duplicate plates were frozen for further expansion while the originals
were used to obtain genomic DNA. Southern blotting with 3' and 5' external probes
and an internal probe was used to screen the colonies.
NMDA Receptor NR2B Subunit Targeting Vector
C-tenninal Valine Deletion
5'probe Pstl-PstI probe. 3'probe-
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Figure 18. NR2B DelValine Targeting Vector.
In the final targeting vector the terminal valine was deleted and Xhol and Nhel sites were
created. PgK-neoPA selection cassette was inserted at the Xhol site. The 3' homology arm
is 2.3 kB and the 5' homology arm is 5.8 kB. The targeting vector is -10 kB.
Southern blots
The neo cassette contains Xbal and Bglll sites, while the Nhel site exists in the lines
containing the mutation (created by mutagenesis). These restriction sites were used
to screen the embryonic stem cell lines obtained after electroporation. First all ES
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cell clones (136) were screened using the 3' flanking probe thereafter the positive
ones were further checked using the internal and the 5' flanking probe.
The 3' probe was obtained by digesting subclone pNR2B-3' probe with Hindlll-
Xbal. The 569 base pair fragment was purified, labelled using Rediprime™ II
random prime labelling system and used for probing the filter containing the
genomic DNA samples as described in materials and methods. The 871 base pair
Pstl-PstI internal probe was obtained from subclone pNR2B-2.6 by digesting with
PstI while the 5' flanking probe was amplified with Roche's Expand Long Template
PCR system using 5' probe-1 and 2 primers (Find sequence information in the
appendix.) and subclone pNR2B-13SacI as a template.
The wild type genomic DNA digested with Xbal and hybridised with the 3' probe
gave a 5 kB band, while the mutant lines with correct homologous recombination
yielded a 2.5 kB band (Figure 19).
In the first Southern Blots presented below 10 pg genomic DNA was digested with
high concentration Xbal restriction enzyme and run on a 0.8% agarose gel. On each
gel wild type genomic DNA was run alongside the ones to be screened. The samples
were transferred onto nitrocellulose (HybondIM-N) and crosslinked to the filter using
UV. The filter was prehybridized at 65 °C for 4 hours then probed at 65 °C
overnight. After washing the filter it was wrapped in Sarah wrap, placed into a
cassette with Kodak X-ray film over it and was left at -80 °C to expose.
A total of 39 ES cell clones were found positive using southern blotting with the 3'
probe. This showed an initial 28.7% targeting efficiency. Clones 1-15, 3-3, 3-8, 3-10,
3-14, 5-18, 6-8, 7-1, 7-11, 7-14, 7-16, 8-4, 8-8, 9-17, 9-20 and 12-11 were chosen for
further characterization. In the following figures those southern blots are
demonstrated alongside with the gel photos, which contained the above clones.
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Figure 19. Southern Blot Using 3' Flanking Probe.
From all the clones picked 136 were screened to check correct homologous recombination
using Xbal digest and the 3' flanking probe. The Xhol-neo-Xhol cassette inserted contains
an Xbal site due to which a 2.5 kB band can be visualized in the positive clones alongside
the 5 kB wild type band.
If the gDNA was digested with Bglll and probed with internal probe or the 5' probe,
I got a ~14 kB band for WT clones and ~8 kB band for mutants with correct
homologous recombination (Figure 24 and 25). When I used Nhel digest and the
internal probe, I again obtained a ~14 kB band for WT clones and ~8 kB band for
mutants.
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Figure 20. Southern Blot DelVal 1 using Xbal digest and the 3' probe.
The photo on the top is the gel picture, while the one at the bottom is the blot after exposure.
The ES cell clones are indicated on the top.
After digesting with Xbal and probing with the 3' probe I obtained a 5 kB wild type and a 2.5
kB homozygous band in the correct clones. 3' positive clones are 2-12, 2-14, 2-24, 3-8, 4-3,
4-8 and 4-11.
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Figure 21. Southern Blot DelVal 2 using Xbal digest and the 3' probe.
The photo on the top is the gel picture, while the one at the bottom is the blot after exposure.
The ES cell clones are indicated on the top.
3' positive clones are 4-16, 4-21, 5-20, 7-11, 7-14, 7-16, 8-4 and 8-8.
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Figure 22. Southern Blot DelVal 5 using Xbal digest and the 3' probe.
The photo on the top is the gel picture, while the one at the bottom is the blot after exposure.
The ES ceil clones are indicated on the top.
3' positive clones are 3-3 and 4-22.
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Figure 23. Southern Blot DelVal 6 using Xbal digest and the 3' probe.
The photo on the top is the gel picture, while the one at the bottom is the blot after exposure.
The ES cell clones are indicated on the top.
3' positive clones are 5-18, 6-8, 7-12, 7-23 and 8-2.
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Identification of Hornolosous Recombination Using
Pstl-PstI Internal Probe



















Figure 24. Southern Blot Using Internal Probe.
I used Bglll digest when screening with the Pstl-PstI internal probe. Due to the existence of
the extra Bglll sites in the neo cassette I could visualize an 8 kB mutant band alongside the
14 kB wild type band in the correct clones.
10 pg genomic DNA was digested with high concentration Bglll or Nhel restriction
enzyme and run on a 0.75% agarose gel. On each gel wild type genomic DNA was
run alongside the ones to be screened. The samples were transferred onto
nitrocellulose (Hybond™-N), crosslinked to the filter using UV, prehybridized,
probed, placed into a cassette with Kodak X-ray film and exposed in the same
manner as in the case of the 3' probe. Cell lines DelVal 3-3, 5-18, 7-11, 7-14 and 8-8
were identified correctly targeted clones. The gel photos can be seen alongside the
Southern Blots below. The cells were then expanded and used for producing
chimaeric mice. In the following figures southern blots (of the positive clones) using
the internal probe and the 5' probe are demonstrated alongside with the gel photos.
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Identification of Homologous Recombination Using
5" Flanking Probe
5' probe



















Figure 25. Southern Blot Using 5' Flanking Probe.
Clones 1-15, 3-3, 5-18, 7-11, 7-14, 7-16, 8-4 and 8-8 were screened using Bglll digest and
the 5' probe amplified by PCR reaction. Correct clones contained two Bglll sites at the 3' end
of the Xhol-neo-Xhol insert therefore I could visualize an 8 kB mutant band alongside the 14
kB wild type band.
The clones were further checked using Bglll and Nhel (Figure 32 and 33) restriction
digests to confirm that the mutation site is correct and that the neo cassette is
inserted. Genomic DNA obtained from the ES cells was used as a template for PCR
reactions to amplify fragments containing either the Nhel site created by mutagenesis
or the Bglll sites inserted with the neo cassette. Two sets of primers were used to
amplify the two fragments, the first DelVal 5603 and pLox 91, the second pLox 1603
and DelVal 6215. The amplified fragments (650 and 430 base pairs respectively)
were purified and digested with Nhel and Bglll respectively. If the mutation site was
intact the Nhel restriction digest yielded two bands (-560 and -90 base pairs) and
although the smaller band was not visible I could see the size difference between the
uncut 650 base pair band and the Nhel digested 560 base pair band (Figure 33). If the
neo cassette was inserted correctly then due to the extra Bglll sites I got two bands
(-320 and -110 base pairs) when running the samples on the agarose gel (Figure 32).
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Figure 26. Southern Blot Internal Probe 3 using Bglll digest and the Pstl-Pstl Probe.
The photo on the top is the gel picture, while the one at the bottom is the blot after exposure.
The ES cell clones are indicated on the top.
Clones 7-14 and 5-18 are positive using the internal probe and tested positive in further
experiments as well. In the case of the 3' probe positive clone 1-15 I only obtained a wild
type band. 3' positive clones 7-16, 8-4, 6-8 didn't give a conclusive result due to the quality
of the blot (possible degradation or contamination) and were tested again. Clone 9-20 was
confirmed wild type and used in later experiments as additional control.
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Figure 27. Southern Blot Internal Probe 5 using Bglll digest and the Pstl-Pstl Probe.
The photo on the top is the gel picture, while the one at the bottom is the blot after exposure.
The ES cell clones are indicated on the top.
Clones 3-3 and 5-18 are positive using the internal probe. In the case of the 3' probe positive
clone 1-15 I only obtained a wild type band.
Please note that the gel was "wavy" possibly due to uneven pressure when transferring the
gDNA to the nitrocellulose membrane. Also the amount of gDNA transferred varied. However
the mutant bands and the wild type bands are clearly visible and are the right size.
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Figure 28. Southern Blot Internal Probe 17 using Bglll digest and the Pstl-Pstl Probe.
The photo on the top is the gel picture, while the one at the bottom is the blot after exposure.
The ES cell clones are indicated on the top.
Clones 3-8, 6-8, 9-17, 12-11, 7-1, 3-14, 3-10 and 8-8, which seemed correct in previous
experiments but had to be retested to further confirm, showed positive using the internal
probe. Clone 9-20 was confirmed wild type in previous experiments and was used here as
an additional control.
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Figure 29. Southern Blot DelVal 9 using Bglll digest and the 5' probe.
The photo on the top is the gel picture, while the one at the bottom is the blot after exposure.
The ES cell clones are indicated on the top.
5' positive clones are 3-3 and 5-18.
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Figure 30. Southern Biot DelVal 11 using Bglil digest and the 5' probe.
The previous blot was repeated to visualize the bands better.
5' positive clones are 3-3 and 5-18.
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Figure 31. Southern Blot DelVal 9 using Bglll digest and the 5' probe.
The photo on the top is the gel picture, while the one at the bottom is the blot after exposure.
The ES cell clones are indicated on the top (Clone 7-11 is represented twice, the sample in
the second lane was digested overnight and then further until the afternoon after adding
extra 1 jxl Bglll enzyme, the sample in the first lane was only digested from the morning until
the afternoon.).
5' positive clones are 7-11,7-14 and 8-8.
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Bglll Site Check Experiments on ES cell clones
Figure 32. Bglll site check experiment on ES cell clones 1-15, 3-3 and 5-18.
On the left the result of the PCR amplification is presented. Using primers pLox 1603 and
DelVal 6215 a 431 base pair fragment is amplified.
If the neo cassette was inserted correctly then due to the two extra Bglll sites (very close to
each other) I got two bands (~320 base pairs and -110 base pairs) when digesting the 431
base pair purified fragment with Bglll restriction enzyme. This is represented on the gel
photo to the right.
Generation of chimaeras
Clones DelVal 3-3, 5-18, 7-14 and 8-8 were injected into blastocysts to generate
chimaeras (Table 4). The targeted embryonic stem cells (E14TG2a isolated from the
light coloured 129 P2/01a Hsd mouse strain) carrying the mutation in one
chromosome were injected into blastocyst-stage embryos obtained from black mice
(C57B1/6). Upon survivor the cells assimilated into the inner cell mass of the
embryos and participated in the formation of the chimaeric mice (mice containing
cells from two different strains). The microinjections were carried out by Jane
Robinson, our chief technician.
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Nhel Site Check Experiments on ES cell clones
Uncut DNA Nhel digest
Figure 33. Nhel site check experiment on ES cell clones 3-3 and 5-18.
On the figure the result of the PCR amplification and that of the Nhel digest is presented.
Using primers DelVal 5603 and pLox 91 a -650 base pair fragment is amplified.
If the mutation site was intact an Nhel site was present in the fragment. By digesting with
Nhel restriction enzyme I got two bands (-560 base pairs and -90 base pairs) and although
the smaller band was not visible I could see the size difference between the uncut 650 base
pair band and the Nhel digested 560 base pair band. This is represented on the gel photo to
the right.
The first round of injections was done in September 2001 using clone DelVal 5-18
(Table 4). Four male and one female chimaeras were born from which three males
survived. They were all mated with two females from the MF1 strain (Find in detail
in section 2C.) each to check germline transmission. When cells that were injected
contributed to the formation of the reproductive cells of the chimaeric mouse then
germline transmission occurred. The event is indicated by the silver fur colour of the
heterozygous offsprings. These mice from the test crosses were then intercrossed to
produce homozygous mice containing the desired mutation in both chromosomes.
The first three chimaeras didn't give germline transmission.
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Date Cell Line Embryos
Injected
Transfers $/<? Chimaeras Germline
Transmission
25.06.01. DelVal 5-18 1 None
27.06.01. DelVal 5-18 29 3 None
03.07.01. DelVal 5-18 14 1 None
04.07.01. DelVal 5-18 29 2 1 Male
10.07.01. DelVal 5-18 26 2 None
11.07.01. DelVal 5-18 29 3 1 Male 1 Female
17.07.01. DelVal 5-18 32 3 2 Male
18.07.01. DelVal 5-18 13 1 None
18.10.02. DelVal 3-3 4 1 None
24.10.02. DelVal 5-18 6 1 None
08.11.02. DelVal 8-8 16 1 Male 3 Female 25.02.03.
22.11.02. DelVal 8-8 7 1 None
28.11.02. DelVal 5-18 14 1 None
29.11.02. DelVal 7-14 15 1 None
23.01.03. DelVal 7-14 21 None
24.01.03. DelVal 7-14 13 1 None
29.01.03. DelVal 8-8 12 1 None
30.01.03. DelVal 8-8 14 1 None
05.02.03. DelVal 8-8 24 None
06.02.03. DelVal 8-8 21 1 None
17.07.03. DelVal 7-14 12 1 2 Male
17.07.03. DelVal 5-18 11 1 2 Male
18.07.03. DelVal 5-18 13 1 None
Table 4. Blastocyst injections of DelValine clones.
On the figure the date of injection, the cell line, the number of embryos injected, the number
of recipients into which the embryos were injected and the sex of the resulting chimaeras is
presented.
Three male and one female chimaeras were obtained from cell line DelVal 5-18, one male
and three female chimaeras from cell line DelVal 8-8 and two male chimaeras from cell line
DelVal 7-14. Germline transmission was achieved from cell line DelVal 8-8.
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These injections were performed in the Centre for Genome Research, where the
tissue culture and animal house facilities were well established. The second round of
injections was postponed until the unproven facilities at the Department of
Neuroscience were tried out and the animal house was set up. Unfortunately this
took longer time than originally estimated and prevented any further injections from
being performed for more than one year.
The second set of injections was done in April 2002, which produced no chimaeras.
The third set of injections in October-November 2002 produced one male and three
female chimaeras from the cell line DelVal 8-8 (Table 4). Further two male
chimaeras were obtained from cell line DelVal 7-14 and another two from cell line 5-
18 from injections done in July 2003. As a total 375 embryos were injected with cell
lines DelVal 3-3, 5-18, 7-14 and 8-8 and used in 26 transfers from which only 13
chimaeras were obtained. This low efficiency was observed when injecting other
clones produced in the laboratory as well.
Germline transmission
The male chimaera from the cell line DelVal 8-8 was set up with two MF1 female
mice and germline transmission was achieved on 25th February 2003 which was
indicated by the silver fur colour of the litter.
The offsprings were genotyped using three different combinations of primers NR2B
5910, pLox 413, pLox 1540 and NR2B 6456 with Qiagen Hot Star Taq. The
different primer combination used amplified different sizes of bands or none (Figure
34) in wild type or heterozygous mice. These same reactions were later used to
genotype the offsprings coming from the heterozygous-heterozygous intercrosses
producing homozygous mice. Alternatively a reaction with Long Range PCR using
primers NR2B 5910 and NR2B 6456 could be used (Figure 34).
After obtaining the initial information about the genotype of the mice, new primers
were designed to get a larger band that is easier to visualize when using the AXB and
CXD combination. Hence primers A' (SWAP NR2A 3924), B' (pLox 91), C' (pLox
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1603) and D' (NR2B 8035) were used instead of A, B, C and D (Figure 34) when
regenotyping mice Wl-10 and Rl-6 (Figure 35 and 36). These mice are the
offsprings of chimaera DelVal 8-8 from the first two litters. In the next figures the
gel photos of the genotyping reaction can be seen.
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Figure 34. NR2B DeiValine Genotyping.
Primers A: NR2B 5910 B: pLox413 C: pLox 1540 D: NR2B 6456.
In wild type mice AXB and CXD combination didn't result in amplification because of the lack
of the neo cassette while the AXD combination gave a 546 base pair band (-0.5 kB). In the
heterozygous offsprings a 642 base pair band was amplified in the AXB combination, a 546
base pair band in the AXD combination (-0.5 kB) and an extra 2346 base pair band using
Long Range PCR. In homozygous mice (further described) I amplified a 642 base pair
band in the AXB and a 734 base pair band in the CXD combination (-0.5 kB). The AXD
combination produced a 2.3 kB homozygous band, but only using Long Range PCR since
the Taq polymerase can't amplify that size fragment.
Primers A': Primer SWAP NR2A 3924 B': pLox 91 C': pLox 1603 D': NR2B 8035.
By using the Qiagen Hot Star Taq system and primer combination A'XB' I obtained a -2.3 kB
band in heterozygous and homozygous mice and no band in wild type mice while the primer
combination C'XD' produced a -2 kB band in heterozygous and homozygous mice and no
band in wild type mice.
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Figure 35. Genotyping of NR2B DelVal 8-8 tails coming from the chimaeraXMFI test cross.
Primers SWAP NR2A 3924 (A') and pLox 91 (B') were used in the PCR reaction. By using
the Qiagen Hot Star Taq system I obtained a -2.3 kB band in heterozygous mice and no
band in wild type mice. Offsprings R1-5 were positive, heterozygous while R6 was negative,
wild type.
The sample in the right side lane, CaMKII 4-12 is a positive control showing the -2.3 kB
band.
In the first litter of the DelVal 8-8 test cross two of the offsprings were heterozygous
out of ten, in the second litter five out of six. Another thirteen heterozygous mice
were obtained before the chimaera was found dead on the 12th September 2003
(Table 5.). None of the chimaeras from cell line DelVal 7-14 or 5-18 produced
germline transmission and consequently were culled after producing several black
litters.
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Genotyping of DelVal 8-8 tails





Figure 36. Genotyping of NR2B DelVal 8-8 tails coming from the chimaeraXMFI test cross.
Primers pLox 1603 (C') and DelVal 8035 (D') were used in the PCR reaction. By using the
Qiagen Hot Star Taq system I obtained a ~2 kB band in heterozygous mice and no band in
wild type mice. Offsprings W2 and 6, R1-5 were shown to be positive coinciding with
previous genotyping results.
CaMKII 4-12 positive control is shown in the right side lane.
The first offsprings of the DelVal 8-8 chimaera were intercrossed to produce
homozygous mice carrying the desired mutation in both chromosomes (Table 6). The
genotyping was done using the same method as described before (Figure 34). On the
next figure an example of the reactions using primers NR2B 5910 (A), pLox 413 (B),
pLox 1540 (C) and NR2B 6456 (D) can be seen (Figure 37). Genomic DNA sample
from mouse J9, which was tested homozygous in these reactions, was later used for




Female Date Litter Born Litter Heterozygous Wild Type
09.01.03. 2XMF1 25.02.03. 10 1 Male 1 Female 3 Male 5 Female
21.03.03. 6 2 Male 3 Female 1 Male
30.04.03. 9 2 Male 2 Female 3 Male 2 Female
10.06.03. 5 1 Male 4 Male
23.04.03. 2X129 19.05.03. 4 1 Male 2 Female 1 Female
26.05.03. 2XBI6 16.06.03. 12 2 Male 1 Female 4 Male 5 Female
26.07.03. 3 None 3 Male
01.08.03. 1 1 Female None
07.09.03. 9 1 Female 5 Male 3 Female
Table 5. Test cross of chimaera DelVal 8-8.
On the figure the date the crosses were set up, the strain of the female to which the
chimaera was mated, the date the litters were born and their number, the number of
heterozygous and wild type offsprings is presented.
Heterozygous offsprings were obtained by breeding the chimaera with all three female
strains indicated. The males and females born from the first two litters (25.02.03. and
21.03.03. MF1 background) were mated to produce homozygous mice.
From cages 52, 53, 54, 70 and 71 25 homozygous, 73 heterozygous and 38 wild type
offsprings were obtained. The homozygous mice were used for initial phenotypic
characterization and further breeding. Another heterozygous female was set up with
a Cre Deleter +/- male obtained from collaborator Dr Thomas J O'Dell to excise the
neo selection cassette with further crosses. The male proved to be sterile and didn't
produce any offsprings therefore the breeding was stopped. Due to a further
relocation of the laboratory from the Centre for Neuroscience in Edinburgh to the
Sanger Centre in Cambridge no further Cre Deleter mice were purchased and
therefore no further breeding could be set up to excise the neo selection cassette. In
table 6 the genotyping results of the various litters coming from the intercrosses are
presented.
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Genotyping of DelVal 8-8 tails
J 5-11
Figure 37. Genotyping of NR2B DelVal 8-8 tails conning from heterozygous intercross.
On the left results of the PCR reaction using primers NR2B 5910 (A) and NR2B 6456 (D), on
the right using NR2B 5910 (A) and pLox 413 (B).
Using the AXD primer combination I got a 546 base pair band in wild type and heterozygous
mice, while there is no amplification in homozygous mice (The Qiagen Hot Star Taq system
cannot amplify the 2.3 kB homozygous band.). Using the AXB combination I didn't get
amplification in wild type mice (lack of neo cassette) and obtained a 642 base pair band in
heterozygous and homozygous mice. R1 heterozygous sample was presented for
comparison.
By analysing the results I concluded that mice J5, 6 and 7 are heterozygous, mice J8, 9 and
10 are homozygous and mouse J11 is wild type.
Southern blot of DelValine homozygous mice
Genomic DNA from the tail and the liver of a homozygous mouse J9 was used to
further check mutation by Southern Blot (Figure 38). The experiment was done in
the same way as in the case of the embryonic stem cell lines (Find in detail in Section
2A.) Using the 3' probe for wild type genomic DNA I obtained the normal 5 kB
band, using the ES cell genomic DNA of cell line DelVal 8-8 I obtain a 5kB wild
type and a 2.5 KB homozygous band, while using the genomic DNA of the
homozygous mouse obtained from tail or liver a single 2.5 kB band could be
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visualised. This further proved the homozygosity of the particular mouse and that the
genotyping reaction (by PCR) could be used in further mice.
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Table 6. Intercross of DelVal 8-8 heterozygous mice.
On the figure the strain of the female and male mice mated, the date the litters were born
and their number, the number of homozygous, heterozygous and wild type offsprings is
presented. 25 homozygous, 73 heterozygous and 38 wild type mice were obtained.
Phenotype
The homozygous mice (Figure 39 and 40) appeared runted, smaller than the other
littermates when born, in some cases only half the size. By about week 10 they more
or less seemed to catch up in weight. The fur was ruffled and the right eye looked
like it was half closed, smaller than in wild type and heterozygous animals. By week
ten they generally developed dermatitis-type skin condition, started scratching and
had inflamed eyes and sore ears. This was seen in 21 of the 25 homozygous animals.
Many had to be culled due to animal house regulations.
Although plans have been made to monitor the body weight of the mice from birth to
about 10 weeks old to quantify the differences and make conclusions based on
statistical analysis, after the relocation of the laboratory there were no successful
injections and no more homozygous mice were obtained so far. These tests will have
to be done when the mice are available in sufficient number.
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Southern Blot Using 3' Probe on DelVal 8-8 gDNA
1 2 3 4 5 6 i 2 3 4 5 6







Figure 38. Southern Blot on DelVal 8-8 homozygous genomic DNA.
To the left is the gel photo, to the right is the blot after exposure. Lanes 1 to 6 on the figure
are the following:
1. gDNA from tail of homozygous mouse J9 2. gDNA from liver of homozygous mouse J9
3. gDNA from ES cell clone DelVal 8-8 4. control gDNA from merged samples
5. control gDNA from clone NR2A 1-7, 6. control gDNA from SynGAP targeting.
Homozygous male mouse J9 came from the second litter (04.08.03) of cage 53 (Table 6).
In lanes 1 and 2 I could only visualize a 2.5 kb homozygous band (indicated by arrow)
showing that the mutation was present in both chromosomes of mouse J9. In lane 3 I could
see a 2.5 kB homozygous and a 5 kb (indicated by arrow) wild type band demonstrating the
heterozygosity of the ES cell line DelVal 8-8. In lanes 4, 5 and 6 I only obtained a 5 kb wild
type band when using various wild type genomic DNA.
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Figure 39. DelVal 8-8 homozygous mice.
On the photo three littermates are shown from the DelVal 8-8 heterozygous intercross. Two
of the mice (J9, 10) are homozygous, one (J11) is wild type (See genotyping results in figure
37.). The wild type mouse is the one in the middle and its larger size is obvious. The mouse
on the far end is runted and shows the strange looking right eye.
Fertility of DelVal 8-8 homozygous mice
The homozygous mice carrying the DelValine mutation were set up to breed to check
their fertility and if possible to produce more homozygous offsprings for further
experiments. One intercross was set up on 17th September 2003. The mice had to be
culled on 15th December 2003 due to the dermatitis-like infection. During that time
period no offsprings were born (Table 7).
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Figure 40. DelVal 8-8 homozygous mice.
J11 wild type mouse is again the one in the middle. The other two J9 (on the right) and J10
(on the left) show the half closed right eye and the small size of J9 is very apparent.
Another male homozygous mouse was set up to breed with an NR2Aac female. The
aim of this cross apart from the fertility check was to obtain mice that have no C-
terminal interactions of the NR2B subunit (because of the valine deletion) and of the
NR2A subunit either (deletion of the C-terminus). Both male and female offsprings
were obtained from this intercross (Table 7), which was set up to produce the mice
explained. I can therefore conclude that the mice carrying the mutation DelValine are
fertile and that DelVal 8-8/ NR2AAt double heterozygous mice are viable.
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Date Male Female utter Born Litter Male Female
17.09.03. DelVal8-8-/- DelVal8-8-/-
cage 90
17.09.03 DelVal8-8-/- NR2Ab¬ 10.10.03. 5 3 2
cage 91 17.11.03. .3 1 2
Table 7. Breeding of DelVal 8-8 homozygous mice.
On the figure the strain of the female and male mice mated, the date the litters were born
and the number of the male and female is presented. 4 male and 4 female double
heterozygous offsprings were obtained.
3C NR2B CaMKII Mutation
Introduction
One of the non-MAGUK proteins interacting with the C-terminus of the NMDA
receptor is the Ca2+-calmodulin-dependent protein kinase II (CaMKII). Postsynaptic
calcium influx results in the autophosphorylation of Thr 286 residue of aCaMKII,
which enables the molecule to remain activated even after dissociating from
Ca2+/CaM, its activator (Miller et ah, 1988; Lou and Schulman, 1989). Thr 286
autophosphorylated aCaMKII is persistently active and it is necessary for NMDA
dependent LTP induction at certain synapses (Giese et ah, 1998; Cooke et ah, 2006).
CaMKII has been suggested as a molecular switch for long-term memory storage
based on its property to autophosphorylate and self-activate and its ability to bind to
NMDA thereby anchoring AMPA receptors at the PSD (Lisman and Zhabotinsky,
2001). Inhibition of CaMKII blocks LTP in the hippocampal CA1 region (Malinow
et ah, 1998). The deletion of aCaMKII impairs E-LTP in the CA1 neurons of the
hippocampus and also spatial learning (Silva et ah, 1992a; Silva et ah, 1992b). The
mutation described in the following sections preventing the interaction ofNR2B with
the non-MAGUK protein, CaMKII can provide further insights into the function of
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CaMKII and the importance of its interaction with the NMDA receptor in synaptic
plasticity, learning and memory.
In the binding site of the NR2B C-terminus various amino acids were identified as
key residues in mediating CaMKII interaction. Several mutations were generated to
identify these critical amino acids in the CaMKII binding domain ofNR2B described
in the article "Mechanism and regulation of CaMKII targeting to the NR2B subunit
of the NMDA Receptor." (Strack et al., 2000). On the bases of these findings three
amino acids were mutated, a leucine to alanine, an arginine to glutamine and a serine
to asparagine (Figure 41).
NR2B CaMKII Site Mutation
NR2B Leu Arg Arg Gin His Ser Tyr Asp Thr Phe Val Asp Leu
ctg cgc egg cag cac tcc tac gac acc ttc gtg gac ctg
NR2B Ala Arg Gin Gin His Asp Tyr Asp Thr Phe Val Asp Leu-
CaMKII
gcg egg cag cag cac gac tac gac acc ttc gta gatctt -
BssHII Bgll!
Figure 41. CaMKII site mutation.
Three amino acids (indicated in blue colour) were mutated in the CaMKII binding site
(residues 1290-1309) of the NR2B C-terminus. The mutagenesis was done using Stratagene
Quick Change™ Site-directed Mutagenesis Kit. Extra restriction sites Bglll and BssHII were
created at the same time by changing the NR2B sequence, but conserving the AS residues
(indicated in pink colour).
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Vector construction
From the plasmid pNR2B-19 the Xbal-Ndel fragment was subcloned into the
artificial polylinker (-Xbal-Ndel-EcoRI) containing pBluescriptllKS vector (Figure
42 Step 1). This new vector was used as a template for site directed mutagenesis to
mutate a leucine (residue 1298) to alanine, an arginine (residue 1300) to glutamine
and a serine (residue 1303) to asparagine in the CaMKII binding site (Find sequence
information in the appendix.) of NR2B using Stratagene Quick Change™ Site-
directed Mutagenesis Kit. At the same time a BssHII and a Bglll site was created to
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Figure 42. Targeting strategy of NR2B CaMKII site mutation.
The mutagenesis was done in the pBlueScriptKSII vector containing the Xbal-Ndel fragment
from pNR2B-19. The 5' and 3' homology arms were obtained from the Kasal-DelValMut
targeting subclones. The final targeting vector contains the neo sequence and is inserted
into the DT-A containing pBluescript vector. The vectors and subclones used were provided
by collaborator Dr Rolf Sprengel or produced during the DelValine mutation.
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Twelve colonies were picked and checked by Bglll and BssHII digests. Only the
ones containing the mutation and the extra restriction sites created were linearised by
these enzymes yielding a -5.4 kB band. All clones were found positive. Clones
CaMKIIMut 1 and 4 were then checked by further digestion with Apal and Sfil
(Figure 43) and sequenced using primers CaMKII 5148, 7130, 7214 and 7461.
CaMKIIMut 4 was missing an A from position 5621 (NR2B sequence from Dr Rolf
Sprengel 22/10/1999. Find sequence information in the appendix.). Clone CaMKII 1
was found correct and was used for later cloning steps.
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Figure 43. NR2B CaMKII mutation- Screening for correct mutagenesis.
On the figure clones 1 and 4, the parental subclone (Par.) the DelValMut targeting subclone
described later is presented.
By digesting with Sfil I obtained correct bands of about 5400 bases in the cases of clones 1
and 4 and the parental subclone. When digesting with Apal I could visualize a slightly
smaller band since the pBluescriptllKS backbone contains an extra Apal site. Digesting with
Apal-Sfil drops the 431 base par band therefore the backbone was again was slightly
smaller.
The DelValMut targeting subclone was analysed for the further cloning steps using the
digests presented. The Sfil, Nhel are unique sites therefore I obtained linearization however
these digests were not complete on this occasion.
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The Xbal-Ndel fragment containing pBluescriptllKS vector (without the mutation)
was then digested with Notl-Sall and this fragment was inserted into the Kasal vector
(Described in section 3B.). This step was done to obtain a vector in which there is
only one Apal site. This vector was digested with Apal-Sfil and the Apal-
CaMKIIMut-Sfil fragment obtained from step 2 (Figure 42) was inserted instead
(Figure 42 Step 4). With this ligation step I ensured that apart from the Apal-Sfil
fragment the rest of the vector was obtained from an existing subclone. Therefore the
only segment that had to be checked by sequencing was the 431 base pair long Apal-
CaMKIIMut-Sfil fragment.
For further cloning steps, such as inserting the 5' homology arm, I utilized an already
existing subclone (Figure 7 Step 8, Figure 16a and b) from the DelValine targeting.
This subclone contained the whole targeting vector DelValMut inclusive the Xhol-
neo-XhoI fragment in the Kasal backbone. The vector was digested with Notl-SacI
and this 5' homology arm was ligated into the mutated CaMKII site-containing
vector (Figure 42 Step 5).
The same Kasal-DelValMut vector was digested with Sfil-Nhel to ablate the
mutation created by the previous targeting. By inserting the Sfil-STOP-Nhel-Aflll-
Spel fragment (amplified from pNR2B-2.6 in a way that extra sites Nhel, Aflll, Spel
were created) into the Kasal-DelValMut vector utilizing the compatible sticky ends
of Spel and Nhel I produced a vector without the DelValine mutation, but with the
various restriction sites usable for further targeting steps.
From this targeting subclone (Described in the previous paragraph.) I purified the
Sfil-Sall fragment, which contained the Xho-neo-XhoI segment. It was then inserted
into the vector containing the mutated CaMKII site and the 5' homology arm (Figure
42 Step 8).
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The vector then was excised by Notl-Sall and inserted into DTA containing
pBluescript vector, which was digested by Notl-Xhol (Figure 42 Step 9). This
cloning step ablated the Sail site at the 3' end, but allowed linearization by NotI
before ES cell targeting (Figure 44). Six colonies were picked from the bacterial
plates and prescreened using restriction digest by Bglll and BssHII. All were
positive. Clone pBlueDTA-CaMKIIMut 1, 4, 5 and 6 were used for further testing by










Uncut NotI Xluol Bglll BssHII
Figure 44. NR2B CaMKIIMut targeting vector.
On the figure clone 1 and 2 are different midipreps of the final targeting vector while clone 3
is the DelValMut targeting vector. These (in pBluescript-DTA vector) were compared using
various restriction digests.
The NotI digest linearised both vectors since the site was preserved in the final ligation step
while the Sail site was ablated. On the figure it can be seen that the DelValMut vector DNA
was only partially digested.
The Xhol digest produced a -1.9 kB band in all cases which corresponds to the Xhol-neo-
Xhol fragment. In the case of the Bglll digest I only saw a~2.2 kB band in the pBlueDTA-
CaMKIIMut clones since in these there was a site created during mutagenesis while the two
Bglll sites in the neo cassette are very close to each other (the small band was not
visualized). The BssHII digest similarly yielded a -1.7 kB band in the pBlueDTA-CaMKIIMut
clones and linearization in the pBlueDTA-DelValMut clone.
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Clones pBlueDTA-CaMKIIMut 1, 4, 5 and 6 were further screened by sequencing
with primers DelVal 358, CaMKII 3597, 5148, 5603, DelVal 6102, 7897 and 3261
(Find sequence information in the appendix.) to check whether the ligation junctions
were correct and the mutation site was intact. The details of the sequencing reaction
can be found in the materials and methods. Sequencing results revealed that the
targeting vector pBlueDTA-CaMKIIMut 1 was correct and ready for electroporation
into embryonic stem cells.
The final vector (Figure 45) is the same size as the DelValine targeting vector -10
kB (plus the 4 kB pBlue-DTA vector backbone) with a 3' homology arm of 2.3 kB
and a 5' homology arm of 5.8 kB. It contains three point mutations in the CaMKII
binding site of NR2B alongside with two sites created for further analysis (Bglll,
BssHII). The neo selection cassette is inserted at the Xhol site. The final clone
pBlueDTA-CaMKIIMut 1 was further tested by Spel, Clal, Ncol, Nhel and Ndel
digests and was shown to be correct and ready for electroporation into embryonic
stem cells.
ES cell targeting
The pBlueDTA-CaMKIIMut vector was electroporated into E14TG2a ES cells as
described in detail in the materials and methods.
150pg of vector was linearised with NotI, precipitated, washed with 70% ethanol and
resuspended in 100 pi PBS the night before electroporation. Passage number 11
E14TG2a cells (4.5xl05) were grown up from frozen stock to yield about 5xl07
cells, trypsinized and resuspended in a final volume of PBS that will give about
1X108 cells/600 pi. The cells (passage 17, 4xl07 in total) were electroporated at 0.8
kV, 3 pF (time constant 0.1 sec) in the gene pulsar and plated at the density of 5xl06,
2.5X106, 106, 0.5X106 and 2x10^ cells per plate (20 plates in total).
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NMDA Receptor NR2B Subunit Targeting Vector
CaMKII Mutation














Figure 45. NR2B CaMKIIMut Targeting Vector.
In the final targeting vector three point mutations were created along with Bglll and BssHII
restriction sites. PgK-neoPA selection cassette was inserted at the Xhol site. The 3'
homology arm is 2.3 kB and the 5' homology arm is 5.8 kB. The targeting vector is ~10 kB.
G418 (200|.ig/ml) was added one day after electroporation and selection was
continued for 10 days. From the surviving neomycin-resistant colonies 148 were
picked and grown up in 24 well plates. Duplicate plates containing 103 colonies were
frozen for further expansion while the originals were used to obtain genomic DNA.
Southern blotting with 3' and 5' external probes was used to screen the colonies.
Southern blots
The neo cassette contains Xbal and Bglll sites, while the Nhel, Bsshll and another
Bglll site exists in the lines containing the mutation (created by mutagenesis). These
restriction sites were used to screen the embryonic stem cell lines obtained after
electroporation. First all ES cell clones (103) were screened using the 3' flanking
probe thereafter the positive ones were further checked using the 5' flanking probe.
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The Hindlll-Xbal 3' probe and the PCR amplified (using 5' probe-1 and 2 primers)
5' probe was the same as in the case of the DelValine targeting vector. They were
labelled using Rediprime™ II random prime labelling system and used for probing
the filter containing the genomic DNA samples as described in materials and
methods.
The wild type genomic DNA digested with Xbal and hybridised with the 3' probe
gave a 5 kB band, while the mutant lines with correct homologous recombination
yielded a 2.5 kB band as in the case of the previous, DelValine mutation (Figure 19).
In the Southern Blots 10 pg wild type and targeted genomic DNA was digested with
high concentration Xbal restriction enzyme and run on a 0.8% agarose gel. The
samples were transferred onto nitrocellulose (HybondIM-N) and crosslinked to the
filter using UV. The filter was prehybridized at 65 °C for 4 hours then probed at 65
°C overnight. After washing the filter it was wrapped in Sarah wrap, placed into a
cassette with Kodak X-ray film over it and was left at -80 °C to expose. In the
following figures southern blots (of the positive clones) using the 3' probe are
demonstrated alongside with the gel photos (Figure 46).
The gDNA was then digested with Bglll and probed with the 5' probe. I got a -14
kB band for WT clones and a -7 kB band (there is a Bglll site created by
mutagenesis next to the CaMKII binding site) for mutants with correct homologous
recombination. 10 pg wild type and targeted genomic DNA was digested with high
concentration Bglll restriction enzyme and run on a 0.75% agarose gel. The samples
were treated in the same manner as in the case of the 3' probe. Cell lines CaMKII 1-6
and 4-12 were identified as correctly targeted clones. The gel photos can be seen
alongside the Southern Blots below. The cells were then expanded and used for
producing chimaeric mice. In the following figures southern blots (of the positive
clones) using the 5' probe are demonstrated alongside with the gel photos (Figure
47).
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Figure 46. Southern Blot using Xbal digest and the 3' probe.
The photo on the top is the gel picture, while the one at the bottom is the blot after exposure.
The ES cell clones are indicated on the top. C stands for CaMKII clones, A for NR2A clones
(Find in detail in section 3D.).
After digesting with Xbal and probing with the 3' probe I obtained a 5 kB wild type and a 2.5
kB homozygous band in the correct clones. 3' positive clones were CaMKII 1-6, 4-12 NR2A
2-20 (band clearly seen) and possibly CaMKII 5-10 and 5-16 (band was not visible in the
scanned image).
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Figure 47. Southern Blot EGK 16C using Bglll digest and the 5' probe.
The photo on the top is the gel picture, while the one at the bottom is the blot after exposure.
The 5' positive ES cell clones are indicated. The size difference between the homozygous
bands of the CaMKII clones (~7 kB) and the control DelValine clone (~8kB) could be seen.
The wild type band was -14 kB.
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Generation of chimaeras
Clones CaMKII 1-6 and 4-12 were injected into blastocysts to generate chimaeras in
February-April 2003. The microinjections were carried out by Jane Robinson, our
chief technician. The details of the injections can be seen in table 8.
Date Cell Line Embryos Injected Transfers 9/c? Chimaeras
13.02.03. CaMKII 4-12 14 1 None
17.03.03. CaMKII 4-12 13 1 None
08.04.03. CaMKII 4-12 15 1 None
09.04.03. CaMKII 1-6 18 2 1 Male
24.04.03. CaMKII 4-12 17 2 None
24.04.03. CaMKII 1-6 14 1 None
04.07.03. CaMKII 4-12 18 1 None
Table 8. Blastocyst injections of CaMKII clones.
On the figure the date of injection, the cell line, the number of embryos injected, the number
of recipients into which the embryos were injected and the sex of the resulting chimaeras is
presented.
In total 109 embryos were injected and used for 9 transfers from which one chimaera
was obtained from clone CaMKII 1-6. A test cross was set up with two MF1 females.
The offsprings were all black. Germline transmission wasn't achieved. The test cross
was terminated. No further injections were done to produce other chimaeras due to
the relocation of the laboratory from the Centre for Neuroscience in Edinburgh to the
Sanger Centre in Cambridge.
3D NR2A/NR2B COOH-Exon Swapping Mutation
Introduction
According to the time expression of the different subunits NR1 and NR2B play an
important role in brain development and therefore it is not surprising that mice
lacking these subunits die shortly after birth (Forrest et al., 1994; Li et al., 1994;
Kutsuwada 1996). Mice without postnatally expressed NR2A and NR2C subunits are
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viable (Sakimura et al., 1995; Ebralidze et al., 1996) nonetheless the equal
importance of these subunits was also shown by numerous experiments.
In the hippocampus both NR2A and NR2B subunit-dependent signalling is
implicated in long-term synaptic plasticity (McHugh et al., 1996; Kohr et al., 2003)
(Find in detail in section IF). The NR2A containing NMDA receptors were
implicated in the induction of LTP while NR2B containing receptors were shown to
be important for LTD in the hippocampus (Liu et al., 2004; Massey et al., 2004).
Previous studies however using NR2B overexpressing mice with enhanced CA1 LTP
and long-term memory suggested the contribution ofNR2B subunits to hippocampal
LTP and learning (Tang et al., 1999). Both NR2A and NR2B subunits were shown to
be important for LTP induction in the ACC and the NR2B subunit was implicated in
mediating contextual fear memory tested by assessing freezing behaviour (Zhao et
al., 2005).
Since the NR2A and NR2B subunits of the NMDA receptor bind to different
molecules (Table 2b and 2c), are involved in different mechanisms of synaptic
plasticity and are implicated in different types of learning and memory (Find in detail
in section IE and IF), I thought it to be interesting to delete the COOH-exon of the
NR2B subunit and replace it by that of the NR2A. By doing so it can be seen what
functional differences of the NR2A and NR2B containing NMDA receptors can be
accounted for by the different cytoplasmic tails and the interactions mediated via
them, which regions of the NR2B subunit are important for producing viable mutant
mice and also to tell whether the interactions mediated by the NR2A C-terminus can
rescue the lack of the NR2B subunit C-terminus. In the next section the key steps of
the vector construction will be summarized.
Vector construction
The artificial polylinker (-Notl-Sphl-Xbal-BamHI-Nhel-Sall-) designed to provide
restriction sites suitable for the cloning steps (Figure 48) was inserted into the Kasal
vector (described in section 3B). For the next step I utilized an already existing
subclone (Figure 7 Step 5) from the DelValine targeting. This subclone contained
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the NR2B COOH-exon with the terminal valine deleted and the Nhel site created by
mutagenesis. The BamHI-Nhel fragment from this subclone was inserted into the
pKS vector, Kasal vector containing the artificial polylinker (Figure 48 Step 1).
Targeting Strategy
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Figure 48. Targeting strategy of NR2A/NR2B COOH-exon swapping mutation.
The mutagenesis was done in the Kasal vector containing an artificial polylinker (-Notl-Sphl-
Xbal-BamHI-Nhel-Sall-). The NR2A COOH-exon was amplified from genomic DNA and
inserted to replace the COOH-exon of the NR2B. The 5' and 3' homology arms were
obtained from existing subclones. The final targeting vector contains the neo sequence and
is inserted into the DT-A containing pBluescript vector. The vectors and subclones indicated
in figure 56 were provided by collaborator Dr Rolf Sprengel, the rest were produced during
the DelValine mutation.
The NR2A COOFI-exon was amplified (Figure 48 Step 2) from genomic DNA using
primers NR2A-COOF1 1 and 2 (Find sequence information in the appendix.). The
~1800 base pair fragment was purified as described in materials and methods,
digested by BamHI-Nhel and ligated into the vector described in the previous
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paragraph (Figure 48 Step 3). Six colonies were picked from the bacterial plates and
checked by restriction digestion using SacI and Bglll. Clone pKS-NR2A 3 was
further screened with other restriction digests, the results of which can be seen in
figures 49 and 50. The clone was sequenced using primers SWAP 4277, SWAP-
NR2A 170, 396, 609, 810, 1052, 1291 and 1515 (Find sequence information in the
appendix.) to check correct amplification of the NR2A COOH-exon. It was
confirmed positive and used for further cloning steps.
Insertion of NR2A COOH-exon
into NR2B Coding Sequence
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Figure 49. Restriction digests of clone pKS-NR2A 3.
On the figure the parental subclone (1) and clone pKS-NR2A 3 (2) is presented. Xbal digest
linearised both parental and pKS-NR2A clones, because the restriction site was present in
the artificial polylinker yielding an about 4.5 kB band. The Ndel site was present in the pKS
vector and the NR2B COOH-exon, but not the NR2A COOH-exon. Therefore restriction
digest linearised the pKS-NR2A clone and dropped a 1850 base pair band in the case of the
parental clone. The SacI site was absent in the NR2A COOH-exon therefore I only saw
linearization in the parental clone resulting in a 4.5 kB band. The Bglll and Ncol sites on the
other hand were only present in the NR2A COOH-exon (two each). Using these enzymes
the parental subclone remained undigested and I got a 345 base pair Bglll-BgllI fragment
and the backbone or a 438 base pair Ncol-Ncol fragment and the backbone. The Pstl digest
resulted in a 1229 base pair band in the case of the pKS-NR2A clone and in two bands (152
and 871 base pairs) in the parental subclone (apart from the backbone).
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The 5' homology arm was inserted in two steps by ligating first the Xbal-BamHI
fragment from subclone pNR2B-5.4 (Figure 48 Step 4) then the Sphl-SacI fragment
from subclone pNR2B-13 (Figure 48 Step 5). For the next cloning step, which was to
insert the 3' homology arm, I utilized an already existing subclone (Figure 10 Step 8,
Figure 16a and b) from the DelValine targeting, the same that was used for the
CaMKII targeting as well. This subclone contained the whole targeting vector
DelValMut inclusive the XhoI-neo-XhoI fragment in the Kasal backbone.
Figure 50. Restriction digests of clone pKS-NR2A 3.
On the figure results of further digests of the parental subclone and clone pKS-NR2A 3 is
presented. Hindi 11 linearised the parental clone and dropped a 247 base pair band in the
case of the pkS-NR2A clone since there is an extra site in the NR2A COOH-exon. Apal and
Sfil were absent in the pKS-NR2A clone, but I saw digest in the parental clone (738 base
pair band and linearization respective). EcoRV linearised the pKS-NR2A clone, but didn't
digest the parental clone.
Based on the screening by restriction digests the clone was confirmed positive and used for
further targeting steps.
The vector previously described was digested with Nhel-Sall and this 3' homology
arm containing the neo cassette was inserted into the NR2A-Swap vector (Figure 48
Insertion of NR2A COOH-exon
into NR2B Coding Sequence
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Step 6). Six colonies were picked from the bacterial plates and test digested with
Ncol, SacI, EcoRI, EcoRV and Apal digests (Figure 51). Clones 1 and 6 were used
for the next step.
The vector then was excised by Notl-Sall and inserted into DTA containing
pBluescript vector, which was digested by Notl-Xhol (Figure 48 Step 7). This
cloning step ablated the Sail site at the 3' end, but allowed linearization by NotI
before ES cell targeting. Six colonies were picked from the bacterial plates and
prescreened using restriction digest by NotI and Sail. Clones 1, 2, 3 and 6 were
found positive (Figure 52).








Figure 51. Restriction digests of clone pKS-NR2A 3.
On the figure clones pKS-NR2A-Swap 1 and 6 are presented. The same restriction digests
(Ncol, SacI, EcoRI, EcoRV and Apal) were used as in the previous cloning step. Both clones
were confirmed positive and used for the next cloning step.
Clone pBlueDTA-NR2A-Swap 1 was further tested by NotI, Sail, Xhol, PvuII and
Apal digests and was sequenced using primers SWAP 4277, SWAP-NR2A 170, 396,
609, 810, 1052, 1291, 1515, CaMKII 3597, DelVal 3261, V and 7914 to check
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whether the ligation junctions were correct and the amplified fragment was intact.
The details of the sequencing reaction can be found in section 2A. The sequencing
results revealed that the targeting vector pBlueDTA-NR2A-Swap was correct and
ready for electroporation into embryonic stem cells.
The final vector is the same size as the DelValine targeting vector -10 kB (plus the 4
kB pBlue-DTA vector backbone) with a 3' homology arm of 1.8 kB and a 5'
homology arm of 6 kB. It contains the NR2A COOH-exon inserted instead of that of
the NR2B, and an Nhel site created by mutagenesis of the DelValine vector
subclone. The neo selection cassette was inserted together with the 3' homology arm
and was flanked by two Xhol sites.
Test Digests of pBlue-DTA-NR2A Swap Vector
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Figure 52. Restriction digests of the final targeting vector.
On the picture clones 1 to 6 and the parental clones (P) are presented. The correct clones
were linearised by Notl digest, but remained undigested after Sail digest since the Sail
restriction site was ablated by the Sall-Xhol ligation step. The size difference between the
vectors could also be seen (indicated by the double arrows) since the Kasal vector was
smaller (~2.3 kB) than the pBluescript-DTA vector (~4 kB). Clones 1, 2, 3 and 6 were
confirmed correct by restriction digest.
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ES cell targeting
The pBlueDTA-NR2A-SWAP vector was electroporated into E14TG2a ES cells as
described in detail in the materials and methods in two separate rounds.
150pg of vector was linearised with NotI on both occasions, precipitated, washed
with 70% ethanol and resuspended in 100 pi PBS the night before electroporation.
Passage number 11 and 12 E14TG2a cells (4.5xl05) were grown up from frozen
stock to yield about 5xl07 cells, trypsinized and resuspended in a final volume of
o
PBS that will give about 1X10 cells/600 pi. The cells were then electroporated at
0.8 kV, 3 pF (time constant 0.1 sec) in the gene pulsar and plated at densities ranging
from 5xl06 to 2x105 cells per plate (40 plates in total).
G418 (200pg/ml) was added one day after electroporation and selection was
continued for 10 days. In total 238 neomycin-resistant colonies were picked and
grown up in 24 well plates. 166 colonies were frozen for further expansion while the
originals were used to obtain genomic DNA. Southern blotting with 3' and 5'
external probes were used to screen the colonies.
Southern blots
The neo cassette contains Xbal and Bglll sites, while the Nhel, Bsshll and another
Bglll site exists in the lines containing the mutation (created by mutagenesis). These
restriction sites were used to screen the embryonic stem cell lines obtained after
electroporation. First all ES cell clones (103) were screened using the 3' flanking
probe thereafter the positive ones were further checked using the 5' flanking probe.
The Hindlll-Xbal 3' probe was the same as in the case of the DelValine targeting
vector. The 5' probe (-500 base pairs) was PCR amplified using primers Swap 5'
probe 1 and 2 and subclone pNR2B-13/SacI as the template. The probes were
labelled using RediprimeIM II random prime labelling system and used for probing
the filter containing the genomic DNA samples as described in materials and
methods.
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Southern BlotNR2A SWAP Using 33 Probe
Figure 53. Southern Blot using Xbal digest and the 3' probe.
The photo on the top is the gel picture, while the one at the bottom is the blot after exposure.
The ES cell clones are indicated on the top. C stands for CaMKII clones, A for NR2A clones.
After digesting with Xbal and probing with the 3' probe I obtained a 5 kB wild type and a 2.5
kB homozygous band in the correct clones. 3' positive clone was NR2A 2-20.
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Figure 54. Southern Blot EGK 19 using Bglll digest and the 5' probe.
The photo on the top is the gel picture, which was run further until the 5 kB marker ran right
to the bottom so that I had better separation of the top bands. The photo at the bottom is the
blot after exposure.
The 5' positive ES cell clone NR2A 2-20 clearly showed the wild type and the homozygous
bands.
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The wild type genomic DNA digested with Xbal and hybridised with the 3' probe
gave a 5 kB band, while the mutant lines with correct homologous recombination
yielded a 2.5 kB band as in the case of the previous, DelValine mutation (Figure 19).
In the Southern Blots 10 pg wild type and targeted genomic DNA was digested with
high concentration Xbal restriction enzyme and run on a 0.8% agarose gel. The
samples were transferred onto nitrocellulose (Hybond™-N) and crosslinked to the
filter using UV. The filter was prehybridized at 65 °C for 4 hours then probed at 65
°C overnight. After washing the filter it was wrapped in Sarah wrap, placed into a
cassette with Kodak X-ray film over it and was left at -80 °C to expose. In the
following figures southern blots (of the positive clones) using the 3' probe are
demonstrated alongside with the gel photos (Figure 53).
The gDNA was then digested with Nhel and probed with the 5' probe. I got a -14-15
kB band for WT clones, which was previously approximated by doing a southern
blot on wild type genomic DNA. The mutant band was smaller due to the extra Nhel
site created by mutagenesis for mutants with correct homologous recombination. 10
pg wild type and targeted genomic DNA was digested with high concentration Bglll
restriction enzyme and run on a 0.75% agarose gel. The samples were treated in the
same manner as in the case of the 3' probe. Cell line NR2A 2-20 was identified
correctly targeted. In the next figure the southern blot (of the positive clone) using
the 5' probe is demonstrated alongside with the gel photo (Figure 54).
The only correctly targeted clone was NR2A 2-20. The 24-well plate containing the
frozen clone was defrosted and treated as usual described in materials and methods.
The cells however didn't start multiplying therefore I couldn't recover the clone.
Another round of ES cell targeting is needed to be done to get more positive clones
to be used for chimaera generation.
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Chapter 4: Discussion
Scientists' attention and interest has always been drawn to subjects that are relevant
to the health of the human being. With the development of various laboratory
techniques such as gene manipulation, cloning or the possibility to duplicate in vivo
processes in vitro, neuroscience and genetics now has a very important impact on
medicine and consequently on the individual cases of millions of patients. To find
out the underlying mechanisms of pain, the core processes in the development of
cancer or, like in our research, to map the molecular interactions involved in learning
and memory to help people suffering from neurodegenerative diseases, is an exciting
challenge. Here we discuss our results obtained by generation of transgenic animals
that have genetically manipulated NMDA receptors. The obvious question is why the
NMDA receptor is so interesting. In many neurological and psychiatric conditions
the contribution of the NMDA receptor, especially its NR2B subunit plays a very
important role. Therefore, the use of various NMDA receptor mutations should
generate useful data to then develop novel treatments.
The involvement of the NMDA receptor in Parkinson's disease seems more and
more apparent. In animal studies where 6-hydroxydopamine lesion is used to imitate
and produce the syndromes of Parkinson's, the NR1 and NR2B subunit expression is
decreased (Dunah et al., 2000) and tyrosine phosphorylation of NR2B is decreased.
Ifenprodil selectively blocks NR2B containing receptors and if rats with induced
Parkinson's are treated then their locomotor activity significantly increases (Nash et
al., 1999). Using levadopa, the decrease in the subunit expression and
phosphorylation can be reversed (Oh et al., 1998). In another study the levadopa
treatment induced hyperphosphorylation of NR1 on serine and of NR2A and NR2B
on tyrosine residues (Dunah et al., 2000; Hallett et al., 2005). CP-101,606, a selective
antagonist of the NR2B containing NMDA receptors had antiparkinsonian effects on
levadopa-induced symptomes by decreasing locomotor disfunction (Steece-Collier et
al., 2000). Amantidine, a non-competitive NMDA antagonist, also has anti-
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parkinsonic properties providing further evidence for the involvement of the NMDA-
connected synaptic plasticity in the development of the disease.
In Huntington's chorea there is also evidence for the involvement of the NMDA
receptor. The NR1 and NR2B containing receptors show an increased current (Chen
et al., 1999) and both NR1/NR2A and NR1/NR2B receptors produce an increased
level of excitotoxic cell death upon glutamate stimulation when coexpressed with the
mutant huntingtin protein (Zeron et al., 2001). Hypofunction of the NMDA receptor
system produces schizophrenia-like psychotic state in healthy individuals (Olney et
al., 1999). Specifically, upregulation of the NR2B subunit appears to mediate the
disease (Grimwood et al., 1999). The NR2B subunit of the NMDA receptor is also
involved in pain (Chizh et al., 2001). Overexpression ofNR2B in forebrain increased
the paw-licking behaviour in rats upon peripheral formaline injection (Wei et al.,
2001). After producing hindpaw inflammation using complete Freund's adjuvant,
NR1, NR2A and NR2B mRNA levels were upregulated (Miki et al., 2002). The
NR2B subunit expression is also involved in chronic ethanol exposure suggesting a
role in alcohol tolerance, dependence and withdrawal (Nagy, 2004).
In some previous NMDA receptor mutants complete analysis of the animals was not
possible because the homozygous mice didn't survive (Forrest et al., 1994;
Kutsuwada et al., 1996; Sprengel et al., 1998). The NR1 knockout mice died 8-15
hours after birth due to respiratory failure (Forrest et al., 1994). While the overall
neuroanatomy in these animals was normal, the NR1 expression was abolished and
the NR2B expression was reduced. The condition could be rescued by ectopic
expression of NRl-la suggesting that the viability is dependent on the level of
expression (Forrest et al., 1994; Li et al., 1994; Iwasato et al., 1997). The NR2B
knockout mice died perinatally as a result of an impairement in the suckling response
(Kutsuwada et al., 1996). Their cardiovascular and respiratory systems were normal,
the trigeminal neuronal pattern formation however was impaired (Kutsuwada et al.,
1996). The NR2B C-terminal deletion mice also died perinatally. The cause of
lethality was suggested to be the lack of protein-protein interactions (Sprengel et al.,
1998). The NR2B protein level was decreased by about half, the intracellular
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signalling was impaired due to the missing domain and the clustering and synaptic
localization of the receptor was impaired (Sprengel et ah, 1998; Mori et ah, 1998).
The various NR2A mutants are viable (Sakimura et ah, 1995; Sprengel et ah, 1998).
Based on these findings, the NR1 and NR2B subunits are thought to play a major
role in development, viability, neuronal pattern formation and synaptic plasticity.
The aim of this project was to generate novel mutations in the NR2B subunit of the
NMDA receptor, specifically in the C-terminal region, ones which disrupt crucial
interactions with downstream molecules, but that conserve viability at the same time,
to give us the possibility of a thorough analysis.
One of the important molecular interactions involves the E-S/T-X-V motif located at
the extreme C-termini of the NR2 subunits. This sequence binds the PDZ domain
containing MAGUK proteins such as PSD-95, chapsyn-110 or SAP 102. These
further interact with nNOS (Holscher et al., 1997), fyn (Grant et al., 1992) or
SynGAP (Chen et ah, 1998). Deleting the terminal valine from the binding motif was
a candidate for disrupting the interaction of NR2B with PDZ domains without
affecting normal expression levels of the protein still producing viable mice. In vitro
data generated in the laboratory by Dr Holger Husi showed that the valine deletion
does in fact disrupt the interaction with PSD-95.
As we predicted the NR2B DelValine homozygous mice were in fact viable and
although they had a severe phenotype, they survived to adulthood. The homozygous
DelValine mice (J9 or 10 Figure 39 and 40) were runted, appeared smaller than the
other littermates when born, their fur was ruffled and the right eye looked small, half
closed. By about week 10 they more or less caught up in weight, but developed
dermatitis-type skin condition, started scratching and had inflamed eyes and sore
ears. This was seen in 21 of the 25 homozygous animals. The heterozygous
offsprings showed no apparent phenotypic difference from the wild type littermates.
Tests to monitor the body weight of the mice from birth to about 10 weeks old to
quantify the differences and make conclusions based on statistical analysis have to be
done after obtaining mice in sufficient number.
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The homozygous offsprings were set up to breed to check their fertility. A male
homozygous mouse was intercrossed with an NR2Aac female. The aim of this cross
apart from the fertility check was to obtain mice that have no C-terminal interactions
of the NR2B subunit (because of the valine deletion) and of the NR2A subunit either
(deletion of the C-terminus). We obtained both male and female offsprings from this
intercross (Table 7), which were set up in an intercross to produce the mice
explained. We can therefore conclude that the mice carrying the DelValine mutation
are fertile and that DelVal 8-8/ NR2Aac double heterozygous mice are viable. Since
the NR2Aac and the NR2B DelValine homozygotes are both viable and we
hypothesized that the viability is connected to the non-MAGUK interactions of the
NR2B C-terminus, we could expect the double homozygous offsprings to survive,
too.
While the full analysis of this mutant needs to be carried out, preliminary
electrophysiological data on the DelValine mice produced in collaboration with Dr
Thomas J O'Dell at the University of California showed reduced LTP compared to
wild type using two different induction protocols (Figure 55 and 56). The same
reduction can be observed in the case of the NR2Aac mice (Figure 5), but in a
frequency-dependent manner (only in the 5Hz/3 min protocol). This suggests that
NR2B was in fact prevented from binding to PSD-95, which in turn prevented
coupling to SynGAP. The impaired CA1 LTP observed in SynGAP knockout mice
(Komiyama et al., 2002) therefore might be dependent on that interaction. If that is
so, we would expect that spatial learning will be impaired in our mutant as it was
observed in the case of the SynGAP knockouts.
In the NR2B knockout mice the lack of CA1 LTD was reported (Kutsuwada et al.,
1996). Since the NR2B C-terminal deletion mice were not viable and no such tests
were done in the SynGAP mice either, the DelValine mutants could provide further
evidence for the involvement of the particular subunit and the importance of the
MAGUK or non-MAGUK interaction in the induction of LTD.
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o Wild-type (n = 8 mice)
• NR2BAV (n = 6 slices, 2 mice)
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Figure 55. Electrophysiological data of NR2B DelValine mice using the 5Hz/3 min protocol.
Hippocampal slices obtained from wild-type and NR2B DelValine mutant mice were
prepared using standard techniques. Slices were maintained in interface-type chambers
(Fine Science Tools Inc., Foster City, CA, USA) and continuously perfused (at 1 - 2 ml/min)
with warm (30 °C), oxygenated ACSF for at least 1 hour prior to an experiment. All
recordings were performed in interface-type cambers.
After obtaining a stable, 20 minute long period of baseline synaptic transmission LTP was
induced (at time = 0) by a single 30 second long train of 5 Hz stimulation (150 pulses). The
average of fEPSPs evoked 40 - 45 minutes post 5 Hz stimulation was used for statistical
comparisons (Student t-tests) between wild type and NR2B DelValine mutant mice. The LTP
of the mutant mice is significantly reduced compared to wild type. The data was produced by
collaborator Dr Thomas J O'Dell.
In the barrel cortex of the NR1 knockouts and the NR2B C-terminal deletion mutants
there are no barrel boundaries formed, the cells are distributed uniformly (Iwasato et
ah, 2000; Sprengel et ah, 1998; Mohrmann et ah, 2002). This shows that the NMDA
receptor activity is required to form maps in the somatosensory cortex. If the barrel
formation is dependent on the MAGUK protein interactions of the NR2B subunit
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Figure 56. Electrophysiological data of NR2B DelValine mice using the 2X100 Hz protocol.
Hippocampal slices were prepared, maintained and experiments were conducted as
described before.
At time = 0 LTP was induced by two 1 second long trains of 100 Hz stimulation (inter-train
interval = 10 seconds). The LTP of the mutant mice is reduced compared to wild type in this
induction protocol as well. The data was produced by collaborator Dr Thomas J O'Dell.
The viability of this mutant suggests that the lethality seen in the NR2B C-terminal
deletion mice (suggested to be due to the lack of protein-protein interactions) is not
connected to the interaction with the MAGUK proteins via the NR2B C-terminus. It
is more likely that interactions with the non-MAGUK proteins (such as CaMKII),
binding to other sections of the C-terminus rather than the E-S/T-X-V motif, play an
important role in determining viability. The disrupted clustering and synaptic
localization of the receptors, observed in the NR2B C-terminal deletion mice (Mori
et ah, 1998), needs to be checked in the NR2B DelValine homozygous mutants as
well. Since the PSD-95 mediated enhancement of NMDA receptor clustering and
inhibition of NR2-mediated internalization (Kim et al., 1996; Roche et al., 2001) is
blocked by the interruption between PSD-95 and the NR2B subunit of the NMDA
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receptor in the NR2B DelValine mice, we can expect similar results that were
described in the NR2B C-terminal deletion mutants. The disruption of the NR2B-
PSD-95 interaction can be confirmed by immunoprecipitation and subsequent
immunoblotting.
Although much is needed to be done to properly characterise this mutant, we made a
very important step forward to understand how molecular interactions within the C-
terminal domain of the NR2B subunit affect the function of the NMDA receptor by
generating viable mutants.
The second mutation was aimed to prevent the binding between NR2B and another
highly researched molecule, Ca -calmodulin-dependent protein kinase II, a
serine/threonine kinase that has been proposed as a molecular switch for memory
storage (Lisman, 1985; Lisman et ah, 2002). Previously it was shown that the
induction of LTP was followed by an increased autonomous activity of CaMKII
(Fukunaga et ah, 1993) and an increase in autophosphorylation (Fukunaga et ah,
1995; Barria et ah, 1997; Lengyel et ah, 2004). However a recent report indicates
that there is only a transient increase in autonomous activity, but a persistent increase
in autophosphorylation (Lengyel et ah, 2004) suggesting that instead of maintained
autonomous activity, molecular interactions might be important for the expression of
LTP.
Postsynaptic calcium influx results in the binding of Ca2+/CaM and the activation of
CaMKIIa. In this active state neighbouring CaMKIIa subunits can phosphorylate the
Thr 286 residue, which enables the molecule to remain activated even after
1 • • 2"b • •
dissociating from Ca /CaM, its activator (Miller et ah, 1988; Lou and Schulman,
1989). Further sites then become autophosphorylated in the Ca2+/CaM binding
• • 2"hdomain of CaMKII blocking Ca /CaM reassociation. Thr 286 autophosphorylated
CaMKIIa is persistently active, translocates to the PSD, binds directly to the NMDA
receptor (Strack and Colbran, 1998; Leonard et ah, 1999; Bayer et ah, 2001) and is
necessary for NMDA dependent LTP induction but only at certain synapses such as
Schaffer commissural synapses in CAl region (Giese et ah, 1998; Cooke et ah,
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2006). AP-5 blocks the glutamate-induced translocation, which suggests that NR2B
is necessary for normal function and targeting of CaMKII to the PSD (Shen and
Meyer, 1999).
Various mutations have been analysed to test the effects of the disrupted CaMKII-
NMDA interaction and CaMKII autophosphorylation, which gave further importance
to the production of the proposed novel mutants. In CaMKIIa knockout mice
deficient CA1 LTP was observed in the initial experiments (Silva et al., 1992a)
however in a later study a significantly reduced LTP was shown which was
suggested to be due to the compensatory action of CaMKIip (Hinds et al., 1998). In
CaMKII T286A autophosphorylation deficient mutants no NMDA receptor
dependent LTP was observed (after P9), while LTD was unaffected (Giese et al.,
1998; Yasuda et al., 2003). In a recent study it was shown that switching NR2B-
containing NMDA receptors, which have high affinity to CaMKII, to NR2A-
containing receptors with low affinity to CaMKII reduces LTP in hippocampal slices
(Barria and Malinow, 2005). In these transfection studies it was also shown that
mutations in the NR2B subunit (NR2B RS/QD) that reduce the association with
CaMKII prevent LTP (Barria and Malinow, 2005). To produce mice with similar
modifications as in this particular study and obtain in vivo data is an exciting option
to take these investigations one step further.
The viability of the NR2B DelValine mutant suggests that the lethality seen in the
NR2B C-terminal deletion mice is not connected to the interaction with the MAGUK
proteins via the C-terminus. The NR2B CaMKII mutants could provide evidence
whether it is the interaction with the non-MAGUK protein CaMKII that determines
viability. If they are however viable electrophysiological experiments could be
conducted to produce further evidence for the involvement of the association
between NR2B and CaMKII in some forms of synaptic plasticity.
Apart from testing the NR2B CaMKII mutants in the widely used Morris water
maze, various other learning tasks (provided that the mice are viable), such as cued
fear conditioning or contextual fear conditioning can be used. It can be potentially
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interesting to intercross the NR2B CaMKII homozygous mutants with CaMKII
T286A mutants in the view of some recent studies challenging the proposal that
CaMKII autophosphorylation is essential in long term memory formation (Discussed
in the next paragraphs.). This will result in achieving a prevention of binding via
• • • • • • 2"bboth the substrate binding site, which is proposed to be reversible and Ca /CaM-
dependent, and the T286-site as well, where a persistent interaction is suggested to be
formed (Bayer et al., 2006).
When tested in the Morris water maze the T286A mutants showed impaired spatial
long term memory formation (Giese et al., 1998), but this might have been due to
their inability to learn the task as suggested by a recent study (Irvine et al., 2005). In
these experiments CaMKII T286A mutant mice were tested in different
hippocampus- and amygdala-dependent learning tasks, such as passive avoidance
task, cued fear conditioning and contextual fear conditioning. After a single training
trial the mutants didn't, but after massed training protocol they did form LTM (Irvine
et al., 2005) suggesting a dissociation between LTP (T286A mutants are deficient in
CA1 LTP.) and LTM in certain protocols. CaMKII autophosphorylation however is
needed for LTM formation after a single trial (Irvine et al., 2005). By testing the
NR2B CaMKII mutants and the double mutants in these tasks we could provide
further insight into the bases of LTM formation. It could be interesting to see
whether we observe any differences between the mutants in the massed training
protocol induced long-term memory.
Binding of CaMKII to NR2B can occur in two distinct ways. One is the enzyme-
substrate binding via the catalytic (active) site of CaMKII resulting in the
phosphorylation ofNR2B Serine 1303, the other via the non-catalytic site ofCaMKII
which results in the localization of CaMKII to the PSD (Leonard et al., 1999; Strack
et al., 2000; Bayer et al., 2001; Bayer et al., 2006). In the substrate binding site
residues 1290-1309 of the NR2B subunit are critical for binding to CaMKII (Leonard
et al., 1999). In this region Lys 1292, Leu 1298, Arg 1299, Arg 1300, Glu 1301 and
Ser 1303 have been identified essential for binding by site directed mutagenesis
(Strack et al., 2000). Phosphorylation of Ser 1303 inhibits binding to CaMKII. Based
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on these data we mutated three amino acids, the leucine 1298 to alanine, the arginine
1300 to glutamine and the serine 1303 to asparagine in the CaMKII binding region of
the NR2B subunit by which we aimed to prevent the interaction between the two
molecules. Blastocyst injections were done using two clones, CaMKII 1-6 and
CaMKII 4-12 and we obtained one chimaera from cell line CaMKII 1-6. Further
injections are needed to achieve germline transmission.
The third mutation, the NR2A/NR2B COOH exon swapping mutation, was designed
based on the observations that the NR2A and NR2B subunits of the NMDA receptor
have distinct binding partners, are differentially phosphorylated on their tyrosine and
serine residues and through these, they are involved in distinct signalling and
physiological processes. The following are a few examples. NR2A-containing
NMDA receptors promote, while NR2B-containing receptors inhibit the surface
expression of GluRl (Kim et al., 2005). Developmental replacement of the NR2B
subunits by NR2A in the cerebellum during granule cell maturation is crucial for
normal motor coordination (Schlett et al., 2004). NR2B subunit expression is
increased in cultured hippocampal and cortical neurones after chronic ethanol
exposure suggesting a role in alcohol tolerance, dependence and withdrawal (Nagy,
2004). Another example is the possible involvement of these subunits in governing
the direction of synaptic strength (Discussed in the next paragraphs.). Deleting the
COOH-exon of the NR2B subunit and replacing it by that of the NR2A can highlight
the importance of the NR2B subunit in development, viability, neuronal pattern
formation and synaptic plasticity and can also to tell whether the interactions
mediated by the NR2A C-terminus can rescue the lack of the NR2B subunit C-
terminus. The mutation can show the importance of the interactions mediated via the
NR2B cytoplasmic tail.
Two hypotheses have been proposed to explain what is governing the direction of
synaptic strength, whether it is LTP or LTD elicited. One is that the magnitude and
time course of the postsynaptic calcium entry is crucial, with LTP being triggered
after a brief increase in intracellular Ca2+ concentration with a high magnitude, while
9+
LTD expressed after a prolonged low rise in intracellular Ca concentration (Bear
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and Malenka, 1994; Cummings et al., 1996; Yang et al., 1999). In the other
explanation it is proposed that the induction of LTP or LTD is connected to the
subunit composition of the NMDA receptor (Liu et al., 2004; Massey et al., 2004). In
the hippocampus both NR2A and NR2B subunit-dependent signalling is implicated
in long-term synaptic plasticity (McHugh et al., 1996; Kohr et al., 2003). It has been
suggested that the NR2A containing NMDA receptors are important in the induction
of LTP while NR2B containing receptors are important for LTD in the hippocampus
(Liu et al., 2004; Massey et al., 2004). These results were based on pharmacological
experiments using selective blockade of the particular subunits. Previous studies
however using NR2B overexpressing mice with enhanced CA1 LTP and long-term
memory suggested the contribution of NR2B subunits to hippocampal LTP and
learning (Tang et al., 1999). The contribution of the NR2B subunit to the induction
of LTP was also shown in NR2A knockout mutants, in mice lacking the C-terminus
of the NR2A subunit and in pharmacological experiments using NR2A blockers
(Kohr et al., 2003; Berberich et al., 2005; Weitlauf et al., 2005). In recent studies it
was also shown that NR2B is not involved in LTD induction (Bartlett et al., 2006;
Morishita et al., 2006) and it was suggested that it is more likely the mode of how the
intracellular Ca2+ concentration is increased to be responsible in governing the
direction of synaptic strength rather than the subunit composition of the NMDA
receptor.
The anterior cingulate cortex (ACC) has been suggested to play a role in remote fear
and spatial memory (Maviel et al., 2004; Frankland et al., 2004). Both NR2A and
NR2B subunits were shown to be important for LTP induction in the ACC and the
NR2B subunit was implicated in mediating contextual fear memory (Zhao et al.,
2005). The NR2A/NR2B COOH exon swapping mutation could supply invaluable
data to the importance of the particular subunits in the induction of LTP and LTD in
the hippocampus and other brain regions as well provided that the mice are viable.
The targeting vector for this interesting mutation is ready for electroporation and
further ES cell targeting is essential for obtaining positive clones. Once homozygous
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mice are produced a series of experiments (as described before) are possible to
conduct, if they are viable.
Additionally to obtain more insight into the process of how the particular NMDA
receptor subunits are involved in analgesia, pain, dependence and tolerance, we
could chronically treat the three types of mutant mice with morphine to achieve
dependence or tolerance and to screen for any alterations in the NR1/NR2 protein
levels. Differences in the response to pain after treatment (analysed by hot-plate or
tail-flick tests) can also be checked. By developing drugs, that act on the NMDA
receptor in a subunit and region specific manner in certain pain-related areas of the
brain, a new way of decreasing chronic pain can be developed other than with




Techniques related to manipulation of DNA
Preparation of miniprep DNA using Promega's Wizard Plus Minipreps DNA
Purification System
1. Inoculate one colony into a 3 ml LB media.
2. Incubate overnight at 37 °C providing appropriate aeration by shaking at 225
rpm.
3. Pellet 1.5 ml saturated culture in an eppendorf tube by spinning in picofuge
for 2 minutes (10000 g).
4. Decant supernatant.
5. Add the rest of the culture and spin again.
6. Take off supernatant using Gilson pipette.
7. Resuspend pellet in 200 pi Cell Resuspension Solution (50 mM Tris-HCl pH
7.5, 10 mM EDTA, 100 pg/ml RNase A) by vortexing.
8. Add 200 pi Cell Lysis Solution (0.2 M NaOH, 1% SDS) and invert 4 times to
mix.
9. Add 200 pi Neutralization Solution (1.32 M potassium acetate pH 4.8) and
invert 4 times to mix.
10. Spin at 14000 rpm for 5 minutes.
11. Transfer the plasmid DNA containing supernatant into an eppendorf tube
containing 1 ml ofDNA Purification Resin.
12. Invert 4 times to mix.
13. Insert a 2 ml syringe barrel into a Minicolumn and place it into an eppendorf
tube. Pour the DNA Resin mixture into the syringe. Insert the plunger and
press the solution through the Minicolumn.
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14. Remove the plunger and add 2 ml Column Wash Solution (80 mM potassium
acetate, 8.3 mM Tris-HCl pH 7.5, 40 qM EDTA, 55% ethanol). Insert the
plunger again and press the solution through the Minicolumn.
15. Remove the syringe and spin column at 14000 rpm for two minutes to get rid
of residual Column Wash Solution.
16. Transfer Minicolumn into a new eppendorf tube. Add 50 pi TE (10 mM Tris-
C1 pH 8.0, 1 mM EDTA) buffer and wait 1 minute.
17. Spin at 14000 rpm for 30 seconds.
18. Store plasmid DNA at -20 °C.
Preparation of midiprep DNA using Qiagen's Plasmid Midi Kit
1. Inoculate a few colonies into 50 ml LB media.
2. Incubate overnight at 37 °C providing appropriate aeration by shaking at 225
rpm.
3. Pellet the saturated culture in a Falcon tube by spinning at 3000 rpm for 15
minutes at 4 °C.
4. Decant supernatant.
5. Spin again for 2 minutes.
6. Take off supernatant using Gilson pipette.
7. Resuspend pellet in 4 ml buffer PI (50 mM Tris-HCl pH 8.0, 10 mM EDTA,
100 pg/ml Rnase A) by vortexing.
8. Transfer into Falcon 2059 tube.
9. Add 4 ml buffer P2 (0.2 M NaOH, 1 % SDS) and invert 4 times to mix.
10. Incubate at room temperature for 5 minutes meanwhile prepare QIA filter
cartridge.
11. Add 4 ml buffer P3 (3.0 M potassium acetate pH 5.5) and invert 4 times to
mix.
12. Pour mixture into the equilibrated cartridge and incubate for 10 minutes.
13. Prepare column by equilibrating it with 10 ml buffer QBT (750 mM NaCl, 50
mM MOPS pH 7.0, 15% isopropanol, 0.15% triton X-100).
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14. Press mixture through the cartridge into the column and allow the column to
empty by gravity flow.
15. Wash the column with 10 ml buffer QC (1 M NaCl, 50 mM MOPS pH 7.0,
15% isopropanol) twice.
16. Elute DNA with 5 ml buffer QF (1.25 M NaCl, 50 mM Tris-HCl pH 8.5, 15%
isopropanol).
17. Add 3.5 ml isopropanol and invert 4 times to mix.
18. Spin at 8000 rpm for 30 minutes at 4 °C.
19. Take off supernatant carefully.
20. Add 2 ml 70% ethanol.
21. Spin at 8000 rpm for 10 minutes at 4 °C.
22. Take off supernatant and air dry pellet.
23. Resuspend pellet in appropriate amount of TE (lOmM Tris-Cl pH 8.0, 1 mM
EDTA) buffer.
24. Store plasmid DNA at -20 °C.
Restriction digestion of DNA
1. Perform digests at 1 unit restriction enzyme per pg DNA, in reactions of 50-
100 pg/ml DNA.
2. Perform digests in lx restriction enzyme buffer for 1-2 hours at the
recommended temperature.
3. For vector linearization: Run approx 200 ng digest alongside uncut DNA on
a gel to check digestion. Optional: when digested, inactivate the enzyme by
heating to 70 °C 5 minutes in the water bath. If using for ligations with
phosphorylated insert, the vector must be dephosphorylated to prevent self-
ligation. Do this prior to purification. Otherwise, the linearised vector may
be purified by phenol: chloroform extraction and ethanol precipitation.
4. Otherwise: Purify DNA fragment of interest by electrophoresis on a 0.8 - 2%
agarose gel until the bands are sufficiently separated, and recover the relevant
DNA fragment from the gel.
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Dephosphorylation of vector DNA
Dephosphorylation of the vector 5' end must be performed to prevent self-ligation of
vector digested with only one restriction enzyme.
1. Directly following vector restriction digestion, add 3 units of calf intestinal
alkaline phosphatase (CIAP, Boehringer Mannheim) per pg vector DNA.
2. Incubate at 37 °C for 1 hour.
3. Then add 0.5 units CIAP per pg vector DNA.
4. Incubate for 15 minutes at 55°C.
5. Run the entire reaction on a 1% agarose gel to separate vector backbone from
stuffer fragment.
6. Recover the dephosphorylated vector from the gel, using phenol: chloroform
extraction method. CIAP-treated DNA requires 2x phenol: chloroform
extractions (Stratagene Catalogue) to separate the CIAP as it binds strongly to
the DNA.
Phenol: chloroform: isoamyl alcohol extraction of DNA
1. Estimate the volume of the DNA solution.
2. Add an equal volume of phenol: chloroform: isoamyl alcohol solution
(25:24:1).
3. Vortex (unless purifying genomic DNA, if so invert tube 6 times to minimize
shearing).
4. Spin at 14000 g for 3 minutes.
5. Remove aqueous top phase to a new tube.
6. Add an equivalent volume of TE (0.1 mM EDTA, 10 mM Tris-HCl pH 8) to
the phenol phase, vortex and spin again.
7. Remove the aqueous layer to a new tube to ensure maximum DNA recovery.
8. Ethanol precipitate the DNA.
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Ethanol precipitation of DNA
1. Estimate the volume of the DNA solution.
2. Add 3 M potassium acetate (pH 5.2) to a final concentration of 0.3 M.
3. Mix well.
4. Add 2 volumes -20 °C ethanol and mix the solution well. Store the solution in
the -70 °C freezer to allow DNA precipitation for 15-20 min or snap freeze in
liquid nitrogen.
5. Mix well.
6. Recover the DNA by spinning at 4 °C for 10 min at 14000g (10,500rpm SS-
35).
7. Carefully remove the supernatant
8. Fill the tube half way up with ice cold 70% ethanol and spin at 14000g for 2
minutes at 4°C (10 500rpm SS-35).
9. Carefully remove the supernatant.
10. Air-dry the pellet at room temperature.
11. Dissolve DNA pellet in the desired volume of TE.
12. After phenol: chloroform: IAA DNA extraction and ethanol precipitation,
DNA recovery should be above 80%.
Recovery of DNA from agarose gels (phenol method)
1. Excise DNA bands from the gel using a sterile blade.
2. Estimate volume and double with TE buffer. Melt at 65°C for 5-10 minutes.
3. Add 1 volume of Tris-buffered phenol at room temperature and mix by
inversion.
4. Centrifuge for 3 minutes at 10-12000 rpm.
5. Transfer aqueous phase to a new tube. Repeat phenol extraction step.
6. Centrifuge for 3 minutes at 10-12000 rpm.
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7. Transfer aqueous phase to new tube containing 0.1 volume of 4M lithium
chloride solution.
8. Mix by inversion; a white precipitate forms immediately.
9. Place tube on ice for 2 minutes.
10. Centrifuge for 3 minutes at 10-12000 rpm.
11. Transfer aqueous phase to new tube leaving behind a transparent pellet.
12. Add lpl of carrier (glycogen) and precipitate with 2.5 volumes of cold
ethanol.
13. Mix, leave at -70°C 5-10 minutes or snap freeze in liquid nitrogen and spin as
previously (10-12000 rpm) for 10 minutes.
14. Wash the pellet with 1ml 70% ethanol then dry under vacuum or air-dry.
15. Resuspend in 10-20pl of deionised water or TE buffer.
16. Check DNA recovery using the GeneQuant.
Recovery of DNA from agarose gels using BIO101 Geneclean Spin Kit
1. Excise DNA bands from the gel using a sterile blade and place it into a
Geneclean Spin Filter.
2. Add 400 pi Geneclean Spin Glassmilk. Melt at 65°C for 5-10 minutes. Invert
every minute.
3. Centrifuge for 2 minutes at 10-12000 rpm.
4. Empty tube and add 500 pi Geneclean Spin New Wash to the filter.
5. Centrifuge for 30 seconds at 10-12000 rpm then empty the tube.
6. Spin for 2 minutes to get rid of residual wash solution.
7. Place the Spin Filter into an empty Catch Tube and add 11 pi TE buffer.
Incubate for 1 minute and spin for 30 seconds at 10-12000 rpm.
8. Add an additional 11 pi TE buffer. Incubate for 1 minute and spin for 30
seconds at 10-12000 rpm.
9. Check DNA recovery using the GeneQuant.
10. Store the DNA at-20 °C.
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Ligation of insert and vector
1. Ligate vector and insert in reactions containing 50ng or lOOng vector. Vary
insert: vector ratios from 1:1 to 5:1.
2. Perform control reactions for each ligation:
• No insert DNA control - to assay for re-ligation of the digested vector.
• No DNA control - to monitor ligation reagents for contaminants.
• Competent cells only - check for contaminating plasmids.
• Without ligase - to monitor for background level.
3. Set up ligation reactions containing 3 units T4 DNA ligase (Promega) in lx
ligase buffer.
4. Incubate on ice, allowing ice to melt to room temperature overnight (or at
10°C overnight).
5. Transform competent E. coli cells with ligation mixture.
Preparation of chemical competent cells
1. Spread DH5a cells onto a bacterial plate from glycerol stock-solution kept at
-20 °C.
2. Incubate overnight at 37°C.
3. Inoculate a few colonies into a 50 ml LB media-containing beaker.
4. Incubate overnight at 37 °C providing appropriate aeration by shaking at 225
rpm.
5. Dilute the saturated culture 100X in to 10 ml of fresh LB media.
6. Incubate at 37 °C while shaking at 225 rpm until the optical density reaches
0.6-0.7.
7. Put on ice for 5 minutes.
8. Spin at 3000 rpm for 15 minutes in cold room.
9. Decant supernatant.
10. Spin at 3000 rpm for 5 minutes in cold room.
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11. Take off the rest of the supernatant using Gilson pipette.
12. Dissolve the pellet in 1 ml 10 mM CaCl2 solution by shaking then add up to
10 ml.
13. Put on ice for 1 hour.
14. Spin at 3000 rpm for 15 minutes in cold room.
15. Decant supernatant.
16. Resuspend pellet in 1 ml 10 mM CaCl2 solution.
17. Use 100 pi cell suspension per transformation.
Transformation of chemical competent cells
1. Add 5pl of DNA ligation mix to a lOOpl aliquot of competent cells or use
30ng DNA if growing up stock plasmid.
2. Incubate on ice for 20 minutes.
3. Heat shock the cells at 42°C for 1 minute to allow DNA uptake by the cells.
4. Incubate on ice for 5 minutes.
5. Add 900pl of SOC medium (1.5mL SOB base; 7.5pl 2M MgCl2; 30pl 1M
glucose) to the cells.
6. Shake tubes at 225rpm for 45 minutes at 37°C to allow expression of the
ampicillin resistance gene.
7. For vector stock transformations: spread 50-1 OOpl of the culture onto L-
agar plates containing appropriate antibiotics.
8. For ligation reactions: pellet cells by spinning at 3000rpm for 2 minutes;
resuspend cells in 100-200pl of the supernatant and plate out using lOOpl
stock.
Preparation of electro competent cells
1. Spread DH5a cells onto a bacterial plate from glycerol stock-solution kept at
-20 °C.
2. Incubate overnight at 37°C.
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3. Inoculate a few colonies into a 50 ml LB media-containing beaker.
4. Incubate overnight at 37 °C providing appropriate aeration by shaking at 225
rpm.
5. Dilute the saturated culture 100X by adding 2,5 ml solution to 250 ml of fresh
LB media.
6. Incubate at 37 °C while shaking at 225 rpm until the optical density reaches
0.6-0.7.
7. Put on ice for 30 minutes.
8. Pour solution into 4 Falcon tubes, each containing 45 ml.
9. Spin at 3000 rpm for 15 minutes in cold room.
10. Decant supernatant and add the rest of the culture solution.
11. Spin at 3000 rpm for 15 minutes in cold room.
12. Decant supernatant.
13. Spin at 3000 rpm for 5 minutes in cold room.
14. Take off the rest of the supernatant using Gilson pipette.
15. Dissolve the pellet in 5 ml 10% glycerol solution by shaking then add
glycerol up to 45 ml (per tube).
16. Spin at 3000 rpm for 5 minutes in cold room.
17. Decant supernatant.
18. Repeat step 15-17 once more.
19. Resuspend pellet into 150 pi of 10% glycerol solution/tube.
20. Merge the contents of the four tubes.
21. Aliquot solution into 0.5 pi eppendorf tubes, 40 pi each.
22. Snap freeze tubes in liquid nitrogen.
23. Store at -80 °C.
Transformation of electro competent cells
1. Thaw an aliquot of electro competent cells on ice.
2. Add 5pl of DNA ligation mix to a 40pl aliquot of competent cells or use
30ng DNA if growing up stock plasmid.
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3. Put cell-DNA mixture into prechilled Gene Pulser (BioRad) cuvettes.
4. Electroporate at 25 pF, 200 Q, 2,5 kV.
5. Add 900pl of SOC medium (1.5mL SOB base [2% tryptone, 0.5% yeast
extract, lOmM NaCl]; 7.5pil 2M MgCE; 30pl 1M glucose) to the cells.
6. Shake tubes at 225rpm for 45 minutes at 37°C to allow expression of the
ampicillin resistance gene.
7. For vector stock transformations: spread 50-1 OOpil of the culture onto L-
agar plates containing appropriate antibiotics.
8. For ligation reactions: pellet cells by spinning at 3000rpm for 2 minutes;
resuspend cells in 100-200pl of the supernatant and plate out using lOOpl
stock.
Sequencing reaction for automated sequencer
1. Prepare the reaction mixture in total of 10 pi.
• 0.5 pg DNA template
• 1 pi of 3.2 pmol/pl primer
• 4 pi Big Dye Terminator Ready Reaction Mix
• dFBO up to 10 pi
2. Add a drop ofmineral oil to tube.
3. Run sequencing reaction.
• 96 °C, 30 seconds
• 50 °C, 15 seconds
• 60 °C, 4 minutes
• Repeat 25 times.
4. Add 10 pi dF^O to reaction mixture and remove from under the mineral oil.
5. Add 2 pi 3 M sodium acetate pH 4.6 and 50 pi 95% ethanol.
6. Mix and incubate on ice for 15 minutes.
7. Spin at 14000 rpm for 20 minutes increasing the speed gradually.
8. Remove the supernatant using Gilson pipette.
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9. Add 120 pi 70% ethanol.
10. Spin at 14000 rpm for 5 minutes.
11. Remove supernatant.
12. Air dry pellet.
13. Resuspend pellet in 4 pi ABI loading buffer (deionised formamide and 25
mM EDTA pH 8.0 containing 50 mg/ml Blue dextran in a ratio of 5:1
formamide to EDTA/Blue dextran).
14. Sequence in ABI PRISM 310 Genetic Analyzer.
Southern Blot
Preparation of filter
1. Digest genomic DNA with the appropriate high concentration enzyme
overnight.
2. Add a small amount of extra enzyme and further incubate for 6-8 hours to
ensure complete digestion.
3. Run samples on an agarose gel containing no ethidium bromide at 12-18V
overnight.
4. Stain and photograph the gel as normal; do not forget to put a ruler by the
side of it.
5. Cut off one corner of the gel as an orientation marker.
6. Immerse the gel in 0.2N HC1 for 10 minutes then rinse with dEfO.
7. Immerse the gel in 0.5M NaOH; 1.5M NaCl for 45min. A change of
buffer is useful. Rinse with dfEO.
8. Immerse the gel in 1M Tris-Cl pH 7.4; 1.5M NaCl for 30min. A change
of buffer is useful. Rinse with dEBO.
9. Place the gel on a gel tank turned upside down, which was previously
covered with a layer of dfBO and Saran wrap in a way that no air bubbles
are present.
10. Cut a piece of nitrocellulose (HybondrM-N) to the same dimensions as the
gel and give it an orientation marker.
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11. Place the nitrocellulose carefully onto the gel making sure that no air
bubbles are trapped between the two.
12. Cut a piece of 3mm Whatman filter paper to the same dimensions as the
gel and place it on top.
13. Cut a stack of Kleenex paper to the same dimensions as the gel so that it
stands at 10-15cm high.
14. Place a gel tray on top of the stack and put a small weight on he top.
Leave overnight at room temperature.
15. Remove the sheets of paper with forceps, remove the filter crosslink the
DNA to the filter using UV.
Prehybridization
1. Prewarm the hybridization tube to 65 °C.
2. Prepare the prehybridization solution and put it into the tube.
• 27 ml of 6X SSC and 0.5% SDS
• 3 ml of 50X Denhardts (BSA, Ficoll, PVP)
• 300 pi of Salmon Testes DNA previously fragmented by boiling
at 100 °C for 5 minutes and placing it on ice for 2 minutes.
3. Soak the filter in 20X SSC and place it into the hybridization tube with
the DNA facing to the inside of the tube. Ensure that no air bubbles are
present between the tube and the filter.
4. Rotate at 65 °C for 4 hours.
Probing the filter
1. Dilute the DNA probe to be labelled to a concentration of 2.5-25 ng/45 pi
in TE buffer.
2. Denature the DNA by heating to 95-100 °C for 5 minutes in water bath.
3. Place the tube on ice for 5 minutes.
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4. Add the DNA to the reaction tube of Rediprime1M II, random prime
labelling system (Amersham Pharmacia).
5. Add 5 pi Redivue [32P] dCTP and mix.
6. Incubate at 37 °C for 10 minutes.
7. Add 5 pi 0.2 M EDTA to stop the reaction.
8. Add the reaction mixture to a ProbeQuant G-50 Microcolumn, which has
been previously prepepared (snap off bottom of column and spin at 3000
rpm for 1 minute.)
9. Spin column at 3000 rpm for 1 minute.
10. Denature the labelled DNA by heating to 95-100 °C for 5 minutes in
water bath.
11. Place the tube on ice for 5 minutes.
12. Add probe to hybridization solution.
13. Rotate at 65 °C overnight.
Washing the fdter
1. Leave the filter in the tube and discard the hybridization solution.
2. Rinse the filter with 65 °C wash buffer 1 (2X SSC, 0.5% SDS). Add 30
ml wash buffer 1 and rotate at 65 °C for 10 minutes.
3. Repeat step 2.
4. Add 30 ml wash buffer 2 (IX SSC, 0.25% SDS) and rotate at 65 °C for
15 minutes.
5. Discard wash buffer two and wash with buffer 3 (0.5X SSC, 0.1% SDS)
if background is still high.
6. Wrap filter in Saran wrap while still damp.
7. Place into a cassette and put Kodak X-ray film over it in the dark room.
8. Leave at -80 °C to expose.
9. Develop the film.
177
Preparation of high molecular weight (HMW) DNA from mouse tails
1. Earmark mouse at three weeks of age.
2. Cut half an inch of tail into 750 pi of tail buffer (50 mM Tris pH 8.0, 1 mM
EDTA, 1 mM NaCl, 1% SDS).
3. Add 30 pi of 10 mg/ml Proteinase K.
4. Mix and incubate in rotator at 55 °C overnight.
5. Add 20 pi of 30 mg/ml RNAse A and incubate in water bath at 37 °C for 1
hour.
6. Add 500 pi of phenol, mix and rotate overnight at 4 °C.
7. Spin in microfuge at 14000 rpm for 5 minutes.
8. Transfer aqueous top layer and interphase into new tube.
9. Add 500 pi of phenol: chloroform: isoamyl alcohol solution (25:24:1).
10. Rotate for 4 hours at 4 °C.
11. Spin in microfuge at 14000 rpm for 5 minutes.
12. Transfer aqueous top layer into new tube.
13. Add 500 pi of chloroform: isoamyl alcohol solution (24:1).
14. Rotate for 4 hours at 4 °C.
15. Spin in microfuge at 14000 rpm for 5 minutes.
16. Transfer aqueous top layer into new tube.
17. Add 1 ml of isopropanyl alcohol and invert to mix. Precipitation of fibrous
HMW DNA can be observed.
18. Spool DNA with a yellow tip and dip briefly into 70% ethanol.
19. Place DNA into 100 pi of TE pH 7.4.
20. Allow the DNA to resuspend overnight at 4 °C.
21. Store at 4 °C.
NR2Aac genotyping
1. Prepare the mastermix and dispense 48 pi per tube.
• 5 pi 1 OX buffer
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• 5 pi DMSO
• 1 |.il lOmMdNTP's
• 1 pi 40 pM primer RsplO
• 1 pi 40 pM primer Rsp 26
• 34.75 pi dH20
• 0.25 pi Qiagen Hot Star Taq added last after 2.5 minute UV zap of
mastermix.
2. To precipitate out SDS put tails on dry ice for 1 minute.
3. Spin at 14000 rpm for 15 minutes in cold room.
4. Place tubes on ice and take 2 pi from the top layer of each sample and add to
PCR reaction.
5. Run samples on Hybaid PCR machine.
• 15 minutes at 95 °C then
• 30 seconds at 94 °C
• 1 minute at 57 °C
• 3 minutes at 72 °C X 40 cycles.
NR2Bac genotyping
1. Prepare the mastermix and dispense 48 pi per tube.
• 5 pi 1 OX buffer
• 1 pi lOmMdNTP's
• 1 pi 40 pM primer NR2B-1
• 1 pi 40 pM primer NR2B-3
• 39.75 pi dH20
• 0.25 pi Qiagen Hot Star Taq added last after 2.5 minute UV zap of
mastermix.
2. To precipitate out SDS put tails on dry ice for 1 minute.
3. Spin at 14000 rpm for 15 minutes in cold room.
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4. Place tubes on ice and take 2 )li1 from the top layer of each sample and add to
PCR reaction.
5. Run samples on Hybaid PCR machine.
• 15 minutes at 95 °C then
• 20 seconds at 94 °C
• 30 seconds at 55 °C
• 1 minutes at 72 °C X 35 cycles then
• 10 minutes at 72 °C.
6. The homozygous band is 1311 bp, the WT band is 136 bp.
NR2B DelValine genotyping
Reaction using Qiagen Hot Star Taq
1. Prepare the mastermix and dispense 48 pi per tube.
• 5 pi 1 OX buffer
• 1 pi lOmMdNTP's
• 1 pi 40 pM primer 1
• 1 pi 40 pM primer 2
• 39.75 pi dH20
• 0.25 pi Qiagen Hot Star Taq added last after 2.5 minute UV zap of
mastermix.
2. To precipitate out SDS put tails on dry ice for 1 minute.
3. Spin at 14000 rpm for 15 minutes in cold room.
4. Place tubes on ice and take 2 pi from the top layer of each sample and add
to PCR reaction.
5. Run samples on Hybaid PCR machine.
• 15 minutes at 95 °C then
• 20 seconds at 94 °C
• 30 seconds at 65 °C
• 2 minutes at 72 °C X 35 cycles then
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• 10 minutes at 72 °C.
Long Range PCR
1. Prepare mastermix A.
• 20 pi dH20
• 0.6 pi 25mM dNTP's
• 2 pi 20 pM primer 1
• 2 pi 20 pM primer 2
2. Prepare mastermix B.
• 16 pi dH20
• 5 pi buffer 1
• 1 pi expand enzyme (Roche) was added after hot start of reaction.
3. To precipitate out SDS put tails on dry ice for 1 minute.
4. Spin at 14000 rpm for 15 minutes in cold room.
5. Place tubes on ice and take 2 pi from the top layer of each sample to 2 pi
of dH20.
6. Add 25 pi ofmastermix A, 20 pi of mastermix B, mix and start reaction.
7. Run samples on EppendorfPCR machine.
8. 30 seconds at 93 °C then pause and incubate at 93 °C for 15 minutes. Add
1 pi expand enzyme per sample. Restart reaction.
• 10 seconds at 93 °C
• 30 seconds at 60 °C
• 2 minutes at 65 °C X 10 cycles then
• 10 seconds at 93 °C
• 30 seconds at 60 °C
• 2 minutes at 65 °C with 20 seconds of increment X 20 cycles then
• 7 minutes at 68 °C.
Primers
A: NR2B 5910 A': SWAP NR2A 3924
B: pLox 413 B': pLox 91
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C: pLox 1540 C':pLoxl603
D: NR2B 6456 D': NR2B 8035
Analysis of results
NR2B DelVal genotyping





Wild Type Heternxygpus Homoxygous
AXB
Taq polymerase
NO AMPLIFICATION ~ 0.5 KB BAND
AMPLIFIED




NO AMPLIFICATION ~ 2.3 KB BAND
AMPLIFIED




NO AMPLIFICATION ~ 0.5 KB BAND
AMPLIFIED




NO AMPLIFICATION ~ 2.0 KB BAND
AMPLIFIED




~ 0.5 KB wt BAND
AMPLIFIED





~ 0.5 KB wt BAND
AMPLIFIED
~ 0.5 KB wt AND 2.3 KB
homo BAND AMPLIFIED
~ 2.3 KB homo BAND
AMPLIFIED
















The main supplier of tissue culture is Iwaki from Bibby Sterilin. Other suppliers
used are Falcon, Corning and Nunc.
150 cm2 Flasks IWAKI 1 ml Cryotubes NUNC
75 cm2 Flasks IWAKI 150 ml Tubes CORNING
25 cm2 Flasks IWAKI 15 ml Tubes CORNING
96 Well Plates IWAKI 30 ml Universals BIBBY STERILIN
48 Well Plates NUNC 150 mm Dishes IWAKI
24 Well Plates IWAKI 100 mm Petri Dish BIBBY STERILIN
12 Well Plates IWAKI 60 mm Petri Dish BIBBY STERILIN
6 Well Plates IWAKI 30 mm Petri Dish BIBBY STERILIN
4 Well Plates NUNC 1 Well IVF Dish FALCON
100 mm Dishes IWAKI Electroporation Cuvette BIORAD
100 mm Dishes NUNC Micro-pipett Tips ALPH
60 mm Dishes CORNING 12.5 cm2 Flasks FALCON
Media preparation
1XGMEM 380 ml
Non-essential Amino Acids 4 ml
Glutamine+Sodium Pyruvate 8 ml
B-Mercaptoethanol 400 pi
Foetal Calf Serum 40 ml
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All media should be prepared in the Class II cabinets using sterile technique. Once
the media has been prepared a TESTER should be set up (5ml of media should be
added to the 5ml tester) and incubated overnight to ensure sterility. Do not use media
ifmore than one month old.
Thawing embryonic stem cells
1. Place 9.5 ml of prewarmed media in a universal.
2. Retrieve cells from the liquid nitrogen. It is important that cells are thawed as
quickly as possible, this is done by placing them in the 37°C water bath.
3. Once they are thawed transfer cells to the warm media to dilute out the
DMSO in which the cells are frozen. The cells are transferred to the
universal using a plugged pasteur pipette.
4. Spin cells down in the bench centrifuge, at lOOOrpm for 5 minutes.
5. The media is then aspirated off very carefully to avoid disturbing the cell
pellet.
6. Resuspend cell pellet in 10 ml (or other adequate amount) of prewarmed
media gently, as they are very fragile at this stage.
7. Transfer to appropriate flask followed by gassing with a C02/air mixture
(5%/95%).
8. The cells are checked under the microscope and then placed in the incubator.
9. Cells should be thawed first thing in the morning and then the media should
be changed at the end of the day. This removes any dead cells and dilutes out
the rest of the DMSO.
Passaging embryonic stem cells
1. Draw off media using aspirator.
2. Add 5 ml of PBS down opposite side of the flask from the cells.
3. Wash cells then draw off PBS using aspirator.
4. REPEAT steps 2 + 3.
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5. Add 1ml of trypsin down opposite side of the flask (Use 0.5 ml trypsin for 1
well of a 6 well plate or 4 drops of trypsin for 1 well of a 24 well plate.).
Ensure trypsin covers cell monolayer. Recap flask and place in the incubator
for approx. 30 seconds*.
6. Tap flask to dissociate the cells.
7. Check under microscope to ensure cells have dissociated..
8. Add 4 ml of media for 1ml of trypsin. The media will stop the action of the
trypsin.
9. Transfer cells to a universal and spin down in the bench centrifuge. 5
minutes at 1200rpm.
10. Resuspend cells in 5 ml of media, pipetting up and down 2 or 3 times to
ensure a single cell suspesion. Count cells using haemocytometer.
11. Add 106 cells to a 25cm2 gelatinised flask. The number of cells added to
larger flasks should be adjusted accordingly.
A guide for quantity of media to the size of flask is as follows:
• 10 ml/25cm2 flask
• 30 ml/75cm2 flask
• 50 ml/150cm2 flask
1. For fibroblast cell lines use half the stated quantity of media.
2. For ES cells add 1 ul of LIF / ml of media in the flask to get a final
concentration of 1000 unit LIF/ ml media. Gas flask with 5%CC>2/95% air
mixture and close lid tightly. Return to incubator.
Freezing embryonic stem cells
1. Prepare freezing solution: 10% DMSO in culture media. (Add 2 ml of DMSO
to 18 ml of media to provide a stock solution.)
2. Trypsinise as for normal cultures.
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3. Once cells have dissociated resuspend in 8.5 ml culture media and place in a
universal.
4. Spin cells in bench centrifuge at 1200rpm for 5 minutes.
5. Aspirate off supernatant carefully to prevent disturbing the cell pellet.
6. Resuspend in appropriate volume of freezing solution. Mix gently.
7. Place 0.5ml cell suspension in cryotube, labelled with cell line name, passage
number, date, and your initials. The number of vials per flask is dependent
on the size of the flask:
• 25cm flask gives 2 vials
9 • •
• 75cm flask gives 4-5 vials
2 .
• 150cm flask gives 8-10 vials
8. Place the cryotubes in the -80°C freezer overnight and then transfer to
cellbank the following day.
Embryonic stem cell electroporation
1. 150pg of vector was linearised with NotI, precipitated, washed with 70%
ethanol and resuspended in 100 pi PBS the night before electroporation.
2. E14TG2a cells were grown up from frozen stock to yield ~ 5xl07 cells (4-6
n
#
large- 150 cm tissue culture flasks).
3. Trypsinise cells as usual and resuspend in 5 ml PBS per universal.
4. Combine cells and spin once more at 1200 rpm for 5 minutes.
5. Resuspend final pellet in a volume of PBS that will give about 1X10
cells/600 pi.
6. Using plugged pipette add cells to electroporation cuvette.
7. Add the 100 pi DNA solution and mix gently.
8. Place the cuvette in the gene pulsar and electroporate at 0.8 kV, 3pF. Time
constant should be 0.1 second.
9. Incubate mixture in cuvette at room temperature for 10 minutes.
10. Add 20 ml media and plate cells in 10cm tissue culture dishes at densities of
5x 106, 106, 5x10? and 10? cells per plate.
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11.G418 selection (200 pg/ml) was added one day after electroporation and
selection was continued for 10 days.
12. Pick a large number of colonies 10-12 days after electroporation and grow
them up in 24 well plates.
13. Split the confluent wells to generate one plate to freeze for later expansion of
cell line and a duplicate plate from which DNA was extracted for analysis by
Southern blotting.
Picking colonies
1. Add 2 drops of trypsin or media from plugged Pasteur into alternate rows of
96 well plates.
2. Choose well separated colonies and circle each on the underside of the plate.
3. Wash plate with PBS twice.
4. Add 5 ml PBS.
5. Use a p200 Gilson pipette set to 50 pi and pick up the colony by scraping it
off the plate and drawing it into the pipette tip.
6. Place the colony into the prepared 96 well plate and dissociate.
7. Transfer it into 1 well of a 24 well plate and add 1.5 ml media.




0.05M Tris-HCl pH 8
0.5% SDS
50pg/ml DNase-free RNase
Never vortex HMW DNA!
187
Large scale extraction:
1. Grow up 10 cells as a monolayer or in suspension as required. Yield from
8 •10 cells should be approximately 300pg.
2. For monolayer culture: decant the medium and rinse the cells twice in PBS.
Recover the cells by trypsinisation for ES cells. Quench trypsin with media
and transfer cells to 50ml Falcon tube.
3. For suspension culture: transfer cells to 50ml Falcon tube.
4. Centrifuge at 500 g for 10 minutes.
5. Resuspend cell pellet in 10ml PBS by gentle pipetting.
6. Centrifuge at 500 g for 10 minutes.
7. Resuspend cell pellet in 20 ml Extraction Buffer.
8. Add Proteinase K to 100 pg/ml and gently swirl the tube to mix the
components. Incubate the tube in the water bath for 3 hours, gently inverting
the tube every 20 minutes. Then put the tube on a roller or a wheel overnight
at RT (or 37 °C if possible). The solution should be reasonably clear and
viscous at the end of the incubation. More Proteinase K may be added to
achieve this (add more Proteinase K to 200 pg/ml and incubate again).
9. Transfer to a large beaker. Add 20 ml of pre-equilibrated phenol:
chloroform: IAA (first check pH = 8) and seal with parafilm. Gently swirl by
hand 10-15 min to mix the two phases. The larger the surface area available,
the easier this will be. Ideally you should achieve an emulsion at this stage.
10. Transfer the mixture to a 50 ml disposable plastic tube and centrifuge at 1500
g for 10 min at RT to separate the phases.
11. Remove the aqueous phase into a new tube using a cut-off (to widen the bore)
5 ml disposable pipette tip. Care must be taken not to disturb the interface and
when DNA is very viscous this is hard to achieve
12. Steps 8-10 should be repeated to accomplish at least three extractions. The
aqueous phase should be clear at this point.
13. Dialyse the aqueous phase against 1000 volume of TE. This should be
performed for 30 min at RT to prevent SDS precipitation in the sample
followed by overnight at 4°C. Allow room for expansion in dialysis bag.
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14. The absorbance of DNA at 260nm and 280nm should be measured using
Oft0
quartz cuvettes. The /280 ratio should be >1.8. If this is not the case, repeat
steps 4-9 adding additional SDS to 1%. An A260 of 1.0 in a 1cm light path is
equivalent of a DNA concentration of 50 pg/ml. Store the DNA at 4 °C.
15. An aliquot of the DNA should be analysed by electrophoresis through a 0.3%
gel agarose gel. Multimers of bacteriophage lambda or commercially
available DNAs can serve as mol wt markers. The prepared DNA is
normally at least 100 kb and preferably exceeds 200 kb.
Extraction from 24 well plate:
1. Use 500 pi of extraction buffer/well.
2. Extract overnight at 37 °C as normal.
3. Use 500 pi phenol then 500 pi phenol: chloroform: IAA for cleaning ofDNA.
4. Proceed as before and resuspend DNA in 100 pi TE buffer.
5B Primer Sequences
Name Sequence (51 to 3') Nucleotides Melting
Temperature
°C
DelValMut 1 CTTTCTAGTATTGAGTCTGATTAGCTAGC 53 78.5
TCGAGTGAGGGAAGAGAGAGAGAG
DelValMut 2 CTCTCTCTCTCTTCCCTCACTCGAGCTAG 53 78.5
CTAATCAGACTCAATACTAGAAAG
DelVal 1 GGAGACCACAACGGTTTCCCTCTA 24 69.9
DelVal 2 GGCAGGGGCGTCGAAAACAAGG 22 75.9
DelVal 3 CCCCCGACTCTTTCCGTGACAT 22 72.1
DelVal 4 CTTTGTTAGCAGCCGGATCG 20 66.7
DelVal I TCCCGCGAAATTAATACGATACA 23 66.2
DelVal II AACAAGTCCTCAGTGACCACTGCC 24 69.6
DelVal III GGCAGTGGTCACTGAGGACTTGTT 24 69.6
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Name Sequence (5' to 3') Nucleotides Melting
Temperature
°C
DelVal IV GGACAGACGCGGGAAGAAGAGAAC 24 71.8
DelVal V GTTCTCTTCTTCCCGCGTCTGTCG 24 72.7
DelVal VI CAAGACCCGTTTAGAGGCCCAAG 23 72.7
DelVal 358 GACCTAGTTGACAGACCCACGT 22 64.2
DelVal 3261 TTTCCCTCTGACCTTTTCTGCT 22 65.1
DelVal 6102 CAACAAAAACCCCAGGGC 18 65.2
DelVal 6211 CCCTCCCGCACCCACCTT 18 71.8
DelVal 6662 CCCCTCAGCAGATGCCAACC 20 71.2













NR2B 5'-1 CCTGGAATAGAAAGAGCACTGCCC 24 69.6
NR2B 5'-2 GGACCTAGTTGACAGACCCACGT 23 67.3
5 PGEX GGGCTGGCAAGCCACGTTTGGTG 23 78.5
3 PGEX CCGGGAGCTGCATGTGTCAGAGG 23 75.9
BAMC GGGCCCGGATCCCGGTATCTACAGCTG 42 86.0
TATCCACGGAGTAGC
CECO CCCGGGGAATTCTCAGACATCAGACTC 43 78.4
AATACTAGAAAGTTTC
DelVal 7897 GCTGCCCTGCCCTCCCCTCACACA 24 81.1
DelVal 7898 CTGCCCTGCCCTCCCCTCACAC 22 76.9
BAMC 1 GGGCCCGGATCCCCGGTATCTACAGCT 43 87.0
GTATCCACGGAGTAGC
BAMC 2 GGGCCCGGATCCCCAAGGACAGCTAA 45 92.9
AGAAGCGGCCAGCCTCGGC
CECO 2 CCCGGGGAATTCTCAGACATCAGACTC 43 76.6
AATACTAGAAAGTTTC
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Name Sequence (5' to 3') Nucleotides Melting
Temperature
°C
5' PROBE-1 CCTACCTGGAATGAATGTCTTT 22 60.7










DelVal 6121 TTTCAATGGCTCCAGCAATG 20 65.9
DelVal 6215 CAGCCCTATCCCTCCCGCACCCAC 24 78.9
pLOX 91 AAGCGCCTCCCCTACCCGGT 20 73.6
pLOX 1603 TGAAGGCTCTTTACTATTGCTTTATG 26 62.4
DelVal 8035 AGGATGTGACGTGAAGAGACAT 22 68.4
DelVal 5603 GCCCAGAAGAAGAATCGGAACAAA 24 69.8
CaMKII Mut-1 AAGGCCCAGAAGAAGAATCGGAACAAAG 84 95.0
CGCGCCAGCAGCACGACTACGACACCTT
CGTAGATCTTCAGAAGGAGGAGGCCTTG
CaMKII Mut-2 CAAGGCCTCCTCCTTCTGAAGATCTACGA 84 95.0
AGGTGTCGTAGTCGTGCTGCTGGCGCGC
TTTGTTCCGATTCTTCTTCTGGGCCTT
CaMKII-1 AGGCCCGGCCGCCTTGGCCCCAGGCA 30 93.5
GCGT
CaMKII-2 TCCGGGACTAGTCTAGTTCTTAAGTAGG 60 80.7
CAGCTAGCTCAGACATCAGACTCAATA
CTAGA
CaMKII-3597 GAAAGCAAAAGTTAAAGGGTGAAT 24 62.2
CaMKII-5148 AACAAAGGAGAACTCGCCTCAC 22 65.6
NR2A-COOH 1 CCCGGGCAGCTGCATCCATGGAGTGC 35 87.8
ACATTGAAG












PK-SPH 1 GGCCGCTAAAGCATGCATGTCTAGACT 50 88.9
AGAGTGGATCCGCGTGGGCTAGCTAG
GTTG
PK-SPH 2 TCGACAACCTAGCTAGCCCACGCGGAT 57 87.4
CCACTCTAGTCTAGACATGCATGCTTTA
GC




























SWAP 1929 AGCATTCAGAAGGACCAAGGAC 22 65.5
CECOA CCCGGGGAATTCTTAGACATCAGATTC 43 78.5
AATACTAGGCATTTTC
BAMCA-1 GGGCCCGGATCCCCGGCATCTACAGT 44 92.5
TGCATCCATGGAGTGCAC
BAMCA-2 GGGCCCGGATCCCCGCCACATGCCAC 48 90.0
AGGGGAGCCAGATAATAATAAG
NR2B-1 NEW CATTGCTTCATGGGTGTCTGTTC 23 67.6




NR2B 5910 TCAGTGCTTGCTTCACGGCAGC 22 73.9
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Name Sequence (5' to 3') Nucleotides Melting
Temperature
°C
pLOX 413 CCCAGAAAGCGAAGGAGCAAAG 22 69.9
pLOX 1540 TGGAAGGATTGGAGCTACGGG 21 69.2
pLOX 6456 CTCCTCTCCAGCCTCCCACACT 22 70.1
5C Genomic Sequences
NR2B sequenced area
Genomic Structure of NR2B C-terminus























Figure 57. Genomic structure of the NR2B C-terminus.
On the figure the M4 and the COOH exon of the NR2B subunit is indicated by green
rectangles. The various subclones are demonstrated by blue continuous lines. The
sequenced area is shown by a black continuous line. The most important restriction sites are
indicated.
In the following NR2B sequence (Figure 57 Sequenced area.) the M4 exon is
highlighted in yellow, the COOFI exon is highlighted in light blue. The CaMKII
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binding site (corresponding to residues 1290-1309) is shown in dark blue while the




























































































































































In the following NR2BA sequence the COOH exon is represented with some 5'
flanking sequence (containing the primer sequences) The COOH exon is highlighted
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